<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Front Psychiatry</journal-id><journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id><journal-title-group><journal-title>Frontiers in Psychiatry</journal-title></journal-title-group><issn pub-type="epub">1664-0640</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12098583</article-id><article-id pub-id-type="doi">10.3389/fpsyt.2025.1552992</article-id><article-categories><subj-group subj-group-type="heading"><subject>Psychiatry</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Underlying biological mechanisms of emotion dysregulation in bipolar disorder</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Durdurak</surname><given-names>Buse Beril</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2288386/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Morales-Mu&#x000f1;oz</surname><given-names>Isabel</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1252500/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>de Cates</surname><given-names>Angharad N.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Wiseman</surname><given-names>Chantelle</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Broome</surname><given-names>Matthew R.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/11303/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Marwaha</surname><given-names>Steven</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/834028/overview"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/supervision/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Institute for Mental Health, University of Birmingham</institution>, <addr-line>Edgbaston, Birmingham</addr-line>, <country>United Kingdom</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Coventry and Warwickshire NHS Partnership Trust</institution>, <addr-line>Coventry</addr-line>, <country>United Kingdom</country>
</aff><aff id="aff3">
<sup>3</sup>
<institution>Department of Psychiatry, University of Oxford</institution>, <addr-line>Oxford</addr-line>, <country>United Kingdom</country>
</aff><aff id="aff4">
<sup>4</sup>
<institution>East Birmingham Early Intervention in Psychosis Service, Birmingham Women&#x02019;s and Children&#x02019;s NHS Foundation Trust</institution>, <addr-line>Birmingham</addr-line>, <country>United Kingdom</country>
</aff><aff id="aff5">
<sup>5</sup>
<institution>Specialist Mood Disorders Clinic, The Barberry Centre for Mental Health, Birmingham and Solihull NHS Trust</institution>, <addr-line>Birmingham</addr-line>, <country>United Kingdom</country>
</aff><author-notes><fn fn-type="edited-by"><p>Edited by: Trine Vik Lagerberg, Oslo University Hospital, Norway</p></fn><fn fn-type="edited-by"><p>Reviewed by: Adrian Andrzej Chrobak, Jagiellonian University, Poland</p><p>Margherita Barbuti, University of Pisa, Italy</p></fn><corresp id="fn001">*Correspondence: Buse Beril Durdurak, <email xlink:href="mailto:b.durdurak@bham.ac.uk">b.durdurak@bham.ac.uk</email>
</corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>16</volume><elocation-id>1552992</elocation-id><history><date date-type="received"><day>29</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>3</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Durdurak, Morales-Mu&#x000f1;oz, de Cates, Wiseman, Broome and Marwaha</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Durdurak, Morales-Mu&#x000f1;oz, de Cates, Wiseman, Broome and Marwaha</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Difficulties with emotion regulation (ER) are a key feature of bipolar disorder (BD) contributing to poor psychosocial and functional outcomes. Abnormalities within emotion processing and regulation thus provide key targets for treatment strategies and have implications for treatment response. Although biological mechanisms and ER are typically studied independently, emergent findings in BD research suggest that there are important ties between biological mechanisms and the disturbances in ER observed in BD. Therefore, in this narrative review, we provide an overview of the literature on biological mechanisms underlying emotional dysregulation in BD including genetic and epigenetic mechanisms, neuroimaging findings, inflammation, hypothalamic-pituitary-adrenal (HPA) axis dysfunction, neuroplasticity and brain-derived neurotrophic factor (BDNF), and circadian rhythm disturbances. Finally, we discuss the clinical relevance of the findings and provide future directions for research. The continued exploration of underlying biological mechanisms in ED in BD may not only elucidate fundamental neurobiological mechanisms but also foster advancements in current treatment strategies and the development of novel targeted treatments.</p></abstract><kwd-group><kwd>bipolar disorder</kwd><kwd>emotion regulation</kwd><kwd>biological</kwd><kwd>mechanisms</kwd><kwd>underlying</kwd></kwd-group><funding-group><award-group><funding-source id="cn001"><institution-wrap><institution>National Institute for Health and Care Research
</institution><institution-id institution-id-type="doi">10.13039/501100000272</institution-id></institution-wrap></funding-source></award-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. All authors are supported by National Institutes of Health and Research (NIHR) Mental Health Translational Research Collaboration. MRB is also supported by Wellcome Trust (Grant Ref: 226603/Z/22/Z). The views expressed are those of the author(s) and not necessarily those of the NIHR, the Department of Health and Social Care or the Wellcome Trust. The funding organizations had no role in the design and conduct of the&#x000a0;study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</funding-statement></funding-group><counts><fig-count count="0"/><table-count count="0"/><equation-count count="0"/><ref-count count="303"/><page-count count="17"/><word-count count="7945"/></counts><custom-meta-group><custom-meta><meta-name>section-in-acceptance</meta-name><meta-value>Mood Disorders</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Bipolar Disorder (BD) is a common and highly debilitating condition with recurrent mood episodes and subsyndromal mood symptoms (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). Most contemporary treatment guidelines are designed around an episodic model of BD, emphasizing the management and prevention of acute episodes (<xref rid="B3" ref-type="bibr">3</xref>). However, mood in people with BD is often labile (<xref rid="B1" ref-type="bibr">1</xref>) and can fluctuate considerably even when euthymic (<xref rid="B4" ref-type="bibr">4</xref>), in contrast to the classical episodic presentation (<xref rid="B5" ref-type="bibr">5</xref>).</p><p>Emotion Dysregulation (ED) is a multidimensional transdiagnostic construct encompassing a wide range of mental disorders (<xref rid="B6" ref-type="bibr">6</xref>). In the literature, the term has been used interchangeably with mood instability, affective lability, affective dysregulation, and mood swings (<xref rid="B7" ref-type="bibr">7</xref>&#x02013;<xref rid="B9" ref-type="bibr">9</xref>). Although no agreed-upon definition of the conceptual core of ED exists (<xref rid="B10" ref-type="bibr">10</xref>), one definition is that ED is defined as patterns of emotional experience and expression that interfere with goal-directed activity (<xref rid="B11" ref-type="bibr">11</xref>). Emotion regulation (ER) strategies are generally classified as adaptive or maladaptive based on their effectiveness and their positive or negative effects on mood (<xref rid="B12" ref-type="bibr">12</xref>). Difficulties in managing negative emotions, along with the use of maladaptive coping mechanisms like catastrophizing, self-blame, and rumination, are linked to higher rates of mental health issues (<xref rid="B12" ref-type="bibr">12</xref>), including BD (<xref rid="B13" ref-type="bibr">13</xref>).</p><sec id="s1_1"><title>Emotion dysregulation in bipolar disorder</title><p>People living with BD may have difficulties in ER across various dimensions regardless of current mood episodes (<xref rid="B14" ref-type="bibr">14</xref>). ER difficulties in patients with BD may then result in emotional extremes and mood instability, eventually contributing to the episodic mood states of the condition (<xref rid="B15" ref-type="bibr">15</xref>&#x02013;<xref rid="B18" ref-type="bibr">18</xref>). ED contributes considerably to functional impairments and relapse risk (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>). For example, ED may increase the severity of manic symptoms and residual depressive symptoms (<xref rid="B21" ref-type="bibr">21</xref>). Additionally, people with BD may have difficulties in facial emotion recognition (<xref rid="B22" ref-type="bibr">22</xref>), feel emotions more intensely (<xref rid="B23" ref-type="bibr">23</xref>) and have stronger elevations of negative emotion as compared to positive affectivity problems (<xref rid="B17" ref-type="bibr">17</xref>). ED in BD may also show poor acceptance and differentiation of emotion, as well as difficulties in inhibiting impulsive actions, using appropriate regulation strategies to modulate emotions, and engaging in adaptive behaviours to achieve a desired goal when experiencing negative mood (<xref rid="B14" ref-type="bibr">14</xref>). Patients with BD also tend to feel less confident in their ability to use adaptive emotion regulation strategies (<xref rid="B24" ref-type="bibr">24</xref>). As such, findings have indicated that in the face of a given emotion state, those with BD report more difficulty controlling their speech and behaviour (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B25" ref-type="bibr">25</xref>). This phenomenon is known as emotion-related impulsivity (<xref rid="B25" ref-type="bibr">25</xref>), and individuals with BD report significantly greater concern about this specific type of impulsivity compared to other forms, even during periods of remission (<xref rid="B23" ref-type="bibr">23</xref>). Higher levels of emotion-related impulsivity have been linked to increased suicidality and aggression in individuals with remitted BD I (<xref rid="B25" ref-type="bibr">25</xref>). Unsurprisingly, this form of impulsivity is also strongly associated with significantly lower quality of life and poorer functional outcomes in individuals with BD I (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>).</p><p>Patients with BD may also show decreased emotional reactivity in positive social scenarios, impaired ability to down-regulate positive emotion, as well as a specific deficit in the ability to recognise surprised facial displays of emotion (<xref rid="B28" ref-type="bibr">28</xref>). Poor access to ER strategies can predict depressive propensity in BD, while difficulty in controlling impulses may predict trait (hypo)mania (<xref rid="B14" ref-type="bibr">14</xref>). More specifically, increased sensitivity to reward and deficient emotion processing and regulation in BD may amplify affect, thereby triggering a spiral into both manic and/or depressive states (<xref rid="B29" ref-type="bibr">29</xref>). Many of the facets of emotionality can be observed before onset among those at risk for the disorder (<xref rid="B30" ref-type="bibr">30</xref>). Further, recent findings suggest that abnormal ER may serve as an endophenotype for BD (<xref rid="B31" ref-type="bibr">31</xref>). Specifically, difficulties with ER are observed not only during acute episodes (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>) but also during periods of remission (<xref rid="B34" ref-type="bibr">34</xref>), as well as in genetically predisposed, unaffected relatives of individuals with BD (<xref rid="B35" ref-type="bibr">35</xref>). Indeed, previous functional magnetic resonance imaging (fMRI) studies have shown abnormal fronto-limbic responses during emotional reactivity and regulation in both BD patients and high-risk groups (<xref rid="B36" ref-type="bibr">36</xref>&#x02013;<xref rid="B38" ref-type="bibr">38</xref>). Further, a systematic review found that not only patients with BD but also their unaffected relatives exhibit behavioural and neural difficulties with emotion processing and regulation. This includes impairments in the recognition of facial displays of emotion, reduced ability to successfully down-regulate positive emotions, and increased cognitive interference of emotional stimuli (<xref rid="B29" ref-type="bibr">29</xref>).</p></sec><sec id="s1_2"><title>Emotion dysregulation in bipolar disorder compared to other mental illnesses</title><p>When compared to other psychiatric diagnoses, a meta-analysis found that people with BD were quite similar to patients with Major Depressive Disorder (MDD) in both overall ED and adopted ER strategies, although they showed more positive rumination and risk-taking behaviours (<xref rid="B13" ref-type="bibr">13</xref>). Patients with BD exhibited a lower degree of ED when compared with Borderline Personality Disorder (BPD) patients, as they adopted more adaptive ER strategies and fewer maladaptive ones (<xref rid="B13" ref-type="bibr">13</xref>). A systematic review found that compared to both clinical and non-clinical controls, people with BD may also endorse putatively maladaptive strategies for regulating negative affect such as rumination, self-blame, suppression and catastrophising more strongly than non-clinical controls, but have a similar ER profile to people with unipolar depression (<xref rid="B39" ref-type="bibr">39</xref>). The review also found that although dampening positive affect was higher in BD than controls, it did not distinguish BD and MDD (<xref rid="B39" ref-type="bibr">39</xref>).</p></sec><sec id="s1_3"><title>Potential utility of understanding pathophysiological underpinnings of emotional dysregulation in bipolar disorder</title><p>Psychiatric diagnoses and symptomatology alone cannot fully capture the complexity of ED in BD, emphasizing the need for broader considerations (<xref rid="B40" ref-type="bibr">40</xref>). Contemporary classifications of mental disorders remain primarily based on clinical features (<xref rid="B41" ref-type="bibr">41</xref>), leading many individuals with mental illness to transition through multiple diagnostic categories over their lifetime (<xref rid="B42" ref-type="bibr">42</xref>). The absence of objective markers to confirm diagnoses often delays accurate treatment and early interventions, as overlapping symptoms (e.g., anxiety, insomnia, low mood, suicidal ideation, impulsivity) are common across various disorders (<xref rid="B43" ref-type="bibr">43</xref>). Moreover, these classifications fail to uncover the fundamental mechanisms driving the syndromes (<xref rid="B44" ref-type="bibr">44</xref>), underscoring the urgent need for objective biomarkers to refine diagnostic evaluations and predict illness trajectories (<xref rid="B45" ref-type="bibr">45</xref>).</p><p>BD is a highly heritable condition with a complex aetiology (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>). Its onset is thought to result from the interplay between genetic susceptibility and environmental factors that predispose, precipitate, and perpetuate the disorder (<xref rid="B46" ref-type="bibr">46</xref>). Emerging research highlights the role of genetics, environmental interactions, and prodromal features preceding episodes of (hypo)mania or depression in BD (<xref rid="B48" ref-type="bibr">48</xref>). Evidence suggests that BD involves alterations in numerous biological systems, including disrupted structural and functional brain connectivity (<xref rid="B49" ref-type="bibr">49</xref>&#x02013;<xref rid="B51" ref-type="bibr">51</xref>), oxidative stress (<xref rid="B52" ref-type="bibr">52</xref>), mitochondrial dysfunction (<xref rid="B53" ref-type="bibr">53</xref>), inflammation (<xref rid="B54" ref-type="bibr">54</xref>), circadian rhythm disturbances (<xref rid="B55" ref-type="bibr">55</xref>), dopamine dysregulation (<xref rid="B56" ref-type="bibr">56</xref>), neurotrophic system abnormalities (e.g., elevated brain-derived neurotrophic factor levels), and calcium signaling disruptions (<xref rid="B57" ref-type="bibr">57</xref>&#x02013;<xref rid="B59" ref-type="bibr">59</xref>).</p><p>Many of these biological mechanisms are also likely contributors to ED in BD. Brain regions critical to ER, such as the prefrontal cortex and limbic system, exhibit altered activation patterns in BD (<xref rid="B38" ref-type="bibr">38</xref>). fMRI studies have reported abnormal fronto-limbic responses during emotional reactivity and regulation in individuals with BD and those at high risk (<xref rid="B37" ref-type="bibr">37</xref>). Consequently, deficits in affective cognition (i.e., hot cognition) are increasingly recognized as core components of BD&#x02019;s neurocognitive profile and potential treatment targets (<xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B61" ref-type="bibr">61</xref>). Affective cognition encompasses emotionally charged processes such as emotional processing and regulation, perceptual and attentional biases, feedback sensitivity, emotional decision-making, and reward-punishment processing (<xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B62" ref-type="bibr">62</xref>). Further, beyond cognition, multiple biological factors influence emotional processes in BD, including genetics (<xref rid="B63" ref-type="bibr">63</xref>), epigenetics (<xref rid="B64" ref-type="bibr">64</xref>), inflammation (<xref rid="B65" ref-type="bibr">65</xref>), hypothalamic-pituitary-adrenal axis dysfunction (<xref rid="B66" ref-type="bibr">66</xref>), brain-derived neurotrophic factor abnormalities (<xref rid="B67" ref-type="bibr">67</xref>), and circadian disruptions (<xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B69" ref-type="bibr">69</xref>).</p><p>To advance our understanding of ED in BD, precise definitions and a deeper exploration of its neural, molecular, and genetic mechanisms are essential (<xref rid="B4" ref-type="bibr">4</xref>). However, the relationship between BD and ED remains poorly understood. Given the pivotal role of ED in BD, it is imperative to elucidate its biological underpinnings. This narrative review aims to evaluate and synthesise current knowledge on the biological mechanisms involved in ER processes in BD, providing insights into the biological basis of ER in this disorder and identifying avenues for future research and intervention development.</p></sec></sec><sec id="s2"><title>Genetic and epigenetic mechanisms</title><sec id="s2_1"><title>Genetics</title><p>BD involves numerous risk loci, with most lead single nucleotide polymorphisms (SNPs) being noncoding and having small effect sizes (<xref rid="B70" ref-type="bibr">70</xref>). Findings so far highlight at least three genes; synaptic plasticity proteins (e.g., ANK3, located on chromosome 10q21.2; <xref rid="B71" ref-type="bibr">71</xref>&#x02013;<xref rid="B73" ref-type="bibr">73</xref>), ion channels (e.g., CACNA1C, located on chromosome 12p13; <xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B75" ref-type="bibr">75</xref>), and TRANK1, a protein of unknown function that resides on chromosome 3p22 (<xref rid="B76" ref-type="bibr">76</xref>, <xref rid="B77" ref-type="bibr">77</xref>).</p><p>Regarding ED, the genes most associated with this condition have previously been found to be associated with psychiatric disorders including BD (<xref rid="B63" ref-type="bibr">63</xref>). For example, a study examining genetic risk associated with ED found an overrepresentation of genes from the calcium signalling pathway and inflammation (i.e., IL2RA), also associated with risk for many psychiatric disorders including BD (<xref rid="B63" ref-type="bibr">63</xref>). Likewise, another study investigating genetic factors underlying emotional reactivity in BD patients found an association between ER and genetic variants in BD (<xref rid="B78" ref-type="bibr">78</xref>). The strongest associated SNP located in the 11q14 region has been implicated in nervous system development and the functional pathway of calcium ion binding (<xref rid="B78" ref-type="bibr">78</xref>). The second SNP retained, rs2064689 in the 1p31 region was located in the intron region of the interleukin 23 receptor precursor gene (i.e., IL23R NM_144701.2), which has also been implicated in inflammatory processes (<xref rid="B78" ref-type="bibr">78</xref>).</p></sec><sec id="s2_2"><title>Epigenetic mechanisms</title><p>Histone deacetylase (HDAC) inhibitors have been shown to control epigenetic programming associated with the regulation of cognition and behaviour (<xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B80" ref-type="bibr">80</xref>). Genetic association and clinical pharmacology have been used to identify a potential role for HDACs in BD (<xref rid="B79" ref-type="bibr">79</xref>). Inhibition of class I or II HDACs can protect neurons from mitochondrial oxidative stress induced damage frequently observed in BD (<xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B81" ref-type="bibr">81</xref>, <xref rid="B82" ref-type="bibr">82</xref>). A systematic analysis of GWAS studies found that HDAC2 may be linked to increased genetic risk for BD through its involvement in the development of the amygdala, nucleus accumbens and hippocampus and alterations in these regions could increase BD risk (<xref rid="B83" ref-type="bibr">83</xref>). Additionally, pharmacological treatments for BD act on HDACs (<xref rid="B64" ref-type="bibr">64</xref>, <xref rid="B84" ref-type="bibr">84</xref>). Specifically, valproic acid has the ability to promote gene expression through inhibition of class I and II HDACs activity and increase of acetylated histone H3 and acetylated histone H4 levels (<xref rid="B85" ref-type="bibr">85</xref>&#x02013;<xref rid="B87" ref-type="bibr">87</xref>), lithium downregulates HDAC1 at the translational level by targeting HDAC1 messenger RNA (<xref rid="B88" ref-type="bibr">88</xref>), and lamotrigine increases histone acetylation levels <italic>in vitro</italic> (<xref rid="B89" ref-type="bibr">89</xref>). Regarding ED, a study using <italic>in vivo</italic> imaging of HDAC- specific radiotracers in individuals with BD found that altered levels and activity of HDACs were related to attention and ER, further suggesting a role for HDACs in BD pathophysiology (<xref rid="B64" ref-type="bibr">64</xref>).</p></sec></sec><sec id="s3"><title>Structural and functional brain alterations</title><p>ER involves complex neural pathways integrating cognitive control and emotional responses (<xref rid="B25" ref-type="bibr">25</xref>). These pathways are categorized into implicit (automatic) and explicit (effortful) regulation (<xref rid="B90" ref-type="bibr">90</xref>), both of which involve distinct but interconnected brain regions. Individuals with BD exhibit abnormalities in these circuits, contributing to ED (<xref rid="B91" ref-type="bibr">91</xref>).</p><p>Neuroimaging studies have identified structural and functional abnormalities in BD, particularly within the limbic system (amygdala, hippocampus, and basal ganglia) and the prefrontal cortex (PFC). Meta-analyses of fMRI studies highlight hyperactivity in limbic structures, including the amygdala and hippocampus, alongside hypoactivity in the right inferior frontal gyrus (IFG), a key region involved in cognitive control over emotions (<xref rid="B37" ref-type="bibr">37</xref>). Similarly, another meta-analysis examining abnormal brain activation during ER in BD found clusters of hyperactivation in subcortical structures and limbic regions, including the caudate, amygdala, and parahippocampal gyrus, as well as cortical frontal structures such as the precentral and frontal gyri (<xref rid="B92" ref-type="bibr">92</xref>). Conversely, hypoactivation was observed in cortical regions such as the anterior cingulate and inferior frontal gyri in response to facial stimuli.</p><p>White matter (WM) abnormalities also contribute to ER deficits in BD (<xref rid="B93" ref-type="bibr">93</xref>). Studies have reported reduced fractional anisotropy in WM tracts connecting the PFC, dorsolateral PFC (dlPFC), ventrolateral PFC (vlPFC), medial PFC (mPFC), and left parietal cortex. Increased mean and radial diffusivity in the superficial WM of the right frontal cortex further supports structural connectivity disruptions in BD. These findings align with reports of microstructural abnormalities in the corpus callosum and corticospinal tract, both of which are associated with impaired emotional and cognitive functioning (<xref rid="B94" ref-type="bibr">94</xref>).</p><p>Youth at risk for BD also exhibit altered neural activation patterns during emotional processing (<xref rid="B95" ref-type="bibr">95</xref>). For example, increased right rostral anterior cingulate cortex (ACC) activity in response to happy stimuli and heightened amygdala-to-left caudal ACC connectivity in response to fearful stimuli have been observed (<xref rid="B95" ref-type="bibr">95</xref>). These findings suggest that neural circuits underlying ER are already compromised before illness onset, reinforcing the role of brain-based markers in identifying at-risk populations.</p><p>Overall, research underscores that BD involves widespread disruptions in ER-related neural circuits (<xref rid="B25" ref-type="bibr">25</xref>). FMRI studies introduced a new perspective to studying the neural foundations of psychological disorders associated with ER, offering insights into potential variations in brain network dynamics related to mood or cognition, as well as in their regulation by executive control or reward-related functions (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B96" ref-type="bibr">96</xref>). However, much of the existing literature is correlational, limiting causal inferences. Future studies should focus on elucidating the interplay between brain alterations, ER, and functional outcomes using longitudinal designs (<xref rid="B25" ref-type="bibr">25</xref>). Understanding these mechanisms will inform targeted interventions aimed at improving ER in BD (<xref rid="B25" ref-type="bibr">25</xref>).</p><sec id="s3_1"><title>Disruptions in neural circuits involved in ER in BD and other mental health illnesses</title><p>Since ED is a transdiagnostic construct, disruptions in neural circuits involved in emotional processing are found across a wide range of conditions (<xref rid="B97" ref-type="bibr">97</xref>). For example, a meta-analysis with a transdiagnostic sample identified hyperactivity in the amygdala, hippocampal/parahippocampal gyri, and dorso-medial thalamus, alongside reduced prefrontal cortex activity, not only in BD but also in anxiety, depressive, and substance use disorders, (<xref rid="B98" ref-type="bibr">98</xref>). Likewise, another study found common neural variability correlates of ED in the fronto-limbic system in BD, BPD and ADHD (<xref rid="B97" ref-type="bibr">97</xref>). Dysfunctions in the prefrontal cortex region has been linked to perseverative negative bias in depression (<xref rid="B99" ref-type="bibr">99</xref>), and this region may also contribute to rumination observed across disorders (<xref rid="B98" ref-type="bibr">98</xref>, <xref rid="B100" ref-type="bibr">100</xref>).</p><p>The ventromedial PFC is a key neural region in social and affective function (<xref rid="B101" ref-type="bibr">101</xref>). It is also considered central to the pathophysiology of mood and anxiety disorders (<xref rid="B102" ref-type="bibr">102</xref>). For example, a meta-analysis by Hiser and Koenigs (<xref rid="B103" ref-type="bibr">103</xref>) examined the associations between different subregions of the ventromedial prefrontal cortex (vmPFC) and psychiatric disorders. Their findings indicated that dysfunctions in distinct vmPFC subregions are linked to various mental illnesses, including BD, major depressive disorder, and post-traumatic stress disorder. Specifically, the study found that addiction, BD, and ADHD-related neural activity overlap with the decision-making subregion of the vmPFC, while PTSD, schizophrenia, and social anxiety disorder exhibit dysfunctions in both the decision-making and social processing subregions. These findings emphasize the role of vmPFC dysfunction in emotional and cognitive dysregulation across psychiatric conditions (<xref rid="B98" ref-type="bibr">98</xref>, <xref rid="B103" ref-type="bibr">103</xref>&#x02013;<xref rid="B105" ref-type="bibr">105</xref>).</p><p>On the other hand, notable differences between disorders may reflect underlying psychopathological distinctions. For example, the previously mentioned meta-analysis above (<xref rid="B98" ref-type="bibr">98</xref>) found that while hyperactivity in the amygdala, hippocampal/parahippocampal gyri, and dorso-medial thalamus, alongside reduced prefrontal cortex activity was observed in BD, anxiety, depressive, and substance use disorders, there were also differences, suggesting that therapeutics tuned to specific disruptions within the network may be preferentially effective for some neurobehavioral phenotypes. They found that while anxiety disorders were marked by pronounced amygdala/hippocampal hyperactivation, whereas BD was marked by ventrolateral prefrontal cortex hypoactivation, unipolar disorders by amygdala hyperactivation, and substance use disorders by ventrolateral prefrontal cortex hypoactivation.</p><p>The challenge of differentiating between BD and MDD in clinical settings has prompted researchers to identify differences in the pathophysiological mechanisms underlying BD and MDD (<xref rid="B106" ref-type="bibr">106</xref>). While both patients with MDD and BD exhibit predominantly decreased fronto-limbic connectivity (<xref rid="B107" ref-type="bibr">107</xref>), their disorder-specific pathophysiological mechanisms may differ (<xref rid="B33" ref-type="bibr">33</xref>). For example, different activation patterns in neural networks including the amygdala, ACC, PFC, and striatum during emotion-, reward-, or cognition-related tasks have been reported between BD and MDD (<xref rid="B108" ref-type="bibr">108</xref>). More specifically, a stronger functional connectivity pattern in BD was pronounced in default mode and in frontoparietal networks and brain regions including the PFC, ACC, parietal and temporal regions, and thalamus compared to MDD. Lastly, BD showed reduced integrity in the anterior part of the corpus callosum and posterior cingulum compared to MDD. Another fMRI study investigating ER differences in medication-free patients with MDD and BD revealed that these differences are mood-state dependent (<xref rid="B109" ref-type="bibr">109</xref>). During remission, patients with BD, but not those with MDD, exhibited impaired ER across emotions, which was associated with increased dorsolateral PFC activity. However, during depressive episodes, MDD and BD patients differed in their ER of happy versus sad emotions. BD patients in a depressive phase demonstrated normal ER for happy stimuli but impairments for sad stimuli, whereas MDD patients rated sad pictures as less negative and happy pictures as less positive than BD patients. These ER differences were linked to activity in the dorsolateral PFC and rostral ACC.</p><p>Similar to the overlap between BD and MDD, BD and BPD share neuroimaging findings in addition to behavioural similarities (<xref rid="B110" ref-type="bibr">110</xref>). Shared features include aberrant connections between limbic regions and the PFC (<xref rid="B111" ref-type="bibr">111</xref>&#x02013;<xref rid="B113" ref-type="bibr">113</xref>), reduced brain glucose metabolism in the brainstem, insula, and frontal white matter (<xref rid="B114" ref-type="bibr">114</xref>), gray matter alterations (<xref rid="B115" ref-type="bibr">115</xref>), and dysregulation of the HPA axis (<xref rid="B116" ref-type="bibr">116</xref>&#x02013;<xref rid="B119" ref-type="bibr">119</xref>). Despite these similarities, key differences exist. For instance, a recent study found that patients with BPD had significantly increased WM components mostly regions in the left parietal and frontal lobes (<xref rid="B120" ref-type="bibr">120</xref>). This white matter component largely overlaps with the network involved in top-down cognitive control of emotions (<xref rid="B121" ref-type="bibr">121</xref>&#x02013;<xref rid="B124" ref-type="bibr">124</xref>). The authors suggest that the increased white matter component in BPD may reflect attempts by these patients to exert control over their emotional reactions (<xref rid="B120" ref-type="bibr">120</xref>).</p><p>Lastly, BD and ADHD are neuropsychiatric disorders with a broad overlap in psychopathology, and possibly, pathophysiology (<xref rid="B125" ref-type="bibr">125</xref>). Both disorders are highly comorbid (<xref rid="B126" ref-type="bibr">126</xref>), and share several common symptoms, including impulsivity, psychomotor agitation, poor sleep, and cognitive impairments, including inattention and distractibility (<xref rid="B125" ref-type="bibr">125</xref>). The cognitive deficits observed in BD and ADHD follow a similar pattern across multiple cognitive domains (<xref rid="B125" ref-type="bibr">125</xref>), though their severity and presentation may vary between individuals (<xref rid="B127" ref-type="bibr">127</xref>, <xref rid="B128" ref-type="bibr">128</xref>). Regarding ED, brain regions implicated in ED in BD are also implicated in ADHD (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B129" ref-type="bibr">129</xref>) including reduced gray matter volumes in the right insula and ACC (<xref rid="B130" ref-type="bibr">130</xref>). However, some neurobiological differences have been reported. For instance, ADHD patients exhibit reduced activation in the ventrolateral prefrontal cortex (VLPFC) compared to healthy controls (HC) and paediatric BD patients (<xref rid="B131" ref-type="bibr">131</xref>). Similarly, youth with bipolar spectrum disorders display abnormally heightened functional connectivity between the amygdala and regions of the ventral prefrontal cortex during emotion processing, a pattern not observed in youth with ADHD or HC (<xref rid="B132" ref-type="bibr">132</xref>). Furthermore, adolescents with BD show increased connectivity between the affective and ventral attention networks, as well as within the attention network, compared to those with ADHD (<xref rid="B133" ref-type="bibr">133</xref>).</p><p>Future studies should investigate whether altered functional connectivity serves as an endophenotype of BD and whether it can help identify youth with externalizing symptoms who may later develop bipolar spectrum disorders (<xref rid="B132" ref-type="bibr">132</xref>).</p><p>Overall, these differences suggest that while pleiotropy and inadequate validity of diagnostic categorization remain challenges in psychiatry, the multifactorial nature of causation leaves room for unique combinations of causal factors contributing to each disorder (<xref rid="B42" ref-type="bibr">42</xref>).</p></sec><sec id="s3_2"><title>Investigating the effects of lithium on disturbances in limbic and emotion regulation circuits</title><p>Lithium has long been considered a key and gold-standard pharmacological treatment for BD (<xref rid="B134" ref-type="bibr">134</xref>, <xref rid="B135" ref-type="bibr">135</xref>). However, the specific processes through which its therapeutic effects such as mood stabilisation are affected and maintained remain unclear (<xref rid="B136" ref-type="bibr">136</xref>, <xref rid="B137" ref-type="bibr">137</xref>). Structural neuroimaging studies in patients with BD have suggested that treatment with lithium normalizes or increases gray matter volume in the anterior cingulate, subgenual cingulate cortex, amygdala and hippocampus, which are brain regions involved in ER (<xref rid="B138" ref-type="bibr">138</xref>, <xref rid="B139" ref-type="bibr">139</xref>). Recent research investigating lithium&#x02019;s effect on ER in BD (<xref rid="B15" ref-type="bibr">15</xref>) found that lithium&#x02019;s effect on active reappraisal and emotional processing of negative images was seen in areas of the fronto-parietal and limbic network, and in superior and medial temporal structures. Further, they found that within the fronto-parietal network, lithium decreased activation in prefrontal areas (left anterior PFC or rostra-lateral PFC, and right superior frontal gyrus) and posterior parietal areas (left angular gyrus), during reappraisal. There were also connectivity changes within prefrontal and limbic areas following lithium administration. Further, response to lithium treatment in paediatric BD was associated with normalization of white matter microstructure in regions associated with emotion processing (<xref rid="B140" ref-type="bibr">140</xref>). Likewise, a study examining how treatment with quetiapine or lithium impacts limbic and ER brain circuitry in youth with BD found both treatments had a normalizing effect on brain function, although quetiapine induced a more rapid and widespread normalization of brain function (<xref rid="B141" ref-type="bibr">141</xref>). Lastly, a review examining fMRI studies evaluating the impact of lithium on brain functional activity and connectivity in patients with BD found that selective abnormalities in neural circuitries supporting emotional processing and regulation improve during lithium treatment in BD (<xref rid="B142" ref-type="bibr">142</xref>). However, further research is needed to understand the connection between ER circuitry and the therapeutic action of lithium in BD. Investigating the regional neurophysiological effects of antimanic treatments can offer insights into the mechanisms underlying their clinical efficacy at the systems level (<xref rid="B141" ref-type="bibr">141</xref>). This understanding may also inform strategies for testing new compounds and, in the long term, support clinical decision-making regarding the initiation or adjustment of therapeutic interventions (<xref rid="B141" ref-type="bibr">141</xref>).</p></sec></sec><sec id="s4"><title>Inflammation</title><p>Inflammation is a complex biological process involving cytokine cascades, immune cell responses, and elevated levels of acute-phase proteins and complement factors (<xref rid="B59" ref-type="bibr">59</xref>). Increasing evidence indicates that chronic, low-level inflammation in the body and brain (i.e., neuroinflammation) contributes to the pathophysiology of BD (<xref rid="B143" ref-type="bibr">143</xref>, <xref rid="B144" ref-type="bibr">144</xref>), both as a state and a trait feature (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B145" ref-type="bibr">145</xref>) and can worsen the disease progression (<xref rid="B146" ref-type="bibr">146</xref>). The connection between BD and inflammation is further supported by shared genetic polymorphisms and gene expression patterns (<xref rid="B147" ref-type="bibr">147</xref>).</p><p>Chronic inflammation also impacts brain functions, such as the monoaminergic system, which plays a role in ER (<xref rid="B78" ref-type="bibr">78</xref>). A systematic review found that difficulty regulating emotion was associated with elevated inflammatory markers, while effective ER was linked to lower inflammation levels (<xref rid="B148" ref-type="bibr">148</xref>). Specifically, use of cognitive reappraisal has been associated with lower levels of C-reactive protein (CRP; <xref rid="B149" ref-type="bibr">149</xref>) and interleukin-6 (IL-6; <xref rid="B150" ref-type="bibr">150</xref>) whereas increased inflammation, specifically CRP, tumor necrosis factor-&#x003b1; (TNF-&#x003b1;), and interferon-&#x003b3; (IFN-&#x003b3;), have been linked with routine expressive suppression use (<xref rid="B149" ref-type="bibr">149</xref>, <xref rid="B151" ref-type="bibr">151</xref>&#x02013;<xref rid="B153" ref-type="bibr">153</xref>). Negative self-referential processes (e.g., self-criticism, negative thoughts, and rumination) have also been linked to altered peripheral inflammatory markers and cortisol responses in healthy adults (<xref rid="B148" ref-type="bibr">148</xref>, <xref rid="B154" ref-type="bibr">154</xref>&#x02013;<xref rid="B156" ref-type="bibr">156</xref>).</p><p>Regarding ED in BD, research suggests that inflammation can&#x000a0;affect brain structures, which might lead to a dysregulated stress response and, possibly, to ED disorders such as BD (<xref rid="B110" ref-type="bibr">110</xref>,&#x000a0;<xref rid="B157" ref-type="bibr">157</xref>).&#x000a0;While the causal relationship between inflammation and brain imaging abnormalities in BD remains uncertain (<xref rid="B65" ref-type="bibr">65</xref>), inflammation&#x02019;s neurotoxic effects may impair neural circuits involved in ER, reward processing, motivation, emotional control, and cognition (<xref rid="B158" ref-type="bibr">158</xref>&#x02013;<xref rid="B161" ref-type="bibr">161</xref>). For example, higher inflammatory biomarkers have been identified in BD patients&#x02019; left hippocampus (<xref rid="B162" ref-type="bibr">162</xref>) and higher soluble IL-6 receptor levels were associated with increased functional connectivity between the medial PFC and several subcortical limbic structures, including the amygdala, pallidum, hippocampus, and insula (<xref rid="B163" ref-type="bibr">163</xref>). Moreover, high-sensitivity CRP has been proposed as a potential objective marker of ER difficulties in BD (<xref rid="B164" ref-type="bibr">164</xref>). In one study, remitted BD patients with emotional hyper-reactivity exhibited higher levels of low-grade inflammation (e.g., high-sensitivity CRP), hypertension, impaired glucose metabolism, and a greater number of suicide attempts compared to those without hyper-reactivity (<xref rid="B165" ref-type="bibr">165</xref>). Elevated high-sensitivity CRP levels were also observed in BD patients with emotional hypo-reactivity (<xref rid="B164" ref-type="bibr">164</xref>).</p><p>Evidence from neuroimaging studies further supports the role of fronto-limbic network disruptions in ER difficulties associated with BD (<xref rid="B166" ref-type="bibr">166</xref>), including abnormalities in WM microstructure (<xref rid="B15" ref-type="bibr">15</xref>). Studies also show an association between neuroinflammation (e.g., circulating pro-inflammatory cytokines) and WM integrity (<xref rid="B167" ref-type="bibr">167</xref>). The balance of immune cell subsets, such as T cells and cytokine-producing natural killer cells, may be crucial for maintaining the brain&#x02019;s structural and functional integrity in BD (<xref rid="B168" ref-type="bibr">168</xref>), while also contributing to the chronic low-grade inflammation observed in the disorder (<xref rid="B169" ref-type="bibr">169</xref>). For example, circulating natural killer cell counts, and particularly cytokine-producing natural killer cells, positively associated with Diffusion Tensor Imaging&#x000a0;(DTI) measures of WM integrity and corticolimbic functional response and connectivity during emotional processing (<xref rid="B170" ref-type="bibr">170</xref>). More specifically, the study found an effect of CD56+TNF&#x003b1;+, CD56+INF&#x003b3;+, and CD56+GMCSF+ on functional connectivity and response in brain regions which exert a crucial role in defining emotional experience and mood control such as dorsolateral pre-frontal cortex, hippocampus, precuneus, cuneus and amygdala connections with parahippocampal gyrus and temporal pole (<xref rid="B93" ref-type="bibr">93</xref>, <xref rid="B170" ref-type="bibr">170</xref>). Lastly, they found a positive effect of lithium on cytokine-producing natural killer cell counts (<xref rid="B170" ref-type="bibr">170</xref>), which may in return reduce ED (<xref rid="B15" ref-type="bibr">15</xref>).</p><p>Although the connection between inflammation and ED in BD requires further exploration, preliminary evidence suggests a relationship between specific inflammatory markers and both behavioural changes and neuroanatomical alterations in regions involved in ER (<xref rid="B157" ref-type="bibr">157</xref>). Utilising biomarkers during the early stages of BD may aid in diagnostics and provide potential therapeutic avenues (<xref rid="B171" ref-type="bibr">171</xref>). Notably, anti-inflammatory treatments have shown promise in alleviating BD symptoms, particularly depressive symptoms (<xref rid="B172" ref-type="bibr">172</xref>&#x02013;<xref rid="B175" ref-type="bibr">175</xref>). Additionally, antipsychotics and lithium have been observed to reduce the expression of several inflammatory genes, which are more frequently upregulated in monocytes from BD patients and their offspring than in healthy individuals (<xref rid="B176" ref-type="bibr">176</xref>, <xref rid="B177" ref-type="bibr">177</xref>). Further research exploring the interplay between inflammation and ER in BD, particularly through longitudinal studies incorporating multiple timepoints, is warranted (<xref rid="B110" ref-type="bibr">110</xref>). Evaluating dimensions related to ER (e.g., levels of emotional reactivity) alongside accessible biomarkers such as blood pressure, CRP, and glycaemia, in addition to monitoring mood symptoms in BD patients, may help implement interventions more aligned with the underlying pathophysiology of BD (<xref rid="B178" ref-type="bibr">178</xref>). Finally, psychosocial interventions targeting inflammation through ER skills, such as cognitive-behavioral therapy and mindfullness, may serve as effective strategies for symptom management (<xref rid="B148" ref-type="bibr">148</xref>, <xref rid="B179" ref-type="bibr">179</xref>).</p></sec><sec id="s5"><title>Hypothalamic-pituitary-adrenal axis dysfunction</title><p>Hypothalamic&#x02013;pituitary&#x02013; adrenal axis (HPA) is one of the main biological systems involved in response to stress and shaping the central nervous system (CNS) structures along the lifespan (<xref rid="B180" ref-type="bibr">180</xref>). Chronic stress and HPA axis dysregulation can disrupt inhibitory control, leading to heightened emotional responses (<xref rid="B181" ref-type="bibr">181</xref>). HPA axis dysregulations are also considered to play a major role in the pathophysiology and progression of BD (<xref rid="B182" ref-type="bibr">182</xref>). For example, state and trait hyperactivity of the HPA axis is associated with BD and abnormalities of glucocorticoid signalling are found in several key brain areas which in return may contribute to ED observed in BD (<xref rid="B180" ref-type="bibr">180</xref>). Disturbance in the HPA axis could also increase treatment resistance and relapse, worsen illness outcome, cause cognitive deficits and exacerbate depressive symptoms (<xref rid="B183" ref-type="bibr">183</xref>).</p><p>The link between ER and HPA-axis function has not been extensively investigated. Some research, however, indicates that positive ER strategies, such as problem-solving, are associated with lower cortisol levels over time (<xref rid="B184" ref-type="bibr">184</xref>) and with increased immediate cortisol responses (<xref rid="B185" ref-type="bibr">185</xref>, <xref rid="B186" ref-type="bibr">186</xref>). It is still uncertain whether HPA-axis dysfunctions in BD are directly related to issues with ER (<xref rid="B66" ref-type="bibr">66</xref>). However, trauma experienced in childhood or later in life may influence both HPA-axis function and ER abilities (<xref rid="B66" ref-type="bibr">66</xref>). Both childhood trauma and chronic stress have been associated with dysregulations of the HPA axis (<xref rid="B187" ref-type="bibr">187</xref>) and alterations across various stages of ER (<xref rid="B66" ref-type="bibr">66</xref>), including emotion-related attentional biases and reward processing disturbances (<xref rid="B188" ref-type="bibr">188</xref>, <xref rid="B189" ref-type="bibr">189</xref>).</p><p>Childhood trauma also plays a pervasive role in the development and course of BD (<xref rid="B190" ref-type="bibr">190</xref>, <xref rid="B191" ref-type="bibr">191</xref>). For example, individuals with BD report higher rates of ED and individuals with BD who report childhood trauma also endorse higher rates of ED and impulsivity compared with those without trauma histories (<xref rid="B191" ref-type="bibr">191</xref>&#x02013;<xref rid="B193" ref-type="bibr">193</xref>) and show poor response to lithium (<xref rid="B192" ref-type="bibr">192</xref>, <xref rid="B193" ref-type="bibr">193</xref>). Less genetic risk may be needed to develop a more unstable form of BD when exposed to childhood maltreatment (<xref rid="B194" ref-type="bibr">194</xref>). This may suggest that some ER patterns seen in individuals with BD may not be unique to BD but could instead reflect the effects of early trauma (<xref rid="B66" ref-type="bibr">66</xref>) as childhood adversity, particularly emotional abuse, is associated with affective lability and ER in adulthood across psychiatric disorders (<xref rid="B195" ref-type="bibr">195</xref>). Research further suggests that childhood trauma, particularly emotional abuse, is associated with increased affective instability and less adaptive ER in BD (<xref rid="B196" ref-type="bibr">196</xref>&#x02013;<xref rid="B198" ref-type="bibr">198</xref>). This could explain the relationship between childhood trauma and poor BD outcomes (<xref rid="B191" ref-type="bibr">191</xref>). Thus, it is important to consider contextual factors such as trauma that might contribute to the overlap between biological mechanisms (e.g., HPA-axis dysfunctions) and ER difficulties in BD before concluding that biological mechanisms are truly a central driver for other outcomes (<xref rid="B25" ref-type="bibr">25</xref>). Future research on BD-specific ER should account for the influence of early trauma, which may have either an additive effect or an interactive one, where childhood trauma combined with a genetic predisposition to BD shapes distinct ER patterns (<xref rid="B66" ref-type="bibr">66</xref>).</p></sec><sec id="s6"><title>Neuroplasticity and brain-derived neurotrophic factor</title><p>Brain-derived neurotrophic factor (BDNF) is a multifunctional neurotrophin with numerous functions in the brain such as neuronal plasticity and maintenance of the CNS (<xref rid="B199" ref-type="bibr">199</xref>), modulating reactivity to stress (<xref rid="B200" ref-type="bibr">200</xref>, <xref rid="B201" ref-type="bibr">201</xref>). BDNF has been implicated in the pathophysiology of several psychiatric disorders (<xref rid="B202" ref-type="bibr">202</xref>), including BD (<xref rid="B203" ref-type="bibr">203</xref>, <xref rid="B204" ref-type="bibr">204</xref>) even in at-risk stages (<xref rid="B205" ref-type="bibr">205</xref>). Research shows that the pattern of neurotrophin expression during mood episodes changes (<xref rid="B206" ref-type="bibr">206</xref>&#x02013;<xref rid="B208" ref-type="bibr">208</xref>). For example, serum BDNF levels decrease during manic and depressive episodes in both treated and drug-free subjects when compared to normal controls and to unipolar depression (<xref rid="B209" ref-type="bibr">209</xref>). In relation to ER in BD, BDNF could serve as an objective marker for assessing ER interventions in BD (<xref rid="B210" ref-type="bibr">210</xref>).</p><p>One of the functional SNP of the BDNF gene in humans is in exon 11 and results in an amino-acid substitution from valine (Val) to methionine (Met) at codon 66 (rs6265, also known as Val66Met). Associations have been reported between ED and the 66Met allele of the BDNF, which is associated with reduced amygdala habituation to emotional stimuli during fMRI (<xref rid="B211" ref-type="bibr">211</xref>). Abnormal neural responses of amygdala networks during habituation to repeated emotional stimuli may be a putative endophenotype of psychiatric disorders characterized by ED (<xref rid="B211" ref-type="bibr">211</xref>). The Met allele may also interact with childhood abuse to predict an impaired ability to downregulate negative affect (<xref rid="B212" ref-type="bibr">212</xref>). Patients with BD who carry the Met allele at the BDNF Val66Met polymorphism have been shown to be more likely to develop depressive episodes following stressful life events than Val allele homozygous (<xref rid="B67" ref-type="bibr">67</xref>).</p></sec><sec id="s7"><title>Chrono-rhythmic disturbances</title><p>Circadian rhythm disturbances are integral to the pathophysiology of BD (<xref rid="B213" ref-type="bibr">213</xref>). For example, many circadian genes have previously been associated with BD, including ARNTL1, CLOCK, NPAS2, NR1D1, PER3, RORB, TIMELESS (<xref rid="B214" ref-type="bibr">214</xref>&#x02013;<xref rid="B218" ref-type="bibr">218</xref>). In addition, some evidence suggests that genes involved in circadian rhythm regulation (e.g., CRY1 variants) may be associated with increased risk of relapse of depressive episodes in patients with BD (<xref rid="B219" ref-type="bibr">219</xref>). Disruptions in sleep-wake cycles, social rhythms, and hormonal fluctuations can also significantly influence ER (<xref rid="B220" ref-type="bibr">220</xref>).</p><sec id="s7_1"><title>The role of the suprachiasmatic nucleus</title><p>Many individuals with BD have circadian rhythm alterations of&#x000a0;sleep-wake, activity, melatonin, and other hormones even&#x000a0;in&#x000a0;euthymic periods (<xref rid="B221" ref-type="bibr">221</xref>). Circadian rhythms (e.g., sleep/wake cycles,&#x000a0;body temperature control, and the release of neurotransmitters and hormones) are produced and coordinated by a central biological clock, the SCN, which is located in the anterior hypothalamus (<xref rid="B222" ref-type="bibr">222</xref>). Dysregulation in these rhythms can stem from enduring disruptions within the SCN&#x02019;s own pacemaking functions or from impairments in how the SCN aligns with external cues (<xref rid="B223" ref-type="bibr">223</xref>). Although weakly, multiple SNPs in the genes encoding the core components of the molecular clock have been demonstrated to be associated with schizophrenia, BD and MDD, suggesting a causal role for clock dysfunction in psychiatric disorders (<xref rid="B224" ref-type="bibr">224</xref>). Furthermore, when individuals with or at-risk for BD experience life events that alter their daily routines or social rhythms (e.g., changes in sleep, meals, or work schedules), these disturbances can unsettle their circadian patterns, triggering physical symptoms that may eventually escalate into mood episodes (<xref rid="B68" ref-type="bibr">68</xref>).</p></sec><sec id="s7_2"><title>Sleep-wake cycles</title><p>Delayed sleep-wake and activity patterns are commonly seen in the depressive phase of BD (<xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B225" ref-type="bibr">225</xref>&#x02013;<xref rid="B229" ref-type="bibr">229</xref>), particularly in adolescents and young adults (<xref rid="B226" ref-type="bibr">226</xref>, <xref rid="B227" ref-type="bibr">227</xref>, <xref rid="B229" ref-type="bibr">229</xref>&#x02013;<xref rid="B231" ref-type="bibr">231</xref>). Changes in sleep phase, structure and duration are also reported across all mood states in BD (<xref rid="B232" ref-type="bibr">232</xref>). Several studies using an interview-based assessment of biological rhythm disturbances including sleep and activity have reported that young adults with BD have greater biological rhythm disruption than healthy controls (<xref rid="B233" ref-type="bibr">233</xref>, <xref rid="B234" ref-type="bibr">234</xref>).</p><p>Chronic sleep disruption including insomnia would lead to ER as a result of diminished cognitive functioning by affecting frontal brain regions and diminishing control over executive functions (<xref rid="B235" ref-type="bibr">235</xref>&#x02013;<xref rid="B237" ref-type="bibr">237</xref>). For example, people suffering from insomnia show dysfunctions in the neural circuitry underlying ER (<xref rid="B238" ref-type="bibr">238</xref>&#x02013;<xref rid="B240" ref-type="bibr">240</xref>) and impairments in both basic cognitive functions and higher-order cognitive processing involved in supervisory control, problem solving, flexibility and self-control (<xref rid="B241" ref-type="bibr">241</xref>, <xref rid="B242" ref-type="bibr">242</xref>). As such, insomnia is frequently seen in BD (<xref rid="B243" ref-type="bibr">243</xref>&#x02013;<xref rid="B246" ref-type="bibr">246</xref>) and related to emotional hyper-reactivity during remitted phases (<xref rid="B247" ref-type="bibr">247</xref>, <xref rid="B248" ref-type="bibr">248</xref>). Further, a cross-sectional study assessing the potential association between insomnia, ED and suicidality in subjects with BD found that insomnia symptoms significantly predicted the severity of depressive symptoms, ED, and suicidality in subjects with BD (<xref rid="B69" ref-type="bibr">69</xref>).</p></sec><sec id="s7_3"><title>Evening chronotype</title><p>Morningness-eveningness, or chronotype, reflects individual variations in diurnal preferences (<xref rid="B249" ref-type="bibr">249</xref>). The evening chronotype appears to be independently linked to ER, regardless of factors like sleep quality, duration, timing, or debt (<xref rid="B250" ref-type="bibr">250</xref>). For instance, individuals with a morning chronotype report fewer attentional and emotional difficulties, supported by evidence at the brain structural level (<xref rid="B251" ref-type="bibr">251</xref>). Additionally, research investigating the association between later chronotypes and amygdala reactivity to negative (e.g., fearful) facial expressions found that evening chronotypes exhibit heightened amygdala responses to negative stimuli and reduced dorsal ACC-amygdala functional connectivity (<xref rid="B249" ref-type="bibr">249</xref>). This suggests impaired ER circuitry independent of sleep quality, depression diagnosis, and family history (<xref rid="B249" ref-type="bibr">249</xref>). Additionally, research shows a negative bias in emotion processing in late chronotypes and increased difficulty in anger and sadness recognition for expressive suppressor morning-types, highlighting further the importance of chronotype as a relevant variable in ER and&#x000a0;emotional functioning (<xref rid="B252" ref-type="bibr">252</xref>).</p><p>Studies consistently show that individuals with BD are more likely than healthy controls to display an evening chronotype, characterized by a preference for later sleep, wakefulness, and activity patterns (<xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B225" ref-type="bibr">225</xref>). This relationship is corroborated by findings using objective chronotype measures, such as actigraphy (<xref rid="B253" ref-type="bibr">253</xref>, <xref rid="B254" ref-type="bibr">254</xref>). The evening chronotype is thought to have a genetic basis, as evidenced by heritability studies (<xref rid="B255" ref-type="bibr">255</xref>, <xref rid="B256" ref-type="bibr">256</xref>). While disrupted circadian rhythms and evening chronotypes are commonly observed in BD, their specific roles in mood episodes or emotionality remain uncertain (<xref rid="B55" ref-type="bibr">55</xref>). However, chronotype has been proposed as a potential biomarker for lithium treatment response in BD (<xref rid="B257" ref-type="bibr">257</xref>, <xref rid="B258" ref-type="bibr">258</xref>).</p><p>Lithium may exert its mood-stabilizing effects partially through modulating the circadian system (<xref rid="B43" ref-type="bibr">43</xref>), as alterations in circadian CLOCK genes have been implicated in lithium response (<xref rid="B259" ref-type="bibr">259</xref>, <xref rid="B260" ref-type="bibr">260</xref>). Notably, lithium has been shown to extend the circadian period and enhance circadian rhythm amplitude (<xref rid="B261" ref-type="bibr">261</xref>). More specifically, lithium inhibits glycogen synthase kinase-3 beta, which phosphorylates and stabilizes the circadian nuclear receptor rev-erbalpha (<xref rid="B262" ref-type="bibr">262</xref>) and rev-erbalpha influences mood regulation through circadian control of the dopaminergic system (<xref rid="B263" ref-type="bibr">263</xref>, <xref rid="B264" ref-type="bibr">264</xref>). These finding may suggest that targeting circadian mechanisms could be a key avenue for improving ED in BD.</p></sec></sec><sec id="s8"><title>Clinical relevance of the findings</title><sec id="s8_1"><title>Assessment</title><p>ER difficulties may be detected as part of a standard clinical psychiatric assessment. Specific tools such as the Difficulties in Emotion Regulation Scale (DERS) and the Affective Lability Scale (ALS) may also be used to assess emotional reactivity and poor emotional clarity at individual time points (<xref rid="B265" ref-type="bibr">265</xref>). However, digital tools such as ecological momentary assessment (EMA) allow real-time tracking of emotional states and therefore can provide insights into dynamic fluctuations that may be missed with traditional tools (<xref rid="B266" ref-type="bibr">266</xref>). Behavioural neuropsychological assessments, particularly those relating to executive function, can be used to further clarify cognitive impairments associated with emotional dysregulation (<xref rid="B267" ref-type="bibr">267</xref>). Neuroimaging and physiological measures like heart rate variability, may also potential as adjunctive methods for assessment, although these are not used widely in clinical practice (<xref rid="B267" ref-type="bibr">267</xref>).</p></sec><sec id="s8_2"><title>Treatments</title><p>Psychotherapeutic interventions, such as Dialectical Behaviour Therapy (DBT) and Cognitive Behavioral Therapy (CBT), teach skills such as mindfulness, distress tolerance, and cognitive restructuring that may help to support emotional regulation in patients with BD (<xref rid="B268" ref-type="bibr">268</xref>). Emotion-focused therapies, such as emotion regulation group therapy (ERGT), have specifically shown efficacy in reducing emotional reactivity, but this modality is less widely available (<xref rid="B268" ref-type="bibr">268</xref>).</p><p>Pharmacological treatments, including mood stabilizers like lithium and valproate, may be pivotal in managing ED. As discussed before, lithium, not only stabilises mood but also appears to modulate neural circuits involved in ER, including the prefrontal cortex and amygdala (<xref rid="B134" ref-type="bibr">134</xref>). It has been shown to reduce emotional lability, impulsivity, and aggression, providing long-term protection against mood destabilization (<xref rid="B134" ref-type="bibr">134</xref>). Likewiese, Valproate, a commonly-used mood stabiliser in BD, enhances gamma-aminobutyric acid (GABA) activity in the brain, which reduces hyperactivity in ER pathways (<xref rid="B269" ref-type="bibr">269</xref>), mitigating emotional reactivity and impulsivity. However, recent UK MHRA guidance on valproate is limiting its ongoing use in both males and females of reproductive age (MHRA 2024). Nonetheless, these medications, often used in combination with psychotherapeutic approaches, continue to play a critical role in improving ER and preventing relapse. Furthermore, emerging technologies, such as smartphone-based interventions and virtual reality platforms, show promise as novel supportive therapies to enhance ER assessment and management (<xref rid="B269" ref-type="bibr">269</xref>), which will be discussed further in detail in &#x0201c;Future Directions&#x0201d;.</p><p>In addition to the psychotherapeutic and pharmacological treatments, there is growing interest in the ketogenic diet as a treatment for BD (<xref rid="B270" ref-type="bibr">270</xref>, <xref rid="B271" ref-type="bibr">271</xref>). This is due to BD being recognised more as a disorder of energy dysregulation (<xref rid="B272" ref-type="bibr">272</xref>) and mitochondrial dysfunction (<xref rid="B59" ref-type="bibr">59</xref>). However, although evidence for mitochondrial dysfunction in BD is well-established, the genetic association of mitochondria with BD remains weak (<xref rid="B79" ref-type="bibr">79</xref>). This implies that mitochondrial dysfunction may act as an intermediate phenotype shaped by other causal risk factors, including environmental influences, infections, and drug exposure, rather than being a direct result of genetic factors (<xref rid="B79" ref-type="bibr">79</xref>).</p><p>Ketogenic diet may improve metabolic and biochemical features of BD (<xref rid="B271" ref-type="bibr">271</xref>) such as reduction in oxidative stress and inflammation, improved mitochondrial function and biogenesis, improved glutamate/GABA transmission and reductions in intracellular sodium and calcium (<xref rid="B273" ref-type="bibr">273</xref>), increase of BDNF (<xref rid="B274" ref-type="bibr">274</xref>), reduction of BMI and control of obesity (<xref rid="B275" ref-type="bibr">275</xref>) and regulation of mood (<xref rid="B276" ref-type="bibr">276</xref>). Thus, the ketogenic diet presents a promising avenue for exploring dietary interventions as potential therapeutic strategies for BD, providing an opportunity to assess its effects within specific domains of psychopathology such as cognition and&#x000a0;mood (<xref rid="B270" ref-type="bibr">270</xref>). A comprehensive understanding of how the ketogenic diet can ameliorate mitochondrial function, related gene expression, reward neural network, dopaminergic and GABAergic neurotransmission abnormalities in BD is also crucial to help guide personalized interventions and provide targets for novel therapies for BD (<xref rid="B79" ref-type="bibr">79</xref>).</p></sec></sec><sec id="s9"><title>Future directions</title><sec id="s9_1"><title>Digital phenotyping</title><p>Diagnosis in BD have centred on identifying episodes, with clinical outcomes often reduced to a binary approach (<xref rid="B4" ref-type="bibr">4</xref>). This approach is particularly problematic in BD, where mood can vary significantly, often in both directions, within any given evaluation period (<xref rid="B4" ref-type="bibr">4</xref>). A potential solution involves implementing more frequent and real-time mood assessments (e.g., ESM/EMA). Leveraging new technologies can enhance our ability to capture mood and mental state data with greater efficiency and accuracy, and it can push BD research beyond a sole focus on psychopathology by incorporating physiological, behavioural, and environmental data (<xref rid="B4" ref-type="bibr">4</xref>). For example, actigraphy has been used to derive objective measures of sleep characteristics (<xref rid="B277" ref-type="bibr">277</xref>, <xref rid="B278" ref-type="bibr">278</xref>). An actigraphy study examining the interactive relationships among impulsivity, sleep disturbance, and circadian rhythm disturbance as predictors of mood symptoms in a high-risk and recent-onset BD sample found that less total actigraphic sleep time predicted more next-day depressive symptoms (<xref rid="B220" ref-type="bibr">220</xref>). Longer total sleep time was associated with fewer next-day hypomanic symptoms when participants had low, but not high, behavioural impulsivity. Additionally, for participants with high self-reported impulsivity, later dim light melatonin onset time was associated with higher next-day depressive symptoms. Another study looking at rest-activity cycles in euthymic BD patients found patients who presented with unstable rest-activity cycles had delayed sleep-wake timing and greater mood variability, and younger age (<xref rid="B279" ref-type="bibr">279</xref>). Lastly, patients who had later/irregular rest-activity patterns had greater lifetime manic-hypomanic and depressive symptoms (<xref rid="B228" ref-type="bibr">228</xref>).</p><p>Actigraphy has also been used in 24-hour patterns of motor activity (<xref rid="B280" ref-type="bibr">280</xref>), sedentary behaviour (<xref rid="B281" ref-type="bibr">281</xref>), and physical activity or exercise (<xref rid="B282" ref-type="bibr">282</xref>). A case-control study of 242 patients with BD found bidirectional associations between motor activity with subjectively rated energy level and sleep duration as well as unidirectional associations between motor activity and mood level (<xref rid="B283" ref-type="bibr">283</xref>). Further, a systematic review looking at motor activity patterns in patients with BD and MDD found lower mean activity (<xref rid="B284" ref-type="bibr">284</xref>, <xref rid="B285" ref-type="bibr">285</xref>). In addition, patients with BD and MDD with lower amplitude of the 24-h rest-activity rhythm report greater mood instability (<xref rid="B286" ref-type="bibr">286</xref>).</p><p>Widespread availability of connected and wearable devices (e.g., smartphones) had led to digital phenotyping based on high-resolution measurement of remotely captured data streams (<xref rid="B287" ref-type="bibr">287</xref>). Given that the primary characteristic of BD is a biphasic energy shift, monitoring the corresponding phasic dysregulation in mood, sleep, and behaviour is gaining attention (<xref rid="B288" ref-type="bibr">288</xref>). This comprehensive approach may uncover biological correlates and, ultimately, the underlying mechanisms of the disorder, such as ED. Digital technologies for example in metabolomics, with further exploration, may also assist in moving towards more personalised and stratified healthcare approaches (<xref rid="B289" ref-type="bibr">289</xref>).</p></sec><sec id="s9_2"><title>Measurement issues</title><p>Previous studies using subjective measures of ER have generally not identified any abnormalities in patients with BD (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B266" ref-type="bibr">266</xref>, <xref rid="B290" ref-type="bibr">290</xref>, <xref rid="B291" ref-type="bibr">291</xref>). This may be due to the limited sensitivity of the self- report measures used (<xref rid="B292" ref-type="bibr">292</xref>). While neuroimaging is a sensitive method for detecting subtle neural changes during ER, it is not practical for diagnostic evaluations in routine clinical practice (<xref rid="B292" ref-type="bibr">292</xref>). Therefore, there is a need for research into improved, cost-effective measures with sensitivity to detect abnormalities in the reactivity to and regulation of emotions in BD to use in diagnostic evaluations in routine clinical practice (<xref rid="B292" ref-type="bibr">292</xref>). A multidisciplinary approach combining subtle behavioural measures (e.g., eye-tracking and facial expressions) with subjective responses during emotion reactivity and regulation may offer a more sensitive and cost-effective alternative for detecting aberrant ER in BD (<xref rid="B292" ref-type="bibr">292</xref>). Supporting this, a study investigating trait-related abnormalities in emotional reactivity and regulation in BD using novel behavioural measures, such as facial expressions and eye movements, found subtle differences in visual gaze patterns and facial displays of emotion between remitted BD patients and healthy controls during emotion processing and regulation (<xref rid="B292" ref-type="bibr">292</xref>). The authors suggest that these subtle differences in visual gaze and facial expressions may provide sensitivity comparable to neuroimaging techniques, while being less costly and more feasible for clinical applications. Further, evidence from fMRI studies is often inconsistent (<xref rid="B60" ref-type="bibr">60</xref>). On the contrary, studies using eye&#x02010;tracking methodology revealed relatively consistent abnormalities such as oculomotor abnormalities including slower inhibitory control during facial emotion processing in remitted and symptomatic patients (<xref rid="B293" ref-type="bibr">293</xref>&#x02013;<xref rid="B295" ref-type="bibr">295</xref>). The consistency within eye-tracking studies may suggest that this may be a sensitive measure to detect subtle behavioural differences in ER, particularly implicit ER (<xref rid="B60" ref-type="bibr">60</xref>).</p></sec><sec id="s9_3"><title>The need for longitudinal data</title><p>To determine whether an etiological mechanism precedes the development of ED in BD, the biomarkers should be assessed before the development of BD. Thus, prospective studies investigating biomarkers underlying ED in BD before the onset of the first episode are necessary. This is crucial also because there is a lack of reliable disease biomarkers in BD (<xref rid="B296" ref-type="bibr">296</xref>, <xref rid="B297" ref-type="bibr">297</xref>) and this is partly due to the cross-sectional nature of the biomarker studies (<xref rid="B298" ref-type="bibr">298</xref>). The results can help develop novel treatments (e.g., preventive emotion-based treatments) that aim to improve emotion resilience in at-risk individuals by enhancing their emotional knowledge, and regulation which in return delay the onset of the disorder or reduce the severity of pathological affective states and ED (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B299" ref-type="bibr">299</xref>). The identification of specific endophenotypes (e.g., aberrant ER and emotion and reward processing) that reflect underlying pathophysiological processes could later be implemented in the clinical assessments to improve future diagnostic discrimination between UD and BD (<xref rid="B29" ref-type="bibr">29</xref>). However, despite the need for large cohort studies, obtaining funding has been a hurdle (<xref rid="B300" ref-type="bibr">300</xref>). Many cohort studies (e.g., Iowa 500, STEP- BD, EMBLEM, WAVE-BD, the Stanley Foundation Network, FACE-BD, CIBERSAM) were limited in time due to short-term funding, missing the opportunity of following the participants over a long time (<xref rid="B300" ref-type="bibr">300</xref>). Therefore, the creation of an international early BD data network could coordinate international big data approaches and integrate with real-world clinical interventions (<xref rid="B298" ref-type="bibr">298</xref>). In addition to the promising &#x0201c;Big Data&#x0201d; and machine learning approaches, there is also a need for an overarching theoretical framework (<xref rid="B301" ref-type="bibr">301</xref>). Recently, Mansur et&#x000a0;al. (<xref rid="B301" ref-type="bibr">301</xref>) proposed a comprehensive disease model of BD. According to the model, disruptions in the network that regulates energy homeostasis, within its paths and/or nodes, leads to &#x0201c;BD-like phenomena&#x0201d; and a &#x0201c;BD-like clinical trajectory&#x0201d;, applying the equifinality principle and the &#x0201c;homeostatic property cluster&#x0201d; concept (<xref rid="B301" ref-type="bibr">301</xref>). This disease model could also be tested longitudinally in its relation to ED in BD as research showed that subjective mood in BD is directly affected by subjective energy and objectively measured activity (<xref rid="B283" ref-type="bibr">283</xref>).</p></sec></sec><sec sec-type="conclusions" id="s10"><title>Conclusions</title><p>ED is a transdiagnostic construct observed in individuals with BD and is significantly correlated with its symptomatology (<xref rid="B40" ref-type="bibr">40</xref>). While ED is recognized as a transdiagnostic dimension and a potential target for personalized interventions, it is essential to delineate the aspects of ED that are specific to BD versus those shared with other psychiatric disorders (<xref rid="B13" ref-type="bibr">13</xref>). Various biological mechanisms, including altered structural and functional brain alterations, inflammation, HPA axis, dysfunction, genetics and circadian rhythm disruptions, have been linked to ED in BD. Despite this, ER has often been studied independently of these biological underpinnings. Given the strong evidence connecting biological mechanisms to ER difficulties in BD, adopting a more integrative perspective is both timely and necessary.</p><p>If robust evidence supports the hypothesis that biological mechanisms underpin emotional difficulties in BD, it could offer a novel framework for understanding and treating these challenges (<xref rid="B25" ref-type="bibr">25</xref>). However, no biomarker for BD has yet demonstrated sufficient robustness, specificity, or clinical utility for diagnostic or therapeutic use (<xref rid="B302" ref-type="bibr">302</xref>). This gap in understanding the pathophysiology of BD and the lack of reliable biomarkers have constrained clinical practice to a trial-and-error approach (<xref rid="B303" ref-type="bibr">303</xref>). To address these limitations, larger-scale and more comprehensive studies are needed to generate conclusive results and identify potential clinico-pathological correlates and subgroups within BD (<xref rid="B302" ref-type="bibr">302</xref>). Longitudinal, international cohort studies with repeated multiple biomarkers that integrate peripheral blood measures, electrophysiology, neuroimaging and cognitive neuroscience, coupled by deep clinical phenotyping may overcome current methodological problems in biomarker studies in psychiatry (<xref rid="B296" ref-type="bibr">296</xref>).</p><p>Integrating advanced biomarker research with investigations into emotional processes in BD could promote a more holistic understanding of functionality and vulnerability, ultimately informing novel treatment interventions (<xref rid="B25" ref-type="bibr">25</xref>). Such research may also facilitate the development of a new biological model of emotion in BD, focusing on the interaction of various biological systems involved in both voluntary and automatic processes of ER. This model could not only elucidate the biological basis of ER in BD but also be extended to youth at risk for BD, enabling earlier interventions and preventive strategies. Furthermore, exploring how ER difficulties respond to targeted biological interventions, such as treatments addressing inflammation or cognitive impairments, could clarify the directional relationship between biological factors and ER in BD. This knowledge has the potential to significantly advance the understanding and treatment of ED in BD (<xref rid="B25" ref-type="bibr">25</xref>).</p></sec></body><back><sec sec-type="author-contributions" id="s11"><title>Author contributions</title><p>BBD: Conceptualization, Methodology, Project administration, Writing &#x02013; original draft. IMM: Conceptualization, Methodology, Supervision, Writing &#x02013; review &#x00026; editing. AC: Conceptualization, Methodology, Supervision, Writing &#x02013; review &#x00026; editing. CW: Conceptualization, Methodology, Supervision, Writing &#x02013; review &#x00026; editing. MRB: Conceptualization, Methodology, Supervision, Writing &#x02013; review &#x00026; editing. SM: Conceptualization, Methodology, Supervision, Writing &#x02013; review &#x00026; editing.</p></sec><sec sec-type="COI-statement" id="s13"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="s14"><title>Generative AI statement</title><p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="s15"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McIntyre</surname><given-names>RS</given-names></name><name><surname>Alda</surname><given-names>M</given-names></name><name><surname>Baldessarini</surname><given-names>RJ</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name><name><surname>Correll</surname><given-names>CU</given-names></name><etal/></person-group>. <article-title>The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management</article-title>. <source>World Psychiatry</source>. (<year>2022</year>) <volume>21</volume>:<page-range>364&#x02013;87</page-range>.</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yatham</surname><given-names>LN</given-names></name><name><surname>Kauer-Sant&#x02019;Anna</surname><given-names>M</given-names></name><name><surname>Bond</surname><given-names>DJ</given-names></name><name><surname>Lam</surname><given-names>RW</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name></person-group>. <article-title>Innovation in bipolar disorder treatment</article-title>. <source>Nat Rev Drug Discovery</source>. (<year>2018</year>) <volume>17</volume>:<fpage>387</fpage>&#x02013;<lpage>405</lpage>.</mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McKnight</surname><given-names>RF</given-names></name><name><surname>Bilderbeck</surname><given-names>AC</given-names></name><name><surname>Miklowitz</surname><given-names>DJ</given-names></name><name><surname>Hinds</surname><given-names>C</given-names></name><name><surname>Goodwin</surname><given-names>GM</given-names></name><name><surname>Geddes</surname><given-names>JR</given-names></name></person-group>. <article-title>Longitudinal mood monitoring in bipolar disorder: course of illness as revealed through a short messaging service</article-title>. <source>J Affect Disord</source>. (<year>2017</year>) <volume>223</volume>:<page-range>139&#x02013;45</page-range>.</mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harrison</surname><given-names>PJ</given-names></name><name><surname>Cipriani</surname><given-names>A</given-names></name><name><surname>Harmer</surname><given-names>CJ</given-names></name><name><surname>Nobre</surname><given-names>AC</given-names></name><name><surname>Saunders</surname><given-names>K</given-names></name><name><surname>Goodwin</surname><given-names>GM</given-names></name><etal/></person-group>. <article-title>Innovative approaches to bipolar disorder and its treatment</article-title>. <source>Ann New York Acad Sci</source>. (<year>2016</year>) <volume>1366</volume>:<fpage>76</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="pmid">27111134</pub-id>
</mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mason</surname><given-names>L</given-names></name><name><surname>Eldar</surname><given-names>E</given-names></name><name><surname>Rutledge</surname><given-names>RB</given-names></name></person-group>. <article-title>Mood instability and reward dysregulation&#x02014;a neurocomputational model of bipolar disorder</article-title>. <source>JAMA Psychiatry</source>. (<year>2017</year>) <volume>74</volume>:<page-range>1275&#x02013;6</page-range>.</mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beauchaine</surname><given-names>TP</given-names></name><name><surname>Cicchetti</surname><given-names>D</given-names></name></person-group>. <article-title>Emotion dysregulation and emerging psychopathology: A transdiagnostic, transdisciplinary perspective</article-title>. <source>Dev Psychopathol</source>. (<year>2019</year>) <volume>31</volume>:<fpage>799</fpage>&#x02013;<lpage>804</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1017/S0954579419000671</pub-id>
<pub-id pub-id-type="pmid">31290735</pub-id>
</mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Broome</surname><given-names>MR</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Iftikhar</surname><given-names>M</given-names></name><name><surname>Eyden</surname><given-names>J</given-names></name><name><surname>Marwaha</surname><given-names>S</given-names></name></person-group>. <article-title>Neurobiological and behavioural studies of affective instability in clinical populations: a systematic review</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2015</year>) <volume>51</volume>:<page-range>243&#x02013;54</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neubiorev.2015.01.021</pub-id>
</mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marwaha</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Broome</surname><given-names>M</given-names></name><name><surname>Singh</surname><given-names>SP</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>Eyden</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>How is affective instability defined and measured? A systematic review</article-title>. <source>psychol Med</source>. (<year>2014</year>) <volume>44</volume>:<page-range>1793&#x02013;808</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1017/S0033291713002407</pub-id>
</mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marwaha</surname><given-names>S</given-names></name><name><surname>Price</surname><given-names>C</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>Weich</surname><given-names>S</given-names></name><name><surname>Cairns</surname><given-names>A</given-names></name><name><surname>Dale</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Affective instability in those with and without mental disorders: a case control study</article-title>. <source>J Affect Disord</source>. (<year>2018</year>) <volume>241</volume>:<page-range>492&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2018.08.046</pub-id>
</mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>D&#x02019;Agostino</surname><given-names>A</given-names></name><name><surname>Covanti</surname><given-names>S</given-names></name><name><surname>Rossi Monti</surname><given-names>M</given-names></name><name><surname>Starcevic</surname><given-names>V</given-names></name></person-group>. <article-title>Reconsidering emotion dysregulation</article-title>. <source>Psychiatr Q</source>. (<year>2017</year>) <volume>88</volume>:<page-range>807&#x02013;25</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s11126-017-9499-6</pub-id>
</mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thompson</surname><given-names>RA</given-names></name></person-group>. <article-title>Emotion dysregulation: A theme in search of definition</article-title>. <source>Dev Psychopathol</source>. (<year>2019</year>) <volume>31</volume>:<page-range>805&#x02013;15</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1017/S0954579419000282</pub-id>
</mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pozzi</surname><given-names>E</given-names></name><name><surname>Vijayakumar</surname><given-names>N</given-names></name><name><surname>Rakesh</surname><given-names>D</given-names></name><name><surname>Whittle</surname><given-names>S</given-names></name></person-group>. <article-title>Neural correlates of emotion regulation in adolescents and emerging adults: A meta-analytic study</article-title>. <source>Biol Psychiatry</source>. (<year>2021</year>) <volume>89</volume>:<fpage>194</fpage>&#x02013;<lpage>204</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.biopsych.2020.08.006</pub-id>
<pub-id pub-id-type="pmid">33268030</pub-id>
</mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Prisco</surname><given-names>M</given-names></name><name><surname>Villani</surname><given-names>A</given-names></name><name><surname>Della Vecchia</surname><given-names>A</given-names></name><name><surname>Gaudiano</surname><given-names>C</given-names></name><name><surname>Cigliano</surname><given-names>G</given-names></name><name><surname>Cecere</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Emotion dysregulation in bipolar disorder compared to other mental illnesses: a systematic review and meta-analysis</article-title>. <source>psychol Med</source>. (<year>2023</year>) <volume>53</volume>:<page-range>7484&#x02013;503</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1017/S003329172300243X</pub-id>
</mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Rheenen</surname><given-names>TE</given-names></name><name><surname>Murray</surname><given-names>G</given-names></name><name><surname>Rossell</surname><given-names>SL</given-names></name></person-group>. <article-title>Emotion regulation in bipolar disorder: profile and utility in predicting trait mania and depression propensity</article-title>. <source>Psychiatry Res</source>. (<year>2015</year>) <volume>225</volume>:<page-range>425&#x02013;32</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.psychres.2014.12.001</pub-id>
</mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Artiach Hortelano</surname><given-names>P</given-names></name><name><surname>Martens</surname><given-names>MA</given-names></name><name><surname>Pringle</surname><given-names>A</given-names></name><name><surname>Harmer</surname><given-names>CJ</given-names></name></person-group>. <article-title>Effect of lithium administration on brain activity under an emotion regulation paradigm in healthy participants: a functional magnetic resonance imaging study</article-title>. <source>Psychopharmacology</source>. (<year>2023</year>) <volume>240</volume>:<page-range>1719&#x02013;34</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s00213-023-06395-7</pub-id>
</mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brady</surname><given-names>RO</given-names></name><name><surname>Masters</surname><given-names>GA</given-names></name><name><surname>Mathew</surname><given-names>IT</given-names></name><name><surname>Margolis</surname><given-names>A</given-names></name><name><surname>Cohen</surname><given-names>B</given-names></name><name><surname>Keshavan</surname><given-names>MS</given-names></name><etal/></person-group>. <article-title>State dependent cortico-amygdala circuit dysfunction in bipolar disorder</article-title>. <source>J Affect Disord</source>. (<year>2016</year>) <volume>201</volume>:<fpage>79</fpage>&#x02013;<lpage>87</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2016.04.052</pub-id>
<pub-id pub-id-type="pmid">27177299</pub-id>
</mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnson</surname><given-names>SL</given-names></name><name><surname>Tharp</surname><given-names>JA</given-names></name><name><surname>Peckham</surname><given-names>AD</given-names></name><name><surname>McMaster</surname><given-names>KJ</given-names></name></person-group>. <article-title>Emotion in bipolar I disorder: Implications for functional and symptom outcomes</article-title>. <source>J Abnormal Psychol</source>. (<year>2016</year>) <volume>125</volume>:<fpage>40</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1037/abn0000116</pub-id>
</mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Ji</surname><given-names>E</given-names></name><name><surname>Tang</surname><given-names>F</given-names></name><name><surname>Magioncalda</surname><given-names>P</given-names></name><name><surname>Martino</surname><given-names>M</given-names></name><name><surname>Mathalon</surname><given-names>DH</given-names></name><etal/></person-group>. <article-title>Abnormal brain activation during emo- tion processing of euthymic bipolar patients taking different mood stabilizers</article-title>. <source>Brain Imag Behav</source>. (<year>2019</year>) <volume>13</volume>:<page-range>905&#x02013;13</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s11682-018-9915-z</pub-id>
</mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Faurholt-Jepsen</surname><given-names>M</given-names></name><name><surname>Frost</surname><given-names>M</given-names></name><name><surname>Busk</surname><given-names>J</given-names></name><name><surname>Christensen</surname><given-names>EM</given-names></name><name><surname>Bardram</surname><given-names>JE</given-names></name><name><surname>Vinberg</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Is smartphone-based mood instability associated with stress, quality of life, and functioning in bipolar disorder</article-title>? <source>Bipolar Disord</source>. (<year>2019</year>) <volume>21</volume>:<page-range>611&#x02013;20</page-range>.</mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Faurholt-Jepsen</surname><given-names>M</given-names></name><name><surname>Busk</surname><given-names>J</given-names></name><name><surname>Bardram</surname><given-names>JE</given-names></name><name><surname>Stanislaus</surname><given-names>S</given-names></name><name><surname>Frost</surname><given-names>M</given-names></name><name><surname>Christensen</surname><given-names>EM</given-names></name><etal/></person-group>. <article-title>Mood instability and activity/energy instability in patients with bipolar disorder according to day-to-day smartphone-based data&#x02013;An exploratory <italic>post hoc</italic> study</article-title>. <source>J Affect Disord</source>. (<year>2023</year>) <volume>334</volume>:<fpage>83</fpage>&#x02013;<lpage>91</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2023.04.139</pub-id>
<pub-id pub-id-type="pmid">37149047</pub-id>
</mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rucklidge</surname><given-names>JJ</given-names></name></person-group>. <article-title>Psychosocial functioning of adolescents with and without paediatric bipolar disorder</article-title>. <source>J Affect. Disord</source>. (<year>2006</year>) <volume>91</volume>:<page-range>181&#x02013;8</page-range>.</mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ulusoy</surname><given-names>SI</given-names></name><name><surname>G&#x000fc;lseren</surname><given-names>&#x0015e;.A</given-names></name><name><surname>&#x000d6;zkan</surname><given-names>N</given-names></name><name><surname>Bilen</surname><given-names>C</given-names></name></person-group>. <article-title>Facial emotion recognition deficits in patients with bipolar disorder and their healthy par- ents</article-title>. <source>Gen Hosp Psychiatry</source>. (<year>2020</year>) <volume>65</volume>:<fpage>9</fpage>&#x02013;<lpage>14</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.genhosppsych.2020.04.008</pub-id>
<pub-id pub-id-type="pmid">32361661</pub-id>
</mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Muhtadie</surname><given-names>L</given-names></name><name><surname>Johnson</surname><given-names>SL</given-names></name><name><surname>Carver</surname><given-names>CS</given-names></name><name><surname>Gotlib</surname><given-names>IH</given-names></name><name><surname>Ketter</surname><given-names>TA</given-names></name></person-group>. <article-title>A profile approach to impulsivity in bipolar disorder: The key role of strong emotions</article-title>. <source>Acta Psychiatrica Scandinavica</source>. (<year>2014</year>) <volume>129</volume>:<page-range>100&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/acps.12136</pub-id>
</mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gruber</surname><given-names>J</given-names></name><name><surname>Harvey</surname><given-names>AG</given-names></name><name><surname>Gross</surname><given-names>JJ</given-names></name></person-group>. <article-title>When trying is not enough: Emotion regulation and the effort&#x02013;success gap in bipolar disorder</article-title>. <source>Emotion</source>. (<year>2012</year>) <volume>12</volume>:<fpage>997</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1037/a0026822</pub-id>
<pub-id pub-id-type="pmid">22251049</pub-id>
</mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lima</surname><given-names>IM</given-names></name><name><surname>Peckham</surname><given-names>AD</given-names></name><name><surname>Johnson</surname><given-names>SL</given-names></name></person-group>. <article-title>Cognitive deficits in bipolar disorders: Implications for emotion</article-title>. <source>Clin Psychol Rev</source>. (<year>2018</year>) <volume>59</volume>:<page-range>126&#x02013;36</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.cpr.2017.11.006</pub-id>
</mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnson</surname><given-names>SL</given-names></name><name><surname>Carver</surname><given-names>CS</given-names></name></person-group>. <article-title>Emotion-relevant impulsivity predicts sustained anger and aggression after remission in bipolar I disorder</article-title>. <source>J Affect Disord</source>. (<year>2016</year>) <volume>189</volume>:<page-range>169&#x02013;75</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2015.07.050</pub-id>
</mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnson</surname><given-names>SL</given-names></name><name><surname>Carver</surname><given-names>CS</given-names></name><name><surname>Tharp</surname><given-names>JA</given-names></name></person-group>. <article-title>Suicidality in bipolar disorder: The role of emotion-triggered impulsivity</article-title>. <source>Suicide Life-threatening Behav</source>. (<year>2017</year>) <volume>47</volume>:<page-range>177&#x02013;92</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/sltb.12274</pub-id>
</mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kj&#x000e6;rstad</surname><given-names>HL</given-names></name><name><surname>Mistarz</surname><given-names>N</given-names></name><name><surname>Coello</surname><given-names>K</given-names></name><name><surname>Stanislaus</surname><given-names>S</given-names></name><name><surname>Melbye</surname><given-names>SA</given-names></name><name><surname>Harmer</surname><given-names>CJ</given-names></name><etal/></person-group>. <article-title>Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives</article-title>. <source>psychol Med</source>. (<year>2020</year>) <volume>50</volume>:<page-range>1808&#x02013;19</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1017/S0033291719001867</pub-id>
</mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miskowiak</surname><given-names>KW</given-names></name><name><surname>Kjaerstad</surname><given-names>HL</given-names></name><name><surname>Meluken</surname><given-names>I</given-names></name><name><surname>Petersen</surname><given-names>JZ</given-names></name><name><surname>Maciel</surname><given-names>BR</given-names></name><name><surname>Kohler</surname><given-names>CA</given-names></name><etal/></person-group>. <article-title>The search for neuroimaging and cognitive endophenotypes: a critical systematic review of studies involving unaffected first-degree relatives of individuals with bipolar disorder</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2017</year>) <volume>73</volume>:<fpage>1</fpage>&#x02013;<lpage>22</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.12.011</pub-id>
<pub-id pub-id-type="pmid">27979650</pub-id>
</mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Birmaher</surname><given-names>B</given-names></name><name><surname>Goldstein</surname><given-names>BI</given-names></name><name><surname>Axelson</surname><given-names>DA</given-names></name><name><surname>Monk</surname><given-names>K</given-names></name><name><surname>Hickey</surname><given-names>MB</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Mood lability among offspring of parents with bipolar disorder and community controls</article-title>. <source>Bipolar Disord</source>. (<year>2013</year>) <volume>15</volume>:<page-range>253&#x02013;63</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/bdi.2013.15.issue-3</pub-id>
</mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kessing</surname><given-names>LV</given-names></name><name><surname>Miskowiak</surname><given-names>K</given-names></name></person-group>. <article-title>Does cognitive dysfunction in bipolar disorder qualify as a diagnostic intermediate phenotype? &#x02013; A perspective paper</article-title>. <source>Front Psychiatry</source>. (<year>2018</year>) <volume>9</volume>:<fpage>1</fpage>&#x02013;<lpage>7</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fpsyt.2018.00490</pub-id>
<pub-id pub-id-type="pmid">29410632</pub-id>
</mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Almeida</surname><given-names>JRC</given-names></name><name><surname>Phillips</surname><given-names>ML</given-names></name></person-group>. <article-title>Distinguishing between unipolar depression and bipolar depression: current and future clinical and neuroimaging perspectives</article-title>. <source>Biol Psychiatry</source>. (<year>2013</year>) <volume>73</volume>:<page-range>111&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.biopsych.2012.06.010</pub-id>
</mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Phillips</surname><given-names>ML</given-names></name><name><surname>Ladouceur</surname><given-names>CD</given-names></name><name><surname>Drevets</surname><given-names>WC</given-names></name></person-group>. <article-title>A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder</article-title>. <source>Mol Psychiatry</source>. (<year>2008</year>) <volume>13</volume>:<page-range>833&#x02013;57</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/mp.2008.65</pub-id>
</mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Townsend</surname><given-names>JD</given-names></name><name><surname>Torrisi</surname><given-names>SJ</given-names></name><name><surname>Lieberman</surname><given-names>MD</given-names></name><name><surname>Sugar</surname><given-names>CA</given-names></name><name><surname>Bookheimer</surname><given-names>SY</given-names></name><name><surname>Altshuler</surname><given-names>LL</given-names></name></person-group>. <article-title>Frontal-amygdala connectivity alterations during emotion downregulation in bipolar I disorder</article-title>. <source>Biological Psychiatry</source>. (<year>2013</year>) <volume>73</volume>(<issue>2</issue>):<page-range>127&#x02013;35</page-range>.</mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kanske</surname><given-names>P</given-names></name><name><surname>Sch&#x000f6;nfelder</surname><given-names>S</given-names></name><name><surname>Forneck</surname><given-names>J</given-names></name><name><surname>Wessa</surname><given-names>M</given-names></name></person-group>. <article-title>Impaired regulation of emotion: neural correlates of reappraisal and distraction in bipolar disorder and unaffected relatives</article-title>. <source>Trans Psychiatry</source>. (<year>2015</year>) <volume>5</volume>:<page-range>e497&#x02013;7</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/tp.2014.137</pub-id>
</mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kj&#x000e6;rstad</surname><given-names>HL</given-names></name><name><surname>de Siqueira Rotenberg</surname><given-names>L</given-names></name><name><surname>Knudsen</surname><given-names>GM</given-names></name><name><surname>Vinberg</surname><given-names>M</given-names></name><name><surname>Kessing</surname><given-names>LV</given-names></name><name><surname>Macoveanu</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>The longitudinal trajectory of emotion regulation and associated neural activity in patients with bipolar disorder: a prospective fMRI study</article-title>. <source>Acta Psychiatrica Scandinavica</source>. (<year>2022</year>) <volume>146</volume>:<page-range>568&#x02013;82</page-range>.</mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mesbah</surname><given-names>R</given-names></name><name><surname>Koenders</surname><given-names>MA</given-names></name><name><surname>van der Wee</surname><given-names>NJ</given-names></name><name><surname>Giltay</surname><given-names>EJ</given-names></name><name><surname>van Hemert</surname><given-names>AM</given-names></name><name><surname>de Leeuw</surname><given-names>M</given-names></name></person-group>. <article-title>Association between the fronto-limbic network and cognitive and emotional functioning in individuals with bipolar disorder: a systematic review and meta-analysis</article-title>. <source>JAMA Psychiatry</source>. (<year>2023</year>) <volume>80</volume>:<page-range>432&#x02013;40</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2023.0131</pub-id>
</mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Townsend</surname><given-names>J</given-names></name><name><surname>Altshuler</surname><given-names>LL</given-names></name></person-group>. <article-title>Emotion processing and regulation in bipolar disorder: a review</article-title>. <source>Bipolar Disord</source>. (<year>2012</year>) <volume>14</volume>:<page-range>326&#x02013;39</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.1399-5618.2012.01021.x</pub-id>
</mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dodd</surname><given-names>A</given-names></name><name><surname>Lockwood</surname><given-names>E</given-names></name><name><surname>Mansell</surname><given-names>W</given-names></name><name><surname>Palmier-Claus</surname><given-names>J</given-names></name></person-group>. <article-title>Emotion regulation strategies in bipolar disorder: A systematic and critical review</article-title>. <source>J Affect Disord</source>. (<year>2019</year>) <volume>246</volume>:<page-range>262&#x02013;84</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2018.12.026</pub-id>
</mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oliva</surname><given-names>V</given-names></name><name><surname>De Prisco</surname><given-names>M</given-names></name><name><surname>Fico</surname><given-names>G</given-names></name><name><surname>Possidente</surname><given-names>C</given-names></name><name><surname>Fortea</surname><given-names>L</given-names></name><name><surname>Montejo</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Correlation between emotion dysregulation and mood symptoms of bipolar disorder: A systematic review and meta-analysis</article-title>. <source>Acta Psychiatrica Scandinavica</source>. (<year>2023</year>) <volume>148</volume>:<page-range>472&#x02013;90</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/acps.v148.6</pub-id>
</mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leucht</surname><given-names>S</given-names></name><name><surname>van Os</surname><given-names>J</given-names></name><name><surname>J&#x000e4;ger</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>JM</given-names></name></person-group>. <article-title>Prioritization of psychopathological symptoms and clinical characterization in psychiatric diagnoses: A narrative review</article-title>. <source>JAMA Psychiatry</source>. (<year>2024</year>). doi:&#x000a0;<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2024.2652</pub-id>
</mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Uher</surname><given-names>R</given-names></name><name><surname>Zwicker</surname><given-names>A</given-names></name></person-group>. <article-title>Etiology in psychiatry: embracing the reality of poly-gene-environmental causation of mental illness</article-title>. <source>World Psychiatry</source>. (<year>2017</year>) <volume>16</volume>:<page-range>121&#x02013;9</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/wps.20436</pub-id>
</mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carpenter</surname><given-names>JS</given-names></name><name><surname>Crouse</surname><given-names>JJ</given-names></name><name><surname>Scott</surname><given-names>EM</given-names></name><name><surname>Naismith</surname><given-names>SL</given-names></name><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Circadian depression: a mood disorder phenotype</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2021</year>) <volume>126</volume>:<fpage>79</fpage>&#x02013;<lpage>101</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neubiorev.2021.02.045</pub-id>
<pub-id pub-id-type="pmid">33689801</pub-id>
</mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bigot</surname><given-names>M</given-names></name><name><surname>Alonso</surname><given-names>M</given-names></name><name><surname>Houenou</surname><given-names>J</given-names></name><name><surname>Sarrazin</surname><given-names>S</given-names></name><name><surname>Darg&#x000e9;l</surname><given-names>AA</given-names></name><name><surname>Lledo</surname><given-names>PM</given-names></name><etal/></person-group>. <article-title>An emotional-response model of bipolar disorders integrating recent findings on amygdala circuits</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2020</year>) <volume>118</volume>:<page-range>358&#x02013;66</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neubiorev.2020.07.037</pub-id>
</mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kj&#x000e6;rstad</surname><given-names>HL</given-names></name><name><surname>S&#x000f8;hol</surname><given-names>K</given-names></name><name><surname>Vinberg</surname><given-names>M</given-names></name><name><surname>Kessing</surname><given-names>LV</given-names></name><name><surname>Miskowiak</surname><given-names>KW</given-names></name></person-group>. <article-title>The trajectory of emotional and non-emotional cognitive function in newly diagnosed patients with bipolar disorder and their unaffected relatives: A 16-month follow-up study</article-title>. <source>Eur Neuropsychopharmacol</source>. (<year>2023</year>) <volume>67</volume>:<fpage>4</fpage>&#x02013;<lpage>21</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.euroneuro.2022.11.004</pub-id>
<pub-id pub-id-type="pmid">36462414</pub-id>
</mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McIntyre</surname><given-names>RS</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name><name><surname>Brietzke</surname><given-names>E</given-names></name><name><surname>Goldstein</surname><given-names>BI</given-names></name><name><surname>L&#x000f3;pez-Jaramillo</surname><given-names>C</given-names></name><name><surname>Kessing</surname><given-names>LV</given-names></name><etal/></person-group>. <article-title>Bipolar disorders</article-title>. <source>Lancet</source>. (<year>2020</year>) <volume>396</volume>:<page-range>1841&#x02013;56</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/S0140-6736(20)31544-0</pub-id>
</mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Young</surname><given-names>AH</given-names></name><name><surname>Juruena</surname><given-names>MF</given-names></name></person-group>. <article-title>The neurobiology of bipolar disorder</article-title>. In: <source>Bipolar disorder: from neuroscience to treatment</source> (<year>2021</year>) <publisher-loc>Cham, Switzerland</publisher-loc>: <publisher-name>Springer</publisher-name>. p. <fpage>1</fpage>&#x02013;<lpage>20</lpage>.</mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rowland</surname><given-names>T</given-names></name><name><surname>Perry</surname><given-names>BI</given-names></name><name><surname>Upthegrove</surname><given-names>R</given-names></name><name><surname>Barnes</surname><given-names>N</given-names></name><name><surname>Chatterjee</surname><given-names>J</given-names></name><name><surname>Gallacher</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses</article-title>. <source>Br J Psychiatry</source>. (<year>2018</year>) <volume>213</volume>:<page-range>514&#x02013;25</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1192/bjp.2018.144</pub-id>
</mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hibar</surname><given-names>DP</given-names></name><name><surname>Westlye</surname><given-names>LT</given-names></name><name><surname>Doan</surname><given-names>NT</given-names></name><name><surname>Jahanshad</surname><given-names>N</given-names></name><name><surname>Cheung</surname><given-names>JW</given-names></name><name><surname>Ching</surname><given-names>CRK</given-names></name><etal/></person-group>. <article-title>Cortical abnormalities in bipolar disor- der: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group</article-title>. <source>Mol Psychiatry</source>. (<year>2017</year>) <volume>22</volume>:<page-range>1231&#x02013;9</page-range>.</mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Phillips</surname><given-names>ML</given-names></name><name><surname>Swartz</surname><given-names>HA</given-names></name></person-group>. <article-title>A critical appraisal of neuroimaging studies of bipolar disorder: toward a new concep- tualization of underlying neural circuitry and a road map for future research</article-title>. <source>Am J Psychiatry</source>. (<year>2014</year>) <volume>171</volume>:<page-range>829&#x02013;43</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1176/appi.ajp.2014.13081008</pub-id>
</mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wise</surname><given-names>T</given-names></name><name><surname>Radua</surname><given-names>J</given-names></name><name><surname>Via</surname><given-names>E</given-names></name><name><surname>Cardoner</surname><given-names>N</given-names></name><name><surname>Abe</surname><given-names>O</given-names></name><name><surname>Adams</surname><given-names>TM</given-names></name><etal/></person-group>. <article-title>Voxel-based meta-analytical evidence of structural disconnectivity in major depression and bipolar disorder</article-title>. <source>Biol Psychiatry</source>. (<year>2016</year>) <volume>79</volume>:<fpage>293</fpage>&#x02013;<lpage>302</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.biopsych.2015.03.004</pub-id>
<pub-id pub-id-type="pmid">25891219</pub-id>
</mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>NC</given-names></name><name><surname>Andreazza</surname><given-names>AC</given-names></name><name><surname>Young</surname><given-names>LT</given-names></name></person-group>. <article-title>An updated meta-analysis of oxidative stress markers in bipolar disorder</article-title>. <source>Psychiatry Research</source>. (<year>2014</year>) <volume>218</volume>(<issue>1&#x02013;2</issue>):<page-range>61&#x02013;68</page-range>.</mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andreazza</surname><given-names>AC</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Young</surname><given-names>LT</given-names></name><name><surname>Yatham</surname><given-names>LN</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name><name><surname>Shao</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Bipolar disorder as a mitochondrial disease</article-title>. <source>Biol Psychiatry</source>. (<year>2017</year>) <volume>81</volume>:<fpage>2017</fpage>.</mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goldsmith</surname><given-names>DR</given-names></name><name><surname>Rapaport</surname><given-names>MH</given-names></name><name><surname>Miller</surname><given-names>BJ</given-names></name><name><surname>Ellman</surname><given-names>LM</given-names></name><name><surname>Robinson</surname><given-names>DG</given-names></name><name><surname>Addington</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression</article-title>. <source>Mol Psychiatry</source>. (<year>2016</year>) <volume>21</volume>:<page-range>1696&#x02013;709</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/mp.2016.3</pub-id>
</mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Melo</surname><given-names>MCA</given-names></name><name><surname>Abreu</surname><given-names>RLC</given-names></name><name><surname>Linhares Neto</surname><given-names>VB</given-names></name><name><surname>de Bruin</surname><given-names>PFC</given-names></name><name><surname>de Bruin</surname><given-names>VMS</given-names></name></person-group>. <article-title>Chronotype and circadian rhythm in bipolar disorder: a systematic review</article-title>. <source>Sleep Med Rev</source>. (<year>2017</year>) <volume>34</volume>:<fpage>46</fpage>&#x02013;<lpage>58</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.smrv.2016.06.007</pub-id>
<pub-id pub-id-type="pmid">27524206</pub-id>
</mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ashok</surname><given-names>AH</given-names></name><name><surname>Marques</surname><given-names>TR</given-names></name><name><surname>Jauhar</surname><given-names>S</given-names></name><name><surname>Nour</surname><given-names>MM</given-names></name><name><surname>Goodwin</surname><given-names>GM</given-names></name><name><surname>Young</surname><given-names>AH</given-names></name><etal/></person-group>. <article-title>The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment</article-title>. <source>Mol Psychiatry</source>. (<year>2017</year>) <volume>22</volume>:<page-range>666&#x02013;79</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/mp.2017.16</pub-id>
</mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Anderson</surname><given-names>G</given-names></name><name><surname>Maes</surname><given-names>M</given-names></name></person-group>. <article-title>Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites</article-title>. <source>Curr Psychiatry Rep</source>. (<year>2015</year>) <volume>17</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s11920-014-0541-1</pub-id>
<pub-id pub-id-type="pmid">25617038</pub-id>
</mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andreazza</surname><given-names>AC</given-names></name><name><surname>Young</surname><given-names>LT</given-names></name></person-group>. <article-title>The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment</article-title>. <source>Int J Neuropsychopharmacol</source>. (<year>2014</year>) <volume>17</volume>:<page-range>1039&#x02013;52</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1017/S1461145713000096</pub-id>
</mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berk</surname><given-names>M</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name><name><surname>Andreazza</surname><given-names>AC</given-names></name><name><surname>Dean</surname><given-names>OM</given-names></name><name><surname>Giorlando</surname><given-names>F</given-names></name><name><surname>Maes</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2011</year>) <volume>35</volume>:<page-range>804&#x02013;17</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neubiorev.2010.10.001</pub-id>
</mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miskowiak</surname><given-names>KW</given-names></name><name><surname>Seeberg</surname><given-names>I</given-names></name><name><surname>Kjaerstad</surname><given-names>HL</given-names></name><name><surname>Burdick</surname><given-names>KE</given-names></name><name><surname>Martinez-Aran</surname><given-names>A</given-names></name><name><surname>del Mar Bonnin</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Affective cognition in bipolar disorder: a systematic review by the ISBD targeting cognition task force</article-title>. <source>Bipolar Disord</source>. (<year>2019</year>) <volume>21</volume>:<fpage>686</fpage>&#x02013;<lpage>719</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/bdi.12834</pub-id>
<pub-id pub-id-type="pmid">31491048</pub-id>
</mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Van Rheenen</surname><given-names>TE</given-names></name><name><surname>Ganella</surname><given-names>EP</given-names></name><name><surname>Bauer</surname><given-names>IE</given-names></name><name><surname>Bartholomeusz</surname><given-names>CF</given-names></name></person-group>. <article-title>Characterization of social cognitive deficits on the schizophrenia- bipolar disorder spectrum: an overview of current evidence</article-title>. In: <person-group person-group-type="editor"><name><surname>Lewandowski</surname><given-names>KE</given-names></name><name><surname>Moustafa</surname><given-names>AA</given-names></name></person-group>, editors. <source>Social cognition in psychosis</source>, <edition>1 ed</edition>. <publisher-name>Elsevier</publisher-name>, <publisher-loc>Cambridge, MA</publisher-loc> (<year>2019</year>).</mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cotter</surname><given-names>J</given-names></name><name><surname>Barnett</surname><given-names>JH</given-names></name></person-group>. <article-title>Using affective cognition to enhance precision psychiatry</article-title>. <source>Front Psychiatry</source>. (<year>2018</year>) <volume>9</volume>:<elocation-id>288</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fpsyt.2018.00288</pub-id>
<pub-id pub-id-type="pmid">30008680</pub-id>
</mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Powers</surname><given-names>A</given-names></name><name><surname>Almli</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Lori</surname><given-names>A</given-names></name><name><surname>Leveille</surname><given-names>J</given-names></name><name><surname>Ressler</surname><given-names>KJ</given-names></name><etal/></person-group>. <article-title>A genome-wide association study of emotion dysregulation: Evidence for interleukin 2 receptor alpha</article-title>. <source>J Psychiatr Res</source>. (<year>2016</year>) <volume>83</volume>:<fpage>195</fpage>&#x02013;<lpage>202</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jpsychires.2016.09.006</pub-id>
<pub-id pub-id-type="pmid">27643478</pub-id>
</mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tseng</surname><given-names>CEJ</given-names></name><name><surname>Gilbert</surname><given-names>TM</given-names></name><name><surname>Catanese</surname><given-names>MC</given-names></name><name><surname>Hightower</surname><given-names>BG</given-names></name><name><surname>Peters</surname><given-names>AT</given-names></name><name><surname>Parmar</surname><given-names>AJ</given-names></name><etal/></person-group>. <article-title>
<italic>In vivo</italic> human brain expression of histone deacetylases in bipolar disorder</article-title>. <source>Trans Psychiatry</source>. (<year>2020</year>) <volume>10</volume>:<fpage>224</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41398-020-00911-5</pub-id>
</mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saccaro</surname><given-names>LF</given-names></name><name><surname>Crokaert</surname><given-names>J</given-names></name><name><surname>Perroud</surname><given-names>N</given-names></name><name><surname>Piguet</surname><given-names>C</given-names></name></person-group>. <article-title>Structural and functional MRI correlates of inflammation in bipolar disorder: A systematic review</article-title>. <source>J Affect Disord</source>. (<year>2023</year>) <volume>325</volume>:<fpage>83</fpage>&#x02013;<lpage>92</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2022.12.162</pub-id>
<pub-id pub-id-type="pmid">36621677</pub-id>
</mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koenders</surname><given-names>MA</given-names></name><name><surname>Dodd</surname><given-names>AL</given-names></name><name><surname>Karl</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>MJ</given-names></name><name><surname>Elzinga</surname><given-names>BM</given-names></name><name><surname>Wright</surname><given-names>K</given-names></name></person-group>. <article-title>Understanding bipolar disorder within a biopsychosocial emotion dysregulation framework</article-title>. <source>J Affect Disord Rep</source>. (<year>2020</year>) <volume>2</volume>:<fpage>100031</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jadr.2020.100031</pub-id>
</mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hosang</surname><given-names>GM</given-names></name><name><surname>Uher</surname><given-names>R</given-names></name><name><surname>Keers</surname><given-names>R</given-names></name><name><surname>Cohen-Woods</surname><given-names>S</given-names></name><name><surname>Craig</surname><given-names>I</given-names></name><name><surname>Korszun</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder</article-title>. <source>J Affect Disord</source>. (<year>2010</year>) <volume>125</volume>:<page-range>345&#x02013;9</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2010.01.071</pub-id>
</mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alloy</surname><given-names>LB</given-names></name><name><surname>Ng</surname><given-names>TH</given-names></name><name><surname>Titone</surname><given-names>MK</given-names></name><name><surname>Boland</surname><given-names>EM</given-names></name></person-group>. <article-title>Circadian rhythm dysregulation in bipolar spectrum disorders</article-title>. <source>Curr Psychiatry Rep</source>. (<year>2017</year>) <volume>19</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s11920-017-0772-z</pub-id>
<pub-id pub-id-type="pmid">28091799</pub-id>
</mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Palagini</surname><given-names>L</given-names></name><name><surname>Cipollone</surname><given-names>G</given-names></name><name><surname>Masci</surname><given-names>I</given-names></name><name><surname>Caruso</surname><given-names>D</given-names></name><name><surname>Paolilli</surname><given-names>F</given-names></name><name><surname>Perugi</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Insomnia symptoms predict emotional dysregulation, impulsivity and suicidality in depressive bipolar II patients with mixed features</article-title>. <source>Compr Psychiatry</source>. (<year>2019</year>) <volume>89</volume>:<fpage>46</fpage>&#x02013;<lpage>51</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.comppsych.2018.12.009</pub-id>
<pub-id pub-id-type="pmid">30593973</pub-id>
</mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gordovez</surname><given-names>FJA</given-names></name><name><surname>McMahon</surname><given-names>FJ</given-names></name></person-group>. <article-title>The genetics of bipolar disorder</article-title>. <source>Mol Psychiatry</source>. (<year>2020</year>) <volume>25</volume>:<page-range>544&#x02013;59</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41380-019-0634-7</pub-id>
</mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>A</given-names></name><name><surname>Le Gal</surname><given-names>K</given-names></name><name><surname>S&#x000f6;dersten</surname><given-names>K</given-names></name><name><surname>Vizlin-Hodzic</surname><given-names>D</given-names></name><name><surname>&#x000c5;gren</surname><given-names>H</given-names></name><name><surname>Funa</surname><given-names>K</given-names></name></person-group>. <article-title>Calcium-dependent intracellular signal pathways in primary cultured adipocytes and ANK3 gene variation in patients with bipolar disorder and healthy controls</article-title>. <source>Mol Psychiatry</source>. (<year>2015</year>) <volume>20</volume>:<page-range>931&#x02013;40</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/mp.2014.104</pub-id>
</mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lim</surname><given-names>CH</given-names></name><name><surname>Zain</surname><given-names>SM</given-names></name><name><surname>Reynolds</surname><given-names>GP</given-names></name><name><surname>Zain</surname><given-names>MA</given-names></name><name><surname>Roffeei</surname><given-names>SN</given-names></name><name><surname>Zainal</surname><given-names>NZ</given-names></name><etal/></person-group>. <article-title>Genetic association of LMAN2L gene in schizophrenia and bipolar disorder and its interaction with ANK3 gene polymorphism</article-title>. <source>Progress in Neuro-Psychopharmacology and Biological Psychiatry</source>. (<year>2014</year>) <volume>54</volume>:<page-range>157&#x02013;162</page-range>.</mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lippard</surname><given-names>ETC</given-names></name><name><surname>Jensen</surname><given-names>KP</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Johnston</surname><given-names>JAY</given-names></name><name><surname>Spencer</surname><given-names>L</given-names></name><name><surname>Pittman</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Effect of ANK3 variation on gray and white matter in bipolar disorder</article-title>. <source>Mol Psychiatry</source>. (<year>2017</year>) <volume>22</volume>:<page-range>1345&#x02013;51</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/mp.2016.76</pub-id>
</mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>MAR</given-names></name><name><surname>O&#x02019;Donovan</surname><given-names>MC</given-names></name><name><surname>Meng</surname><given-names>YA</given-names></name><name><surname>Jones</surname><given-names>IR</given-names></name><name><surname>Ruderfer</surname><given-names>DM</given-names></name><name><surname>Jones</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder</article-title>. <source>Nat Genet</source>. (<year>2008</year>) <volume>40</volume>:<page-range>1056&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/ng.209</pub-id>
</mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stahl</surname><given-names>EA</given-names></name><name><surname>Breen</surname><given-names>G</given-names></name><name><surname>Forstner</surname><given-names>AJ</given-names></name><name><surname>McQuillin</surname><given-names>A</given-names></name><name><surname>Ripke</surname><given-names>S</given-names></name><name><surname>Trubetskoy</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Genome-wide association study identifies 30 loci associated with bipolar disorder</article-title>. <source>Nat Genet</source>. (<year>2019</year>) <volume>51</volume>:<fpage>793</fpage>&#x02013;<lpage>803</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41588-019-0397-8</pub-id>
<pub-id pub-id-type="pmid">31043756</pub-id>
</mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Kamatani</surname><given-names>Y</given-names></name><name><surname>Okahisa</surname><given-names>Y</given-names></name><name><surname>Kunugi</surname><given-names>H</given-names></name><name><surname>Mori</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder</article-title>. <source>Mol Psychiatry</source>. (<year>2018</year>) <volume>23</volume>:<page-range>639&#x02013;47</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/mp.2016.259</pub-id>
</mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Detera-Wadleigh</surname><given-names>SD</given-names></name><name><surname>Akula</surname><given-names>N</given-names></name><name><surname>Mallon</surname><given-names>BS</given-names></name><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Sodium valproate rescues expression of TRANK1 in iPSC-derived neural cells that carry a genetic variant associated with serious mental illness</article-title>. <source>Mol Psychiatry</source>. (<year>2019</year>) <volume>24</volume>:<page-range>613&#x02013;24</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41380-018-0207-1</pub-id>
</mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mathieu</surname><given-names>F</given-names></name><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Dizier</surname><given-names>MH</given-names></name><name><surname>Lajnef</surname><given-names>M</given-names></name><name><surname>Lathrop</surname><given-names>M</given-names></name><name><surname>Cabon</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Genetics of emotional reactivity in bipolar disorders</article-title>. <source>J Affect Disord</source>. (<year>2015</year>) <volume>188</volume>:<page-range>101&#x02013;6</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2015.08.037</pub-id>
</mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Freyberg</surname><given-names>Z</given-names></name><name><surname>Andreazza</surname><given-names>AC</given-names></name><name><surname>McClung</surname><given-names>CA</given-names></name><name><surname>Phillips</surname><given-names>ML</given-names></name></person-group>. <article-title>Linking mitochondrial dysfunction, neurotransmitter, neural network abnormalities and mania: Elucidating neurobiological mechanisms of the therapeutic effect of the ketogenic diet in Bipolar Disorder</article-title>. <source>Biol Psychiatry: Cogn Neurosci Neuroimaging</source>. (<year>2024</year>).</mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>B</given-names></name><name><surname>Dwivedi</surname><given-names>Y</given-names></name></person-group>. <article-title>Dissecting bipolar disorder complexity through epigenomic approach</article-title>. <source>Mol Psychiatry</source>. (<year>2016</year>) <volume>21</volume>:<page-range>1490&#x02013;8</page-range>.</mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>MaChado-Vieira</surname><given-names>R</given-names></name><name><surname>Ibrahim</surname><given-names>L</given-names></name><name><surname>Zarate</surname><given-names>CA</given-names><suffix>Jr</suffix></name></person-group>. <article-title>Histone deacety- lases and mood disorders: Epigenetic programming in gene- environment interactions</article-title>. <source>CNS Neurosci Ther</source>. (<year>2011</year>) <volume>17</volume>:<fpage>699</fpage>&#x02013;<lpage>704</lpage>.<pub-id pub-id-type="pmid">20961400</pub-id>
</mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ryu</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Olofsson</surname><given-names>BA</given-names></name><name><surname>Mwidau</surname><given-names>A</given-names></name><name><surname>Dedeoglu</surname><given-names>A</given-names></name><name><surname>Escudero</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>2003</year>) <volume>100</volume>:<fpage>4281</fpage>&#x02013;<lpage>4286</lpage>.<pub-id pub-id-type="pmid">12640146</pub-id>
</mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xiang</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lei</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Systematic genetic analyses of genome-wide association studydata reveal an association between the key nucleosome remodeling anddeacetylase complex and bipolar disorder development</article-title>. <source>Bipolar Disord</source>. (<year>2018</year>) <volume>20</volume>:<page-range>370&#x02013;80</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/bdi.2018.20.issue-4</pub-id>
</mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pisanu</surname><given-names>C</given-names></name><name><surname>Papadima</surname><given-names>EM</given-names></name><name><surname>Del Zompo</surname><given-names>M</given-names></name><name><surname>Squassina</surname><given-names>A</given-names></name></person-group>. <article-title>Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics</article-title>. <source>Neurosci Lett</source>. (<year>2018</year>) <volume>669</volume>:<fpage>24</fpage>&#x02013;<lpage>31</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neulet.2016.06.045</pub-id>
<pub-id pub-id-type="pmid">27343410</pub-id>
</mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Delcuve</surname><given-names>GP</given-names></name><name><surname>Khan</surname><given-names>DH</given-names></name><name><surname>Davie</surname><given-names>JR</given-names></name></person-group>. <article-title>Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors</article-title>. <source>Clin Epigenetics</source>. (<year>2012</year>) <volume>4</volume>:<fpage>5</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/1868-7083-4-5</pub-id>
<pub-id pub-id-type="pmid">22414492</pub-id>
</mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>CP</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Kundakovic</surname><given-names>M</given-names></name></person-group>. <article-title>Histone deacetylase inhibitors decrease reelin promoter methylation <italic>in vitro</italic>
</article-title>. <source>J Neurochem</source>. (<year>2005</year>) <volume>93</volume>:<page-range>483&#x02013;92</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03040.x</pub-id>
</mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Phiel</surname><given-names>CJ</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>EY</given-names></name><name><surname>Guenther</surname><given-names>MG</given-names></name><name><surname>Lazar</surname><given-names>MA</given-names></name><name><surname>Klein</surname><given-names>PS</given-names></name></person-group>. <article-title>Histone deacetylase is a direct target of valproic acid, a potentanticonvulsant, mood stabilizer, and teratogen</article-title>. <source>J.Biol.Chem</source>. (<year>2001</year>) <volume>276</volume>:<page-range>36734&#x02013;41</page-range>.</mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>S-D</given-names></name><name><surname>Huang</surname><given-names>H-L</given-names></name><name><surname>Yan</surname><given-names>L-C</given-names></name><name><surname>Yin</surname><given-names>X-F</given-names></name><name><surname>Xu</surname><given-names>H-N</given-names></name><etal/></person-group>. <article-title>Lithium down-regulates histone deacetylase 1 (HDAC1) andinduces degradation of mutant huntingtin</article-title>. <source>J Biol Chem</source>. (<year>2013</year>) <volume>288</volume>:<page-range>35604&#x02013;16</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1074/jbc.M113.479865</pub-id>
</mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leng</surname><given-names>Y</given-names></name><name><surname>Fessler</surname><given-names>EB</given-names></name><name><surname>Chuang</surname><given-names>DM</given-names></name></person-group>. <article-title>Neuroprotective effects of the mood stabilizer lamotrigine against glutamate excitotoxicity: Roles of chromatinremodelling and Bcl-2 induction</article-title>. <source>Int J Neuropsychopharmacol</source>. (<year>2013</year>) <volume>16</volume>:<page-range>607&#x02013;20</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1017/S1461145712000429</pub-id>
</mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gyurak</surname><given-names>A</given-names></name><name><surname>Gross</surname><given-names>JJ</given-names></name><name><surname>Etkin</surname><given-names>A</given-names></name></person-group>. <article-title>Explicit and implicit emotion regulation: A dual-process framework</article-title>. <source>Cogn Emotion</source>. (<year>2011</year>) <volume>25</volume>:<page-range>400&#x02013;12</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1080/02699931.2010.544160</pub-id>
</mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>C</given-names></name><name><surname>Rosenblat</surname><given-names>JD</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>Z</given-names></name><name><surname>Cao</surname><given-names>B</given-names></name><name><surname>Iacobucci</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The neural systems of emotion regulation and abnormalities in major depressive disorder</article-title>. <source>Behav Brain Res</source>. (<year>2019</year>) <volume>367</volume>:<page-range>181&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.bbr.2019.04.002</pub-id>
</mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>YB</given-names></name><name><surname>Al-Bzour</surname><given-names>AN</given-names></name><name><surname>Alzghoul</surname><given-names>SM</given-names></name><name><surname>Ibrahim</surname><given-names>RB</given-names></name><name><surname>Al-Khalili</surname><given-names>AA</given-names></name><name><surname>Ghayda&#x02019;a</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Limbic and cortical regions as functional biomarkers associated with emotion regulation in bipolar disorder: A meta-analysis of neuroimaging studies</article-title>. <source>J Affect Disord</source>. (<year>2023</year>) <volume>323</volume>:<page-range>506&#x02013;13</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2022.11.071</pub-id>
</mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>F</given-names></name><name><surname>Zhong</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Disruption of superficial white matter in the emotion regulation network in bipolar disorder</article-title>. <source>NeuroImage Clin</source>. (<year>2018</year>) <volume>20</volume>:<page-range>875&#x02013;82</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.nicl.2018.09.024</pub-id>
</mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Linke</surname><given-names>JO</given-names></name><name><surname>Stavish</surname><given-names>C</given-names></name><name><surname>Adleman</surname><given-names>NE</given-names></name><name><surname>Sarlls</surname><given-names>J</given-names></name><name><surname>Towbin</surname><given-names>KE</given-names></name><name><surname>Leibenluft</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>White matter microstructure in youth with and at risk for bipolar disorder</article-title>. <source>Bipolar Disord</source>. (<year>2020</year>) <volume>22</volume>:<page-range>163&#x02013;73</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/bdi.12885</pub-id>
</mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Acuff</surname><given-names>HE</given-names></name><name><surname>Versace</surname><given-names>A</given-names></name><name><surname>Bertocci</surname><given-names>MA</given-names></name><name><surname>Ladouceur</surname><given-names>CD</given-names></name><name><surname>Hanford</surname><given-names>LC</given-names></name><name><surname>Manelis</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Association of neuroimaging measures of emotion processing and regulation neural circuitries with symptoms of bipolar disorder in offspring at risk for bipolar disorder</article-title>. <source>JAMA Psychiatry</source>. (<year>2018</year>) <volume>75</volume>:<page-range>1241&#x02013;51</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2018.2318</pub-id>
</mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kurtz</surname><given-names>M</given-names></name><name><surname>Mohring</surname><given-names>P</given-names></name><name><surname>F&#x000f6;rster</surname><given-names>K</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Kanske</surname><given-names>P</given-names></name></person-group>. <article-title>Deficits in explicit emotion regulation in bipolar disorder: a systematic review</article-title>. <source>Int J bipolar Disord</source>. (<year>2021</year>) <volume>9</volume>:<fpage>1</fpage>&#x02013;<lpage>23</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/s40345-021-00221-9</pub-id>
<pub-id pub-id-type="pmid">33392830</pub-id>
</mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kebets</surname><given-names>V</given-names></name><name><surname>Favre</surname><given-names>P</given-names></name><name><surname>Houenou</surname><given-names>J</given-names></name><name><surname>Polosan</surname><given-names>M</given-names></name><name><surname>Perroud</surname><given-names>N</given-names></name><name><surname>Aubry</surname><given-names>JM</given-names></name><etal/></person-group>. <article-title>Fronto-limbic neural variability as a transdiagnostic correlate of emotion dysregulation</article-title>. <source>Trans Psychiatry</source>. (<year>2021</year>) <volume>11</volume>:<fpage>545</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41398-021-01666-3</pub-id>
</mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McTeague</surname><given-names>LM</given-names></name><name><surname>Rosenberg</surname><given-names>BM</given-names></name><name><surname>Lopez</surname><given-names>JW</given-names></name><name><surname>Carreon</surname><given-names>DM</given-names></name><name><surname>Huemer</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Identification of common neural circuit disruptions in emotional processing across psychiatric disorders</article-title>. <source>Am J Psychiatry</source>. (<year>2020</year>) <volume>177</volume>:<page-range>411&#x02013;21</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1176/appi.ajp.2019.18111271</pub-id>
</mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rolls</surname><given-names>ET</given-names></name></person-group>. <article-title>A non-reward attractor theory of depression</article-title>. <source>Neuroscience &#x00026; Biobehavioral Reviews</source>. (<year>2016</year>) <volume>68</volume>:<page-range>47&#x02013;58</page-range>.</mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nolen-Hoeksema</surname><given-names>S</given-names></name><name><surname>Watkins</surname><given-names>ER</given-names></name></person-group>. <article-title>A heuristic for developing transdiagnostic models of psychopathology: explaining multifinality and divergent trajectories</article-title>. <source>Perspect Psychol Sci</source>. (<year>2011</year>) <volume>6</volume>:<fpage>589</fpage>&#x02013;<lpage>609</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1177/1745691611419672</pub-id>
<pub-id pub-id-type="pmid">26168379</pub-id>
</mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Motzkin</surname><given-names>JC</given-names></name><name><surname>Philippi</surname><given-names>CL</given-names></name><name><surname>Wolf</surname><given-names>RC</given-names></name><name><surname>Baskaya</surname><given-names>MK</given-names></name><name><surname>Koenigs</surname><given-names>M</given-names></name></person-group>. <article-title>Ventromedial prefrontal cortex is critical for the regulation of amygdala activity in humans</article-title>. <source>Biol Psychiatry</source>. (<year>2015</year>) <volume>77</volume>:<page-range>276&#x02013;84</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.biopsych.2014.02.014</pub-id>
</mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Myers-Schulz</surname><given-names>B</given-names></name><name><surname>Koenigs</surname><given-names>M</given-names></name></person-group>. <article-title>Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders</article-title>. <source>Mol Psychiatry</source>. (<year>2012</year>) <volume>17</volume>:<page-range>132&#x02013;41</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/mp.2011.88</pub-id>
</mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hiser</surname><given-names>J</given-names></name><name><surname>Koenigs</surname><given-names>M</given-names></name></person-group>. <article-title>The multifaceted role of the ventromedial prefrontal cortex in emotion, decision making, social cognition, and psychopathology</article-title>. <source>Biol Psychiatry</source>. (<year>2018</year>) <volume>83</volume>:<page-range>638&#x02013;47</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.biopsych.2017.10.030</pub-id>
</mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marin</surname><given-names>MF</given-names></name><name><surname>Zsido</surname><given-names>RG</given-names></name><name><surname>Song</surname><given-names>H</given-names></name></person-group>. <article-title>et al: Skin conductance responses and neural activations during fear conditioning and extinction recall across anxiety disorders</article-title>. <source>JAMA Psychiatry</source>. (<year>2017</year>) <volume>74</volume>:<page-range>622&#x02013;31</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2017.0329</pub-id>
</mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Richter</surname><given-names>A</given-names></name><name><surname>Petrovic</surname><given-names>A</given-names></name><name><surname>Diekhof</surname><given-names>EK</given-names></name></person-group>. <article-title>et al: Hyperresponsivity and impaired prefrontal control of the mesolimbic reward system in schizophrenia</article-title>. <source>J Psychiatr Res</source>. (<year>2015</year>) <volume>71</volume>:<fpage>8</fpage>&#x02013;<lpage>15</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jpsychires.2015.09.005</pub-id>
<pub-id pub-id-type="pmid">26522867</pub-id>
</mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rai</surname><given-names>S</given-names></name><name><surname>Griffiths</surname><given-names>KR</given-names></name><name><surname>Breukelaar</surname><given-names>IA</given-names></name><name><surname>Barreiros</surname><given-names>AR</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Boyce</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Default-mode and fronto-parietal network connectivity during rest distinguishes asymptomatic patients with bipolar disorder and major depressive disorder</article-title>. <source>Trans Psychiatry</source>. (<year>2021</year>) <volume>11</volume>:<fpage>547</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/s41398-021-01660-9</pub-id>
</mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Breukelaar</surname><given-names>IA</given-names></name><name><surname>Erlinger</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>A</given-names></name><name><surname>Boyce</surname><given-names>P</given-names></name><name><surname>Hazell</surname><given-names>P</given-names></name><name><surname>Grieve</surname><given-names>SM</given-names></name><etal/></person-group>. <article-title>Investigating the neural basis of cognitive control dysfunction in mood disorders</article-title>. <source>Bipolar Disord</source>. (<year>2020</year>) <volume>22</volume>:<page-range>286&#x02013;95</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/bdi.12844</pub-id>
</mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>KM</given-names></name><name><surname>De Berardis</surname><given-names>D</given-names></name><name><surname>Fornaro</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name></person-group>. <article-title>Differentiating between bipolar and unipolar depression in functional and structural MRI studies</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source>. (<year>2019</year>) <volume>91</volume>:<page-range>20&#x02013;7</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.pnpbp.2018.03.022</pub-id>
</mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rive</surname><given-names>MM</given-names></name><name><surname>Mocking</surname><given-names>RJ</given-names></name><name><surname>Koeter</surname><given-names>MW</given-names></name><name><surname>van Wingen</surname><given-names>G</given-names></name><name><surname>de Wit</surname><given-names>SJ</given-names></name><name><surname>van den Heuvel</surname><given-names>OA</given-names></name><etal/></person-group>. <article-title>State-dependent differences in emotion regulation between unmedicated bipolar disorder and major depressive disorder</article-title>. <source>JAMA Psychiatry</source>. (<year>2015</year>) <volume>72</volume>:<page-range>687&#x02013;96</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2015.0161</pub-id>
</mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saccaro</surname><given-names>LF</given-names></name><name><surname>Schilliger</surname><given-names>Z</given-names></name><name><surname>Dayer</surname><given-names>A</given-names></name><name><surname>Perroud</surname><given-names>N</given-names></name><name><surname>Piguet</surname><given-names>C</given-names></name></person-group>. <article-title>Inflammation, anxiety, and stress in bipolar disorder and borderline personality disorder: A narrative review</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2021</year>) <volume>127</volume>:<page-range>184&#x02013;92</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neubiorev.2021.04.017</pub-id>
</mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baczkowski</surname><given-names>B</given-names></name><name><surname>van Zutphen</surname><given-names>L</given-names></name><name><surname>Siep</surname><given-names>N</given-names></name><name><surname>Jacob</surname><given-names>GA</given-names></name><name><surname>Domes</surname><given-names>G</given-names></name><name><surname>Maier</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Deficient amygdala&#x02013;prefrontal intrinsic connectivity after effortful emotion regulation in borderline personality disorder</article-title>. <source>Eur Arch Psychiatry Clin Neurosci</source>. (<year>2017</year>) <volume>267</volume>:<page-range>551&#x02013;65</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s00406-016-0760-z</pub-id>
</mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chase</surname><given-names>HW</given-names></name><name><surname>Phillips</surname><given-names>ML</given-names></name></person-group>. <article-title>Elucidating neural network functional connectivity abnormalities in bipolar disorder: toward a harmonized methodological approach</article-title>. <source>Biol Psychiatry Cogn. Neurosci Neuroimaging</source>. (<year>2017</year>) <volume>2</volume>:<fpage>1</fpage>&#x02013;<lpage>22</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.bpsc.2015.12.006</pub-id>
</mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Strakowski</surname><given-names>SM</given-names></name><name><surname>Adler</surname><given-names>CM</given-names></name><name><surname>Almeida</surname><given-names>J</given-names></name><name><surname>Altshuler</surname><given-names>LL</given-names></name><name><surname>Blumberg</surname><given-names>HP</given-names></name><name><surname>Chang</surname><given-names>KD</given-names></name><etal/></person-group>. <article-title>The functional neuroanatomy of bipolar disorder: a consensus model</article-title>. <source>Bipolar Disord</source>. (<year>2012</year>) <volume>14</volume>:<page-range>313&#x02013;25</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.1399-5618.2012.01022.x</pub-id>
</mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>B&#x000f8;en</surname><given-names>E</given-names></name><name><surname>Hj&#x000f8;rnevik</surname><given-names>T</given-names></name><name><surname>Hummelen</surname><given-names>B</given-names></name><name><surname>Elvs&#x000e5;shagen</surname><given-names>T</given-names></name><name><surname>Moberget</surname><given-names>T</given-names></name><name><surname>Holtedahl</surname><given-names>JE</given-names></name><etal/></person-group>. <article-title>Patterns of altered regional brain glucose metabolism in borderline personality disorder and bipolar II disorder</article-title>. <source>Acta Psychiatr Scand</source>. (<year>2019</year>) <volume>139</volume>:<page-range>256&#x02013;68</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/acps.2019.139.issue-3</pub-id>
</mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rossi</surname><given-names>R</given-names></name><name><surname>Pievani</surname><given-names>M</given-names></name><name><surname>Lorenzi</surname><given-names>M</given-names></name><name><surname>Boccardi</surname><given-names>M</given-names></name><name><surname>Beneduce</surname><given-names>R</given-names></name><name><surname>Bignotti</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Structural brain features of borderline personality and bipolar disorders</article-title>. <source>Psychiatry Res - Neuroimaging</source>. (<year>2013</year>) <volume>213</volume>:<fpage>83</fpage>&#x02013;<lpage>91</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.pscychresns.2012.07.002</pub-id>
</mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aleknaviciute</surname><given-names>J</given-names></name><name><surname>Tulen</surname><given-names>JHM</given-names></name><name><surname>Kamperman</surname><given-names>AM</given-names></name><name><surname>de Rijke</surname><given-names>YB</given-names></name><name><surname>Kooiman</surname><given-names>CG</given-names></name><name><surname>Kushner</surname><given-names>SA</given-names></name></person-group>. <article-title>Borderline and cluster C personality disorders manifest distinct physiological responses to psychosocial stress</article-title>. <source>Psychoneuroendocrinology</source>. (<year>2016</year>) <volume>72</volume>:<page-range>131&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.psyneuen.2016.06.010</pub-id>
</mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bourvis</surname><given-names>N</given-names></name><name><surname>Aouidad</surname><given-names>A</given-names></name><name><surname>Cabelguen</surname><given-names>C</given-names></name><name><surname>Cohen</surname><given-names>D</given-names></name><name><surname>Xavier</surname><given-names>J</given-names></name></person-group>. <article-title>How do stress exposure and stress regulation relate to borderline personality disorder</article-title>? <source>Front Psychol</source>. (<year>2017</year>) <volume>8</volume>:<elocation-id>2054</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fpsyg.2017.02054</pub-id>
<pub-id pub-id-type="pmid">29250007</pub-id>
</mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duesenberg</surname><given-names>M</given-names></name><name><surname>Wolf</surname><given-names>OT</given-names></name><name><surname>Metz</surname><given-names>S</given-names></name><name><surname>Roepke</surname><given-names>S</given-names></name><name><surname>Fleischer</surname><given-names>J</given-names></name><name><surname>Elias</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Psychophysiological stress response and memory in borderline personality disorder</article-title>. <source>Eur J Psychotraumatol</source>. (<year>2019</year>) <volume>10</volume>:<elocation-id>1568134</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1080/20008198.2019.1568134</pub-id>
<pub-id pub-id-type="pmid">30788063</pub-id>
</mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wieck</surname><given-names>A</given-names></name><name><surname>Grassi-Oliveira</surname><given-names>R</given-names></name><name><surname>do Prado</surname><given-names>CH</given-names></name><name><surname>Rizzo</surname><given-names>LB</given-names></name><name><surname>de Oliveira</surname><given-names>AS</given-names></name><name><surname>Kommers- Molina</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Pro- inflammatory cytokines and soluble receptors in response to acute psychosocial stress: differential reactivity in bipolar disorder</article-title>. <source>Neurosci Lett</source>. (<year>2014</year>) <volume>580</volume>:<fpage>17</fpage>&#x02013;<lpage>21</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neulet.2014.07.040</pub-id>
<pub-id pub-id-type="pmid">25092610</pub-id>
</mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lapomarda</surname><given-names>G</given-names></name><name><surname>Grecucci</surname><given-names>A</given-names></name><name><surname>Messina</surname><given-names>I</given-names></name><name><surname>Pappaianni</surname><given-names>E</given-names></name><name><surname>Dadomo</surname><given-names>H</given-names></name></person-group>. <article-title>Common and different gray and white matter alterations in bipolar and borderline personality disorder: A source-based morphometry study</article-title>. <source>Brain Res</source>. (<year>2021</year>) <volume>1762</volume>:<fpage>147401</fpage>.<pub-id pub-id-type="pmid">33675742</pub-id>
</mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="other">
<person-group person-group-type="author"><name><surname>Buhle</surname><given-names>JT</given-names></name><name><surname>Silvers</surname><given-names>JA</given-names></name><name><surname>Wager</surname><given-names>TD</given-names></name><name><surname>Lopez</surname><given-names>R</given-names></name><name><surname>Onyemekwu</surname><given-names>C</given-names></name><name><surname>Kober</surname><given-names>H</given-names></name><etal/></person-group>. .</mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grecucci</surname><given-names>A</given-names></name><name><surname>Giorgetta</surname><given-names>C</given-names></name><name><surname>Bonini</surname><given-names>N</given-names></name><name><surname>Sanfey</surname><given-names>A</given-names></name></person-group>. <article-title>Reappraising social emotions: the role of inferior frontal gyrus, temporo-parietal junction and insula in interpersonal emotion regulation</article-title>. <source>Front Hum Neurosci</source>. (<year>2013</year>) <volume>7</volume>:<fpage>523</fpage>.<pub-id pub-id-type="pmid">24027512</pub-id>
</mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grecucci</surname><given-names>A</given-names></name><name><surname>Giorgetta</surname><given-names>C</given-names></name><name><surname>van Wout</surname><given-names>M</given-names></name><name><surname>Bonini</surname><given-names>N</given-names></name><name><surname>Sanfey</surname><given-names>A</given-names></name></person-group>. <article-title>Reappraising the Ultimatum: an fMRI study of emotion regulation and decision-making</article-title>. <source>Cereb Cortex</source>. (<year>2013</year>) <volume>23</volume>:<fpage>399</fpage>&#x02013;<lpage>410</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1093/cercor/bhs028</pub-id>
<pub-id pub-id-type="pmid">22368088</pub-id>
</mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Messina</surname><given-names>I</given-names></name><name><surname>Bianco</surname><given-names>S</given-names></name><name><surname>Sambin</surname><given-names>M</given-names></name><name><surname>Viviani</surname><given-names>R</given-names></name></person-group>. <article-title>Executive and semantic processes in reappraisal of negative stimuli: insights from a meta-analysis of neuroimaging studies</article-title>. <source>Front Psychol</source>. (<year>2015</year>) <volume>6</volume>:<elocation-id>956</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fpsyg.2015.00956</pub-id>
<pub-id pub-id-type="pmid">26217277</pub-id>
</mixed-citation></ref><ref id="B125"><label>125</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miskowiak</surname><given-names>KW</given-names></name><name><surname>Obel</surname><given-names>ZK</given-names></name><name><surname>Guglielmo</surname><given-names>R</given-names></name><name><surname>Bonnin</surname><given-names>C</given-names></name><name><surname>del</surname><given-names>M</given-names></name><name><surname>Bowie</surname><given-names>CR</given-names></name><etal/></person-group>. <article-title>Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force</article-title>. <source>Bipolar Disord</source>. (<year>2024</year>) <volume>26</volume>:<page-range>216&#x02013;39</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/bdi.13414</pub-id>
</mixed-citation></ref><ref id="B126"><label>126</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schiweck</surname><given-names>C</given-names></name><name><surname>Arteaga-Henriquez</surname><given-names>G</given-names></name><name><surname>Aichholzer</surname><given-names>M</given-names></name><name><surname>Edwin Thanarajah</surname><given-names>S</given-names></name><name><surname>Vargas-C&#x000e1;ceres</surname><given-names>S</given-names></name><name><surname>Matura</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Comorbidity of ADHD and adult bipolar disorder: A systematic review and meta-analysis</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2021</year>) <volume>124</volume>:<page-range>100&#x02013;23</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neubiorev.2021.01.017</pub-id>
</mixed-citation></ref><ref id="B127"><label>127</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Torres</surname><given-names>I</given-names></name><name><surname>Sole</surname><given-names>B</given-names></name><name><surname>Corrales</surname><given-names>M</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>E</given-names></name><name><surname>Rotger</surname><given-names>S</given-names></name><name><surname>Serra-Pla</surname><given-names>JF</given-names></name><etal/></person-group>. <article-title>Are patients with bipolar disorder and comorbid attention-deficit hyperactivity disorder more neurocognitively impaired</article-title>? <source>Bipolar Disord</source>. (<year>2017</year>) <volume>19</volume>:<page-range>637&#x02013;50</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/bdi.12540</pub-id>
</mixed-citation></ref><ref id="B128"><label>128</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sankar</surname><given-names>A</given-names></name><name><surname>Ziersen</surname><given-names>SC</given-names></name><name><surname>Ozenne</surname><given-names>B</given-names></name><name><surname>Beaman</surname><given-names>EE</given-names></name><name><surname>Dam</surname><given-names>VH</given-names></name><name><surname>Fisher</surname><given-names>PM</given-names></name><etal/></person-group>. <article-title>Association of neurocognitive function with psychiatric hospitalization and socio-demographic conditions in individuals with bipolar and major depressive disorders</article-title>. <source>EClinicalMedicine</source>. (<year>2023</year>) <volume>58</volume>:<elocation-id>101927</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.eclinm.2023.101927</pub-id>
<pub-id pub-id-type="pmid">37007740</pub-id>
</mixed-citation></ref><ref id="B129"><label>129</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lenzi</surname><given-names>F</given-names></name><name><surname>Cortese</surname><given-names>S</given-names></name><name><surname>Harris</surname><given-names>J</given-names></name><name><surname>Masi</surname><given-names>G</given-names></name></person-group>. <article-title>Pharmacotherapy of emotional dysregulation in adults with ADHD: A systematic review and meta-analysis</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2018</year>) <volume>84</volume>:<page-range>359&#x02013;67</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/J.NEUBIOREV.2017.08.010</pub-id>
</mixed-citation></ref><ref id="B130"><label>130</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Long</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>N</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Qin</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Shared and distinct neurobiological bases of bipolar disorder and attention-deficit/hyperactivity disorder in children and adolescents: A comparative meta-analysis of structural abnormalities</article-title>. <source>J Am Acad Child Adolesc Psychiatry</source>. (<year>2024</year>) <volume>63</volume>:<fpage>586</fpage>&#x02013;<lpage>604</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jaac.2023.09.551</pub-id>
<pub-id pub-id-type="pmid">38072245</pub-id>
</mixed-citation></ref><ref id="B131"><label>131</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Passarotti</surname><given-names>AM</given-names></name><name><surname>Sweeney</surname><given-names>JA</given-names></name><name><surname>Pavuluri</surname><given-names>MN</given-names></name></person-group>. <article-title>Differential engagement of cognitive and affective neural systems in pediatric bipolar disorder and attention deficit hyperactivity disorder</article-title>. <source>J Int Neuropsychol Soc</source>. (<year>2010</year>) <volume>16</volume>:<page-range>106&#x02013;17</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1017/S1355617709991019</pub-id>
</mixed-citation></ref><ref id="B132"><label>132</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hafeman</surname><given-names>D</given-names></name><name><surname>Bebko</surname><given-names>G</given-names></name><name><surname>Bertocci</surname><given-names>MA</given-names></name><name><surname>Fournier</surname><given-names>JC</given-names></name><name><surname>Chase</surname><given-names>HW</given-names></name><name><surname>Bonar</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Amygdala-prefrontal cortical functional connectivity during implicit emotion processing differentiates youth with bipolar spectrum from youth with externalizing disorders</article-title>. <source>J Affect Disord</source>. (<year>2017</year>) <volume>208</volume>:<fpage>94</fpage>&#x02013;<lpage>100</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2016.09.064</pub-id>
<pub-id pub-id-type="pmid">27756046</pub-id>
</mixed-citation></ref><ref id="B133"><label>133</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Son</surname><given-names>YD</given-names></name><name><surname>Han</surname><given-names>DH</given-names></name><name><surname>Kim</surname><given-names>SM</given-names></name><name><surname>Min</surname><given-names>KJ</given-names></name><name><surname>Renshaw</surname><given-names>PF</given-names></name></person-group>. <article-title>A functional connectivity comparison between attention deficit hyperactivity disorder and bipolar disorder in medication-na&#x000ef;ve adolescents with mood fluctuation and attention problems</article-title>. <source>Psychiatry Res Neuroimaging</source>. (<year>2017</year>) <volume>263</volume>:<fpage>1</fpage>&#x02013;<lpage>7</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.pscychresns.2017.02.006</pub-id>
<pub-id pub-id-type="pmid">28264765</pub-id>
</mixed-citation></ref><ref id="B134"><label>134</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alda</surname><given-names>M</given-names></name></person-group>. <article-title>Lithium in the treatment of bipolar disorder: Pharmacology and mechanisms of action</article-title>. <source>Mol Psychiatry</source>. (<year>2015</year>) <volume>20</volume>:<page-range>661&#x02013;70</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/mp.2015.4</pub-id>
</mixed-citation></ref><ref id="B135"><label>135</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hidalgo-Mazzei</surname><given-names>D</given-names></name><name><surname>Mantingh</surname><given-names>T</given-names></name><name><surname>P&#x000e9;rez de Mendiola</surname><given-names>X</given-names></name><name><surname>Samalin</surname><given-names>L</given-names></name><name><surname>Undurraga</surname><given-names>J</given-names></name><name><surname>Strejilevich</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Clinicians&#x02019; preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders around the world: a survey from the ISBD Lithium task force</article-title>. <source>Int J Bipolar Disord</source>. (<year>2023</year>) <volume>11</volume>:<fpage>20</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/s40345-023-00301-y</pub-id>
<pub-id pub-id-type="pmid">37243681</pub-id>
</mixed-citation></ref><ref id="B136"><label>136</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Malhi</surname><given-names>GS</given-names></name><name><surname>Outhred</surname><given-names>T</given-names></name></person-group>. <article-title>Therapeutic mechanisms of lithium in bipolar disorder: recent advances and current understanding</article-title>. <source>CNS Drugs</source>. (<year>2016</year>) <volume>30</volume>:<page-range>931&#x02013;49</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s40263-016-0380-1</pub-id>
</mixed-citation></ref><ref id="B137"><label>137</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Won</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name></person-group>. <article-title>An oldie but goodie: lithium in the treatment of bipolar disorder through neuroprotective and neurotrophic mechanisms</article-title>. <source>Int J Mol Sci</source>. (<year>2017</year>) <volume>18</volume>:<fpage>2679</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3390/ijms18122679</pub-id>
<pub-id pub-id-type="pmid">29232923</pub-id>
</mixed-citation></ref><ref id="B138"><label>138</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hartberg</surname><given-names>CB</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>KN</given-names></name><name><surname>Haukvik</surname><given-names>UK</given-names></name><name><surname>Lange</surname><given-names>EH</given-names></name><name><surname>Nesv&#x000e5;g</surname><given-names>R</given-names></name><name><surname>Westlye</surname><given-names>LT</given-names></name><etal/></person-group>. <article-title>Lithium treatment and hippocampal subfields and amygdala volumes in bipolar disorder</article-title>. <source>Bipolar Disord</source>. (<year>2015</year>) <volume>17</volume>:<fpage>496</fpage>&#x02013;<lpage>506</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/bdi.12295</pub-id>
<pub-id pub-id-type="pmid">25809287</pub-id>
</mixed-citation></ref><ref id="B139"><label>139</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Selek</surname><given-names>S</given-names></name><name><surname>Nicoletti</surname><given-names>M</given-names></name><name><surname>Zunta-Soares</surname><given-names>GB</given-names></name><name><surname>Hatch</surname><given-names>JP</given-names></name><name><surname>Soares</surname><given-names>JC</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>A longitudinal study of fronto-limbic brain structures in patients with bipolar I disorder during lithium treatment</article-title>. <source>J Affect Disord</source>. (<year>2013</year>) <volume>150</volume>:<page-range>629&#x02013;33</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2013.04.020</pub-id>
</mixed-citation></ref><ref id="B140"><label>140</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kafantaris</surname><given-names>V</given-names></name><name><surname>Spritzer</surname><given-names>L</given-names></name><name><surname>Doshi</surname><given-names>V</given-names></name><name><surname>Saito</surname><given-names>E</given-names></name><name><surname>Szeszko</surname><given-names>PR</given-names></name></person-group>. <article-title>Changes in white matter microstructure predict lithium response in adolescents with bipolar disorder</article-title>. <source>Bipolar Disord</source>. (<year>2017</year>) <volume>19</volume>:<page-range>587&#x02013;94</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/bdi.12544</pub-id>
</mixed-citation></ref><ref id="B141"><label>141</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lei</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Qin</surname><given-names>K</given-names></name><name><surname>Ai</surname><given-names>Y</given-names></name><name><surname>Tallman</surname><given-names>MJ</given-names></name><name><surname>Patino</surname><given-names>LR</given-names></name><etal/></person-group>. <article-title>Effects of short-term quetiapine and lithium therapy for acute manic or mixed episodes on the limbic system and emotion regulation circuitry in youth with bipolar disorder</article-title>. <source>Neuropsychopharmacology</source>. (<year>2023</year>) <volume>48</volume>(<issue>4</issue>):<page-range>615&#x02013;22</page-range>.</mixed-citation></ref><ref id="B142"><label>142</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bergamelli</surname><given-names>E</given-names></name><name><surname>Del Fabro</surname><given-names>L</given-names></name><name><surname>Delvecchio</surname><given-names>G</given-names></name><name><surname>D&#x02019;Agostino</surname><given-names>A</given-names></name><name><surname>Brambilla</surname><given-names>P</given-names></name></person-group>. <article-title>The impact of lithium on brain function in bipolar disorder: an updated review of functional magnetic resonance imaging studies</article-title>. <source>CNS Drugs</source>. (<year>2021</year>) <volume>35</volume>:<page-range>1275&#x02013;87</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s40263-021-00869-y</pub-id>
</mixed-citation></ref><ref id="B143"><label>143</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hamdani</surname><given-names>N</given-names></name><name><surname>Doukhan</surname><given-names>R</given-names></name><name><surname>Kurtlucan</surname><given-names>O</given-names></name><name><surname>Tamouza</surname><given-names>R</given-names></name><name><surname>Leboyer</surname><given-names>M</given-names></name></person-group>. <article-title>Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications</article-title>. <source>Curr Psychiatry Rep</source>. (<year>2013</year>) <volume>15</volume>:<fpage>387</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s11920-013-0387-y</pub-id>
<pub-id pub-id-type="pmid">23955004</pub-id>
</mixed-citation></ref><ref id="B144"><label>144</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>S-Y</given-names></name><name><surname>Chen</surname><given-names>S-L</given-names></name><name><surname>Chung</surname><given-names>Y-L</given-names></name><name><surname>Li</surname><given-names>C-L</given-names></name><name><surname>Chang</surname><given-names>Y-H</given-names></name><etal/></person-group>. <article-title>The differential levels of inflammatory cytokines and BDNF among bipolar spectrum disorders</article-title>. <source>Int J Neuropsychopharmacol</source>. (<year>2016</year>) <volume>19</volume>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1093/ijnp/pyw012</pub-id>
</mixed-citation></ref><ref id="B145"><label>145</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Misiak</surname><given-names>B</given-names></name><name><surname>Bartoli</surname><given-names>F</given-names></name><name><surname>Carr&#x000e0;</surname><given-names>G</given-names></name><name><surname>Ma&#x00142;ecka</surname><given-names>M</given-names></name><name><surname>Samochowiec</surname><given-names>J</given-names></name><name><surname>Jarosz</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Chemokine alterations in bipolar disorder: a systematic review and meta-analysis</article-title>. <source>Brain Behav Immun</source>. (<year>2020</year>) <volume>88</volume>:<page-range>870&#x02013;7</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.bbi.2020.04.013</pub-id>
</mixed-citation></ref><ref id="B146"><label>146</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kauer-Sant&#x02019;Anna</surname><given-names>M</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name><name><surname>Andreazza</surname><given-names>AC</given-names></name><name><surname>Bond</surname><given-names>DJ</given-names></name><name><surname>Lam</surname><given-names>RW</given-names></name><name><surname>Young</surname><given-names>LT</given-names></name><etal/></person-group>. <article-title>Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs. late-stage bipolar disorder</article-title>. <source>Int J Neuropsychopharmacol</source>. (<year>2009</year>) <volume>12</volume>:<page-range>447&#x02013;58</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1017/S1461145708009310</pub-id>
</mixed-citation></ref><ref id="B147"><label>147</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>BI</given-names></name><name><surname>Kemp</surname><given-names>DE</given-names></name><name><surname>Soczynska</surname><given-names>JK</given-names></name><name><surname>McIntyre</surname><given-names>RS</given-names></name></person-group>. <article-title>Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature</article-title>. <source>J Clin Psychiatry</source>. (<year>2009</year>) <volume>70</volume>:<fpage>9049</fpage>.</mixed-citation></ref><ref id="B148"><label>148</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moriarity</surname><given-names>DP</given-names></name><name><surname>Grehl</surname><given-names>MM</given-names></name><name><surname>Walsh</surname><given-names>RF</given-names></name><name><surname>Roos</surname><given-names>LG</given-names></name><name><surname>Slavich</surname><given-names>GM</given-names></name><name><surname>Alloy</surname><given-names>LB</given-names></name></person-group>. <article-title>A systematic review of associations between emotion regulation characteristics and inflammation</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2023</year>) <volume>150</volume>:<fpage>105162</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neubiorev.2023.105162</pub-id>
<pub-id pub-id-type="pmid">37028579</pub-id>
</mixed-citation></ref><ref id="B149"><label>149</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Appleton</surname><given-names>AA</given-names></name><name><surname>Buka</surname><given-names>SL</given-names></name><name><surname>Loucks</surname><given-names>EB</given-names></name><name><surname>Gilman</surname><given-names>SE</given-names></name><name><surname>Kubzansky</surname><given-names>LD</given-names></name></person-group>. <article-title>Divergent associations of adaptive and maladaptive emotion regulation strategies with inflammation</article-title>. <source>Health Psychol</source>. (<year>2013</year>) <volume>32</volume>:<fpage>748</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1037/a0030068</pub-id>
<pub-id pub-id-type="pmid">23815767</pub-id>
</mixed-citation></ref><ref id="B150"><label>150</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brown</surname><given-names>RL</given-names></name><name><surname>Shahane</surname><given-names>AD</given-names></name><name><surname>Chen</surname><given-names>MA</given-names></name><name><surname>Fagundes</surname><given-names>CP</given-names></name></person-group>. <article-title>Cognitive reappraisal and nasal cytokine production following experimental rhinovirus infection</article-title>. <source>Brain Behavior Immunity-Health</source>. (<year>2020</year>) <volume>1</volume>:<fpage>100012</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.bbih.2019.100012</pub-id>
<pub-id pub-id-type="pmid">32140685</pub-id>
</mixed-citation></ref><ref id="B151"><label>151</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ellis</surname><given-names>EM</given-names></name><name><surname>Prather</surname><given-names>AA</given-names></name><name><surname>Grenen</surname><given-names>EG</given-names></name><name><surname>Ferrer</surname><given-names>RA</given-names></name></person-group>. <article-title>Direct and indirect associations of cognitive reappraisal and suppression with disease biomarkers</article-title>. <source>Psychol Health</source>. (<year>2019</year>) <volume>34</volume>:<page-range>336&#x02013;54</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1080/08870446.2018.1529313</pub-id>
</mixed-citation></ref><ref id="B152"><label>152</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lopez</surname><given-names>RB</given-names></name><name><surname>Brown</surname><given-names>RL</given-names></name><name><surname>Wu</surname><given-names>ELL</given-names></name><name><surname>Murdock</surname><given-names>KW</given-names></name><name><surname>Denny</surname><given-names>BT</given-names></name><name><surname>Heijnen</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Emotion regulation and immune functioning during grief: testing the role of expressive suppression and cognitive reappraisal in inflammation among recently bereaved spouses</article-title>. <source>Psychosom. Med</source>. (<year>2020</year>) <volume>82</volume>:<fpage>2</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">31634318</pub-id>
</mixed-citation></ref><ref id="B153"><label>153</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ospina</surname><given-names>LH</given-names></name><name><surname>Beck-Felts</surname><given-names>K</given-names></name><name><surname>Ifrah</surname><given-names>C</given-names></name><name><surname>Lister</surname><given-names>A</given-names></name><name><surname>Messer</surname><given-names>S</given-names></name><name><surname>Russo</surname><given-names>SJ</given-names></name><etal/></person-group>. <article-title>Inflammation and emotion regulation: Findings from the MIDUS II study</article-title>. <source>Brain Behavior Immunity-Health</source>. (<year>2022</year>) <volume>26</volume>:<fpage>100536</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.bbih.2022.100536</pub-id>
<pub-id pub-id-type="pmid">36247835</pub-id>
</mixed-citation></ref><ref id="B154"><label>154</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Renna</surname><given-names>ME</given-names></name><name><surname>Hoyt</surname><given-names>MA</given-names></name><name><surname>Ottaviani</surname><given-names>C</given-names></name><name><surname>Mennin</surname><given-names>DS</given-names></name></person-group>. <article-title>An experimental examination of worry and relaxation on cardiovascular, endocrine, and inflammatory processes</article-title>. <source>Psychoneuroendocrinology</source>. (<year>2020</year>) <volume>122</volume>:<elocation-id>104870</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.psyneuen.2020.104870</pub-id>
<pub-id pub-id-type="pmid">33010599</pub-id>
</mixed-citation></ref><ref id="B155"><label>155</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Renna</surname><given-names>ME</given-names></name></person-group>. <article-title>A review and novel theoretical model of how negative emotions influence inflammation: The critical role of emotion regulation</article-title>. <source>Brain Behav Immun Health</source>. (<year>2021</year>) <volume>18</volume>:<elocation-id>100397</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.bbih.2021.100397</pub-id>
<pub-id pub-id-type="pmid">34927103</pub-id>
</mixed-citation></ref><ref id="B156"><label>156</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zoccola</surname><given-names>PM</given-names></name><name><surname>Figueroa</surname><given-names>WS</given-names></name><name><surname>Rabideau</surname><given-names>EM</given-names></name><name><surname>Woody</surname><given-names>A</given-names></name><name><surname>Benencia</surname><given-names>F</given-names></name></person-group>. <article-title>Differential effects of poststressor rumination and distraction on cortisol and C-reactive protein</article-title>. <source>Health Psychol</source>. (<year>2014</year>) <volume>33</volume>:<page-range>1606&#x02013;9</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1037/hea0000019</pub-id>
</mixed-citation></ref><ref id="B157"><label>157</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Petruso</surname><given-names>F</given-names></name><name><surname>Giff</surname><given-names>AE</given-names></name><name><surname>Milano</surname><given-names>BA</given-names></name><name><surname>De Rossi</surname><given-names>MM</given-names></name><name><surname>Saccaro</surname><given-names>LF</given-names></name></person-group>. <article-title>Inflammation and emotion regulation: a narrative review of evidence and mechanisms in emotion dysregulation disorders</article-title>. <source>Neuronal Signaling</source>. (<year>2023</year>) <volume>7</volume>:<fpage>NS20220077</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1042/NS20220077</pub-id>
<pub-id pub-id-type="pmid">38026703</pub-id>
</mixed-citation></ref><ref id="B158"><label>158</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Benedetti</surname><given-names>F</given-names></name><name><surname>Aggio</surname><given-names>V</given-names></name><name><surname>Pratesi</surname><given-names>ML</given-names></name><name><surname>Greco</surname><given-names>G</given-names></name><name><surname>Furlan</surname><given-names>R</given-names></name></person-group>. <article-title>Neuroinflammation in bipolar depression</article-title>. <source>FrontPsychiatry</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>71</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fpsyt.2020.00071</pub-id>
</mixed-citation></ref><ref id="B159"><label>159</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grande</surname><given-names>I</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name><name><surname>Birmaher</surname><given-names>B</given-names></name><name><surname>Vieta</surname><given-names>E</given-names></name></person-group>. <article-title>Bipolar disorder</article-title>. <source>Lancet</source>. (<year>2016</year>) <volume>387</volume>:<page-range>1561&#x02013;72</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/S0140-6736(15)00241-X</pub-id>
</mixed-citation></ref><ref id="B160"><label>160</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Phillips</surname><given-names>M</given-names></name></person-group>. <article-title>The neural basis of mood dysregulation in bipolar disorder</article-title>. <source>Cognit Neuropsychiatry</source>. (<year>2006</year>) <volume>11</volume>:<page-range>233&#x02013;49</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1080/13546800444000290</pub-id>
</mixed-citation></ref><ref id="B161"><label>161</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Piguet</surname><given-names>C</given-names></name><name><surname>Karahano&#x0011f;lu</surname><given-names>FI</given-names></name><name><surname>Saccaro</surname><given-names>LF</given-names></name><name><surname>Van De Ville</surname><given-names>D</given-names></name><name><surname>Vuilleumier</surname><given-names>P</given-names></name></person-group>. <article-title>Mood disorders disrupt the functional dynamics, not spatial organization of brain resting state networks</article-title>. <source>NeuroImage Clin</source>. (<year>2021</year>) <volume>32</volume>:<elocation-id>102833</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.nicl.2021.102833</pub-id>
<pub-id pub-id-type="pmid">34619652</pub-id>
</mixed-citation></ref><ref id="B162"><label>162</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haarman</surname><given-names>BCM</given-names></name><name><surname>Burger</surname><given-names>H</given-names></name><name><surname>Doorduin</surname><given-names>J</given-names></name><name><surname>Renken</surname><given-names>RJ</given-names></name><name><surname>Sibeijn-Kuiper</surname><given-names>A</given-names></name><name><surname>Marsman</surname><given-names>J-BC</given-names></name><etal/></person-group>. <article-title>Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder &#x02013; a combined magnetic resonance imaging and Positron Emission Tomography Study</article-title>. <source>Brain Behavior Immun</source>. (<year>2016</year>) <volume>56</volume>:<fpage>21</fpage>&#x02013;<lpage>33</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.bbi.2015.09.004</pub-id>
</mixed-citation></ref><ref id="B163"><label>163</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tu</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>CT</given-names></name><name><surname>Lin</surname><given-names>WC</given-names></name><name><surname>Chen</surname><given-names>MH</given-names></name><name><surname>Su</surname><given-names>TP</given-names></name><name><surname>Bai</surname><given-names>YM</given-names></name></person-group>. <article-title>Structural and functional correlates of serum soluble IL-6 receptor level in patients with bipolar disorder</article-title>. <source>J Affect. Disord</source>. (<year>2017</year>) <volume>219</volume>:<page-range>172&#x02013;7</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2017.04.036</pub-id>
</mixed-citation></ref><ref id="B164"><label>164</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Darg&#x000e9;l</surname><given-names>AA</given-names></name><name><surname>Godin</surname><given-names>O</given-names></name><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Hirakata</surname><given-names>V</given-names></name><name><surname>Azorin</surname><given-names>JM</given-names></name><name><surname>M&#x02019;bailara</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Emotional reactivity, functioning, and C-reactive protein alterations in remitted bipolar patients: Clinical relevance of a dimensional approach</article-title>. <source>Aust New Z J Psychiatry</source>. (<year>2017</year>) <volume>51</volume>:<page-range>788&#x02013;98</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1177/0004867417691850</pub-id>
</mixed-citation></ref><ref id="B165"><label>165</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Darg&#x000e9;l</surname><given-names>AA</given-names></name><name><surname>Roussel</surname><given-names>F</given-names></name><name><surname>Volant</surname><given-names>S</given-names></name><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Grant</surname><given-names>R</given-names></name><name><surname>Azorin</surname><given-names>JM</given-names></name><etal/></person-group>. <article-title>Emotional hyper-reactivity and cardiometabolic risk in remitted bipolar patients: a machine learning approach</article-title>. <source>Acta Psychiatrica Scandinavica</source>. (<year>2018</year>) <volume>138</volume>:<page-range>348&#x02013;59</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/acps.12901</pub-id>
</mixed-citation></ref><ref id="B166"><label>166</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Radaelli</surname><given-names>D</given-names></name><name><surname>Papa</surname><given-names>GS</given-names></name><name><surname>Vai</surname><given-names>B</given-names></name><name><surname>Poletti</surname><given-names>S</given-names></name><name><surname>Smeraldi</surname><given-names>E</given-names></name><name><surname>Colombo</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Fronto-limbic disconnection in bipolar disorder</article-title>. <source>Eur Psychiatry</source>. (<year>2015</year>) <volume>30</volume>:<page-range>82&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.eurpsy.2014.04.001</pub-id>
</mixed-citation></ref><ref id="B167"><label>167</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Benedetti</surname><given-names>F</given-names></name><name><surname>Poletti</surname><given-names>S</given-names></name><name><surname>Hoogenboezem</surname><given-names>TA</given-names></name><name><surname>Mazza</surname><given-names>E</given-names></name><name><surname>Ambr&#x000e9;e</surname><given-names>O</given-names></name><name><surname>de Wit</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Inflammatory cytokines influence measures of white matter integrity in bipolar disorder</article-title>. <source>J Affect Disord</source>. (<year>2016</year>) <volume>202</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2016.05.047</pub-id>
<pub-id pub-id-type="pmid">27253210</pub-id>
</mixed-citation></ref><ref id="B168"><label>168</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poletti</surname><given-names>S</given-names></name><name><surname>de Wit</surname><given-names>H</given-names></name><name><surname>Mazza</surname><given-names>E</given-names></name><name><surname>Wijkhuijs</surname><given-names>AJ</given-names></name><name><surname>Locatelli</surname><given-names>C</given-names></name><name><surname>Aggio</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Th17 cells correlate positively to the structural and functional integrity of the brain in bipolar depression and healthy controls</article-title>. <source>Brain Behav Immun</source>. (<year>2017</year>) <volume>61</volume>:<page-range>317&#x02013;25</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.bbi.2016.12.020</pub-id>
</mixed-citation></ref><ref id="B169"><label>169</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Snijders</surname><given-names>G</given-names></name><name><surname>Brouwer</surname><given-names>R</given-names></name><name><surname>Kemner</surname><given-names>S</given-names></name><name><surname>Bootsman</surname><given-names>F</given-names></name><name><surname>Drexhage</surname><given-names>HA</given-names></name><name><surname>Hillegers</surname><given-names>MHJ</given-names></name></person-group>. <article-title>Genetic and environmental influences on circulating NK and T cells and their relation to bipolar disorder</article-title>. <source>Int J Bipolar Disord</source>. (<year>2019</year>) <volume>7</volume>:<fpage>4</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/s40345-018-0139-3</pub-id>
<pub-id pub-id-type="pmid">30739250</pub-id>
</mixed-citation></ref><ref id="B170"><label>170</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Furlan</surname><given-names>R</given-names></name><name><surname>Melloni</surname><given-names>E</given-names></name><name><surname>Finardi</surname><given-names>A</given-names></name><name><surname>Vai</surname><given-names>B</given-names></name><name><surname>Di Toro</surname><given-names>S</given-names></name><name><surname>Aggio</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Natural killer cells protect white matter integrity in bipolar disorder</article-title>. <source>Brain Behavior Immun</source>. (<year>2019</year>) <volume>81</volume>:<page-range>410&#x02013;21</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.bbi.2019.06.037</pub-id>
</mixed-citation></ref><ref id="B171"><label>171</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brietzke</surname><given-names>E</given-names></name><name><surname>Mansur</surname><given-names>RB</given-names></name><name><surname>Soczynska</surname><given-names>JK</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name><name><surname>Bressan</surname><given-names>RA</given-names></name><name><surname>McIntyre</surname><given-names>RS</given-names></name></person-group>. <article-title>Towards a multifactorial approach for prediction of bipolar disorder in at risk populations</article-title>. <source>J Affect. Disord</source>. (<year>2012</year>) <volume>140</volume>:<fpage>82</fpage>&#x02013;<lpage>91</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2012.02.016</pub-id>
<pub-id pub-id-type="pmid">22406334</pub-id>
</mixed-citation></ref><ref id="B172"><label>172</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Altinoz</surname><given-names>MA</given-names></name><name><surname>Ozpinar</surname><given-names>A</given-names></name></person-group>. <article-title>Acetylsalicylic acid and its metabolite gentisic acid may act as adjunctive agents in the treatment of psychiatric disorders</article-title>. <source>Behav Pharmacol</source>. (<year>2019</year>) <volume>30</volume>:<page-range>626&#x02013;40</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1097/FBP.0000000000000517</pub-id>
</mixed-citation></ref><ref id="B173"><label>173</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Husain</surname><given-names>MI</given-names></name><name><surname>Strawbridge</surname><given-names>R</given-names></name><name><surname>Stokes</surname><given-names>PR</given-names></name><name><surname>Young</surname><given-names>AH</given-names></name></person-group>. <article-title>Anti-inflammatory treatments for mood disorders: systematic review and meta-analysis</article-title>. <source>J Psychopharmacol</source>. (<year>2017</year>) <volume>31</volume>:<page-range>1137&#x02013;48</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1177/0269881117725711</pub-id>
</mixed-citation></ref><ref id="B174"><label>174</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosenblat</surname><given-names>J</given-names></name><name><surname>McIntyre</surname><given-names>R</given-names></name></person-group>. <article-title>Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications</article-title>. <source>Brain Sci</source>. (<year>2017</year>) <volume>7</volume>:<fpage>144</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3390/brainsci7110144</pub-id>
<pub-id pub-id-type="pmid">29084144</pub-id>
</mixed-citation></ref><ref id="B175"><label>175</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosenblat</surname><given-names>JD</given-names></name><name><surname>Kakar</surname><given-names>R</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name><name><surname>Kessing</surname><given-names>LV</given-names></name><name><surname>Vinberg</surname><given-names>M</given-names></name><name><surname>Baune</surname><given-names>BT</given-names></name><etal/></person-group>. <article-title>Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis</article-title>. <source>Bipolar Disord</source>. (<year>2016</year>) <volume>18</volume>:<fpage>89</fpage>&#x02013;<lpage>101</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/bdi.2016.18.issue-2</pub-id>
<pub-id pub-id-type="pmid">26990051</pub-id>
</mixed-citation></ref><ref id="B176"><label>176</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knijff</surname><given-names>EM</given-names></name><name><surname>Nadine</surname><given-names>BM</given-names></name><name><surname>Kupka</surname><given-names>RW</given-names></name><name><surname>De Wit</surname><given-names>HJ</given-names></name><name><surname>Ruwhof</surname><given-names>C</given-names></name><name><surname>Akkerhuis</surname><given-names>GW</given-names></name><etal/></person-group>. <article-title>An imbalance in the production of IL-1&#x003b2; and IL-6 by monocytes of bipolar patients: restoration by lithium treatment</article-title>. <source>Bipolar Disord</source>. (<year>2007</year>) <volume>9</volume>:<page-range>743&#x02013;53</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.1399-5618.2007.00444.x</pub-id>
</mixed-citation></ref><ref id="B177"><label>177</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Padmos</surname><given-names>R</given-names></name><name><surname>Hillegers</surname><given-names>MHJ</given-names></name><name><surname>Knijff</surname><given-names>EM</given-names></name><name><surname>Vonk</surname><given-names>R</given-names></name><name><surname>Bouvy</surname><given-names>A</given-names></name><name><surname>Staal</surname><given-names>FJT</given-names></name><etal/></person-group>. <article-title>A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes</article-title>. <source>Arch Gen Psychiatry</source>. (<year>2008</year>) <volume>65</volume>:<fpage>395</fpage>&#x02013;<lpage>407</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1001/archpsyc.65.4.395</pub-id>
<pub-id pub-id-type="pmid">18391128</pub-id>
</mixed-citation></ref><ref id="B178"><label>178</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Darg&#x000e9;l</surname><given-names>AA</given-names></name><name><surname>Volant</surname><given-names>S</given-names></name><name><surname>Brietzke</surname><given-names>E</given-names></name><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Oli&#x000e9;</surname><given-names>E</given-names></name><name><surname>Azorin</surname><given-names>JM</given-names></name><etal/></person-group>. <article-title>Allostatic load, emotional hyper-reactivity, and functioning in individuals with bipolar disorder</article-title>. <source>Bipolar Disord</source>. (<year>2020</year>) <volume>22</volume>:<page-range>711&#x02013;21</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/bdi.12927</pub-id>
</mixed-citation></ref><ref id="B179"><label>179</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carruthers</surname><given-names>SP</given-names></name><name><surname>Rossell</surname><given-names>SL</given-names></name><name><surname>Murray</surname><given-names>G</given-names></name><name><surname>Karantonis</surname><given-names>J</given-names></name><name><surname>Furlong</surname><given-names>LS</given-names></name><name><surname>Van Rheenen</surname><given-names>TE</given-names></name></person-group>. <article-title>Mindfulness, mood symptom tendencies and quality of life in bipolar disorder: An examination of the mediating influence of emotion regulation difficulties</article-title>. <source>J Affect. Disord</source>. (<year>2022</year>) <volume>298</volume>:<page-range>166&#x02013;72</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2021.10.107</pub-id>
</mixed-citation></ref><ref id="B180"><label>180</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murri</surname><given-names>MB</given-names></name><name><surname>Prestia</surname><given-names>D</given-names></name><name><surname>Mondelli</surname><given-names>V</given-names></name><name><surname>Pariante</surname><given-names>C</given-names></name><name><surname>Patti</surname><given-names>S</given-names></name><name><surname>Olivieri</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>The HPA axis in bipolar disorder: systematic review and meta-analysis</article-title>. <source>Psychoneuroendocrinology</source>. (<year>2016</year>) <volume>63</volume>:<page-range>327&#x02013;42</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.psyneuen.2015.10.014</pub-id>
</mixed-citation></ref><ref id="B181"><label>181</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mbiydzenyuy</surname><given-names>NE</given-names></name><name><surname>Qulu</surname><given-names>LA</given-names></name></person-group>. <article-title>Stress, hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-gonadal axis, and aggression</article-title>. <source>Metab Brain Dis</source>. (<year>2024</year>) <volume>39</volume>:<fpage>1</fpage>&#x02013;<lpage>24</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s11011-024-01393-w</pub-id>
<pub-id pub-id-type="pmid">37999885</pub-id>
</mixed-citation></ref><ref id="B182"><label>182</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Girshkin</surname><given-names>L</given-names></name><name><surname>Matheson</surname><given-names>SL</given-names></name><name><surname>Shepherd</surname><given-names>AM</given-names></name><name><surname>Green</surname><given-names>MJ</given-names></name></person-group>. <article-title>Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis</article-title>. <source>Psychoneuroendocrinology</source>. (<year>2014</year>) <volume>49</volume>:<fpage>187</fpage>&#x02013;<lpage>206</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.07.013</pub-id>
<pub-id pub-id-type="pmid">25108162</pub-id>
</mixed-citation></ref><ref id="B183"><label>183</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Juruena</surname><given-names>MF</given-names></name><name><surname>Cleare</surname><given-names>AJ</given-names></name><name><surname>Young</surname><given-names>AH</given-names></name></person-group>. <article-title>Neuroendocrine stress system in bipolar disorder</article-title>. <source>Bipolar Disorder: From Neuroscience to Treatment</source>. (<year>2021</year>) <fpage>49</fpage>&#x02013;<lpage>171</lpage>.</mixed-citation></ref><ref id="B184"><label>184</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoyt</surname><given-names>MA</given-names></name><name><surname>Marin-Chollom</surname><given-names>AM</given-names></name><name><surname>Bower</surname><given-names>JE</given-names></name><name><surname>Thomas</surname><given-names>KS</given-names></name><name><surname>Irwin</surname><given-names>MR</given-names></name><name><surname>Stan- ton</surname><given-names>AL</given-names></name></person-group>. <article-title>Approach and avoidance coping: diurnal cortisol rhythm in prostate cancer survivors</article-title>. <source>Psychoneuroendocrinology</source>. (<year>2014</year>) <volume>49</volume>:<page-range>182&#x02013;6</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.07.007</pub-id>
</mixed-citation></ref><ref id="B185"><label>185</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Denson</surname><given-names>TF</given-names></name><name><surname>Creswell</surname><given-names>JD</given-names></name><name><surname>Terides</surname><given-names>MD</given-names></name><name><surname>Blundell</surname><given-names>K</given-names></name></person-group>. <article-title>Cognitive reappraisal in- creases neuroendocrine reactivity to acute social stress and physical pain</article-title>. <source>Psychoneu- roendocrinology</source>. (<year>2014</year>) <volume>49</volume>:<fpage>69</fpage>&#x02013;<lpage>78</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.07.003</pub-id>
</mixed-citation></ref><ref id="B186"><label>186</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>K</given-names></name><name><surname>Mineka</surname><given-names>S</given-names></name><name><surname>Zinbarg</surname><given-names>RE</given-names></name><name><surname>Craske</surname><given-names>MG</given-names></name><name><surname>Adam</surname><given-names>EK</given-names></name></person-group>. <article-title>Emotion regulation regulates more than emotion: associations of momentary emotion regulation with diurnal cortisol in current and past depression and anxiety</article-title>. <source>Clin Psychol Sci</source>. (<year>2017</year>) <volume>5</volume>:<fpage>37</fpage>&#x02013;<lpage>51</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1177/2167702616654437</pub-id>
<pub-id pub-id-type="pmid">28944106</pub-id>
</mixed-citation></ref><ref id="B187"><label>187</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nemeroff</surname><given-names>CB</given-names></name></person-group>. <article-title>Paradise lost: the neurobiological and clinical consequences of child abuse and neglect</article-title>. <source>Neuron</source>. (<year>2016</year>) <volume>89</volume>:<fpage>892</fpage>&#x02013;<lpage>909</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neuron.2016.01.019</pub-id>
<pub-id pub-id-type="pmid">26938439</pub-id>
</mixed-citation></ref><ref id="B188"><label>188</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jaffee</surname><given-names>SR</given-names></name></person-group>. <article-title>Child maltreatment and risk for psychopathology in childhood and adulthood</article-title>. <source>Annu Rev Clin Psychol</source>. (<year>2017</year>) <volume>13</volume>:<page-range>525&#x02013;51</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1146/annurev-clinpsy-032816-045005</pub-id>
</mixed-citation></ref><ref id="B189"><label>189</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pechtel</surname><given-names>P</given-names></name><name><surname>Pizzagalli</surname><given-names>DA</given-names></name></person-group>. <article-title>Effects of early life stress on cognitive and affective function: an integrated review of human literature</article-title>. <source>Psychopharmacol (Berl.)</source>. (<year>2011</year>) <volume>214</volume>:<fpage>55</fpage>&#x02013;<lpage>70</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s00213-010-2009-2</pub-id>
</mixed-citation></ref><ref id="B190"><label>190</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cotter</surname><given-names>J</given-names></name><name><surname>Kaess</surname><given-names>M</given-names></name><name><surname>Yung</surname><given-names>AR</given-names></name></person-group>. <article-title>Childhood trauma and functional disability in psychosis, bipolar disorder and borderline personality disorder: a review of the literature</article-title>. <source>Irish J psychol Med</source>. (<year>2015</year>) <volume>32</volume>:<fpage>21</fpage>&#x02013;<lpage>30</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1017/ipm.2014.74</pub-id>
</mixed-citation></ref><ref id="B191"><label>191</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hett</surname><given-names>D</given-names></name><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Marwaha</surname><given-names>S</given-names></name></person-group>. <article-title>Childhood trauma in bipolar disorder: new targets for future interventions</article-title>. <source>BJPsych Open</source>. (<year>2022</year>) <volume>8</volume>:<elocation-id>e130</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1192/bjo.2022.529</pub-id>
<pub-id pub-id-type="pmid">35815760</pub-id>
</mixed-citation></ref><ref id="B192"><label>192</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Lajnef</surname><given-names>M</given-names></name><name><surname>Brichant-Petitjean</surname><given-names>C</given-names></name><name><surname>Geoffroy</surname><given-names>PA</given-names></name><name><surname>Henry</surname><given-names>C</given-names></name><name><surname>Gard</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Childhood trauma and mixed episodes are associated with poor response to lithium in bipolar disorders</article-title>. <source>Acta Psychiatrica Scandinavica</source>. (<year>2017</year>) <volume>135</volume>:<page-range>319&#x02013;27</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/acps.2017.135.issue-4</pub-id>
</mixed-citation></ref><ref id="B193"><label>193</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Lajnef</surname><given-names>M</given-names></name><name><surname>Henry</surname><given-names>C</given-names></name><name><surname>Aubin</surname><given-names>V</given-names></name><name><surname>Azorin</surname><given-names>JM</given-names></name><name><surname>Bellivier</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Childhood trauma, dimensions of psychopathology and the clinical expression of bipolar disorders: a pathway analysis</article-title>. <source>J Psychiatr Res</source>. (<year>2017</year>) <volume>95</volume>:<fpage>37</fpage>&#x02013;<lpage>45</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jpsychires.2017.07.013</pub-id>
<pub-id pub-id-type="pmid">28777981</pub-id>
</mixed-citation></ref><ref id="B194"><label>194</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aas</surname><given-names>M</given-names></name><name><surname>Bellivier</surname><given-names>F</given-names></name><name><surname>Bettella</surname><given-names>F</given-names></name><name><surname>Henry</surname><given-names>C</given-names></name><name><surname>Gard</surname><given-names>S</given-names></name><name><surname>Kahn</surname><given-names>JP</given-names></name><etal/></person-group>. <article-title>Childhood maltreatment and polygenic risk in bipolar disorders</article-title>. <source>Bipolar Disord</source>. (<year>2020</year>) <volume>22</volume>:<page-range>174&#x02013;81</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/bdi.12851</pub-id>
</mixed-citation></ref><ref id="B195"><label>195</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Palmier-Claus</surname><given-names>J</given-names></name><name><surname>Golby</surname><given-names>R</given-names></name><name><surname>Stokes</surname><given-names>LJ</given-names></name><name><surname>Saville</surname><given-names>CW</given-names></name><name><surname>Velemis</surname><given-names>K</given-names></name><name><surname>Varese</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>The relationship between childhood adversity and affective instability across psychiatric disorders: A meta-analysis</article-title>. <source>Acta Psychiatrica Scandinavica</source>. (<year>2024</year>). doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/acps.13745</pub-id>
</mixed-citation></ref><ref id="B196"><label>196</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aas</surname><given-names>M</given-names></name><name><surname>Aminoff</surname><given-names>SR</given-names></name><name><surname>Lagerberg</surname><given-names>TV</given-names></name><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Agartz</surname><given-names>I</given-names></name><name><surname>Andreassen</surname><given-names>OA</given-names></name><etal/></person-group>. <article-title>Affective lability in patients with bipolar disorders is associ- ated with high levels of childhood trauma</article-title>. <source>Psychiatry Res</source>. (<year>2014</year>) <volume>218</volume>:<page-range>252&#x02013;5</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.psychres.2014.03.046</pub-id>
</mixed-citation></ref><ref id="B197"><label>197</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Henry</surname><given-names>C</given-names></name><name><surname>Bellivier</surname><given-names>F</given-names></name><name><surname>Mathieu</surname><given-names>F</given-names></name><name><surname>Leboyer</surname><given-names>M</given-names></name></person-group>. <article-title>Beyond genetics: childhood affective trauma in bipolar disorder</article-title>. <source>Bipolar Disord</source>. (<year>2008</year>) <volume>10</volume>:<page-range>867&#x02013;76</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.1399-5618.2008.00635.x</pub-id>
</mixed-citation></ref><ref id="B198"><label>198</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marwaha</surname><given-names>S</given-names></name><name><surname>Gordon-Smith</surname><given-names>K</given-names></name><name><surname>Broome</surname><given-names>M</given-names></name><name><surname>Briley</surname><given-names>PM</given-names></name><name><surname>Perry</surname><given-names>A</given-names></name><name><surname>Forty</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Affective instability, childhood trauma and major affective disorders</article-title>. <source>J Affect. Disord</source>. (<year>2016</year>) <volume>190</volume>:<page-range>764&#x02013;71</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2015.11.024</pub-id>
</mixed-citation></ref><ref id="B199"><label>199</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Numakawa</surname><given-names>T</given-names></name><name><surname>Yokomaku</surname><given-names>D</given-names></name><name><surname>Richards</surname><given-names>M</given-names></name><name><surname>Hori</surname><given-names>H</given-names></name><name><surname>Adachi</surname><given-names>N</given-names></name><name><surname>Kunugi</surname><given-names>H</given-names></name></person-group>. <article-title>Functional interactions between steroid hormones and neurotrophin BDNF</article-title>. <source>World J Biol Chem</source>. (<year>2010</year>) <volume>1</volume>:<fpage>133</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.4331/wjbc.v1.i5.133</pub-id>
<pub-id pub-id-type="pmid">21540998</pub-id>
</mixed-citation></ref><ref id="B200"><label>200</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alexander</surname><given-names>N</given-names></name><name><surname>Osinsky</surname><given-names>R</given-names></name><name><surname>Schmitz</surname><given-names>A</given-names></name><name><surname>Mueller</surname><given-names>E</given-names></name><name><surname>Kuepper</surname><given-names>Y</given-names></name><name><surname>Hennig</surname><given-names>J</given-names></name></person-group>. <article-title>The BDNF Val66Met polymorphism affects HPA-axis reactivity to acute stress</article-title>. <source>Psychoneuroendocrinology</source>. (<year>2010</year>) <volume>35</volume>:<page-range>949&#x02013;53</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.psyneuen.2009.12.008</pub-id>
</mixed-citation></ref><ref id="B201"><label>201</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kowianski</surname><given-names>P</given-names></name><name><surname>Lietzau</surname><given-names>G</given-names></name><name><surname>Czuba</surname><given-names>E</given-names></name><name><surname>Waskow</surname><given-names>M</given-names></name><name><surname>Steliga</surname><given-names>A</given-names></name><name><surname>Morys</surname><given-names>J</given-names></name></person-group>. <article-title>BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity</article-title>. <source>Cell Mol Neurobiol</source>. (<year>2018</year>) <volume>38</volume>:<page-range>579&#x02013;93</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s10571-017-0510-4</pub-id>
</mixed-citation></ref><ref id="B202"><label>202</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Balaratnasingam</surname><given-names>S</given-names></name><name><surname>Janca</surname><given-names>A</given-names></name></person-group>. <article-title>Brain derived neurotrophic factor: a novel neurotrophin involved in psychiatric and neurological disorders</article-title>. <source>Pharmacol Ther</source>. (<year>2012</year>) <volume>134</volume>:<page-range>116&#x02013;24</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.pharmthera.2012.01.006</pub-id>
</mixed-citation></ref><ref id="B203"><label>203</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grande</surname><given-names>I</given-names></name><name><surname>Fries</surname><given-names>GR</given-names></name><name><surname>Kunz</surname><given-names>M</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name></person-group>. <article-title>The role of BDNF as a mediator of neuroplasticity in bipolar disorder</article-title>. <source>Psychiatry Investig</source>. (<year>2010</year>) <volume>7</volume>:<page-range>243&#x02013;50</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.4306/pi.2010.7.4.243</pub-id>
</mixed-citation></ref><ref id="B204"><label>204</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vega-N&#x000fa;&#x000f1;ez</surname><given-names>A</given-names></name><name><surname>G&#x000f3;mez-S&#x000e1;nchez-Lafuente</surname><given-names>C</given-names></name><name><surname>Mayoral-Cleries</surname><given-names>F</given-names></name><name><surname>Bordallo</surname><given-names>A</given-names></name><name><surname>Rodr&#x000ed;guez de Fonseca</surname><given-names>F</given-names></name><name><surname>Su&#x000e1;rez</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Clinical value of inflammatory and neurotrophic biomarkers in bipolar disorder: a systematic review and meta-analysis</article-title>. <source>Biomedicines</source>. (<year>2022</year>) <volume>10</volume>:<fpage>1368</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3390/biomedicines10061368</pub-id>
<pub-id pub-id-type="pmid">35740389</pub-id>
</mixed-citation></ref><ref id="B205"><label>205</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duffy</surname><given-names>A</given-names></name><name><surname>Goodday</surname><given-names>SM</given-names></name><name><surname>Keown-Stoneman</surname><given-names>C</given-names></name><name><surname>Scotti</surname><given-names>M</given-names></name><name><surname>Maitra</surname><given-names>M</given-names></name><name><surname>Nagy</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Epigenetic markers in inflammation-related genes associated with mood disorder: a cross-sectional and longitudinal study in high-risk offspring of bipolar parents</article-title>. <source>Int J Bipolar. Disord</source>. (<year>2019</year>) <volume>7</volume>:<fpage>1</fpage>&#x02013;<lpage>8</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/s40345-019-0152-1</pub-id>
<pub-id pub-id-type="pmid">30610400</pub-id>
</mixed-citation></ref><ref id="B206"><label>206</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cunha</surname><given-names>AB</given-names></name><name><surname>Frey</surname><given-names>BN</given-names></name><name><surname>Andreazza</surname><given-names>AC</given-names></name><name><surname>Goi</surname><given-names>JD</given-names></name><name><surname>Rosa</surname><given-names>AR</given-names></name><name><surname>Goncalves</surname><given-names>CA</given-names></name><etal/></person-group>. <article-title>Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes</article-title>. <source>Neurosci Lett</source>. (<year>2006</year>) <volume>398</volume>:<page-range>215&#x02013;9</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neulet.2005.12.085</pub-id>
</mixed-citation></ref><ref id="B207"><label>207</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Oliveira</surname><given-names>GS</given-names></name><name><surname>Ceres&#x000e9;r</surname><given-names>KM</given-names></name><name><surname>Fernandes</surname><given-names>BS</given-names></name><name><surname>Kauer-Sant&#x02019;Anna</surname><given-names>M</given-names></name><name><surname>Fries</surname><given-names>GR</given-names></name><name><surname>Stertz</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients</article-title>. <source>J Psychiatr Res</source>. (<year>2009</year>) <volume>43</volume>:<page-range>1171&#x02013;4</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jpsychires.2009.04.002</pub-id>
</mixed-citation></ref><ref id="B208"><label>208</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>MaChado-Vieira</surname><given-names>R</given-names></name><name><surname>Dietrich</surname><given-names>MO</given-names></name><name><surname>Leke</surname><given-names>R</given-names></name><name><surname>Cereser</surname><given-names>VH</given-names></name><name><surname>Zanatto</surname><given-names>V</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode</article-title>. <source>Biol Psychiatry</source>. (<year>2007</year>) <volume>61</volume>:<page-range>142&#x02013;4</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.biopsych.2006.03.070</pub-id>
</mixed-citation></ref><ref id="B209"><label>209</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>BS</given-names></name><name><surname>Gama</surname><given-names>CS</given-names></name><name><surname>Kauer-Sant&#x02019;Anna</surname><given-names>M</given-names></name><name><surname>Lobato</surname><given-names>MI</given-names></name><name><surname>Belmonte-de-Abreu</surname><given-names>P</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name></person-group>. <article-title>Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis</article-title>. <source>J Psychiatr Res</source>. (<year>2009</year>) <volume>43</volume>:<page-range>1200&#x02013;4</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jpsychires.2009.04.010</pub-id>
</mixed-citation></ref><ref id="B210"><label>210</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tramontina</surname><given-names>JF</given-names></name><name><surname>Andreazza</surname><given-names>AC</given-names></name><name><surname>Kauer-Sant&#x02019;anna</surname><given-names>M</given-names></name><name><surname>Stertz</surname><given-names>L</given-names></name><name><surname>Goi</surname><given-names>J</given-names></name><name><surname>Chiarani</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Brain-derived neurotrophic factor serum levels before and after treatment for acute mania</article-title>. <source>Neurosci Lett</source>. (<year>2009</year>) <volume>452</volume>:<page-range>111&#x02013;3</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neulet.2009.01.028</pub-id>
</mixed-citation></ref><ref id="B211"><label>211</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Perez-Rodriguez</surname><given-names>MM</given-names></name><name><surname>New</surname><given-names>AS</given-names></name><name><surname>Goldstein</surname><given-names>KE</given-names></name><name><surname>Rosell</surname><given-names>D</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Brain-derived neurotrophic factor Val66Met genotype modulates amygdala habituation</article-title>. <source>Psychiatry Research: Neuroimaging</source>. (<year>2017</year>) <volume>263</volume>:<fpage>85</fpage>&#x02013;<lpage>92</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.pscychresns.2017.03.008</pub-id>
<pub-id pub-id-type="pmid">28371657</pub-id>
</mixed-citation></ref><ref id="B212"><label>212</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miu</surname><given-names>AC</given-names></name><name><surname>C&#x00103;rnu&#x00163;&#x00103;</surname><given-names>M</given-names></name><name><surname>Vulturar</surname><given-names>R</given-names></name><name><surname>Szekely-Cop&#x000ee;ndean</surname><given-names>RD</given-names></name><name><surname>B&#x000ee;lc</surname><given-names>MI</given-names></name><name><surname>Chi&#x0015f;</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>BDNF Val66Met polymorphism moderates the link between child maltreatment and reappraisal ability</article-title>. <source>Genes Brain Behav</source>. (<year>2017</year>) <volume>16</volume>:<page-range>419&#x02013;26</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/gbb.2017.16.issue-4</pub-id>
</mixed-citation></ref><ref id="B213"><label>213</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takaesu</surname><given-names>Y</given-names></name></person-group>. <article-title>Circadian rhythm in bipolar disorder: a review of the literature</article-title>. <source>Psychiatry Clin Neurosci</source>. (<year>2018</year>) <volume>72</volume>:<page-range>673&#x02013;82</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/pcn.2018.72.issue-9</pub-id>
</mixed-citation></ref><ref id="B214"><label>214</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kishi</surname><given-names>T</given-names></name><name><surname>Kitajima</surname><given-names>T</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Yamanouchi</surname><given-names>Y</given-names></name><name><surname>Kinoshita</surname><given-names>Y</given-names></name><name><surname>Kawashima</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population</article-title>. <source>Eur Arch Psychiatry Clin Neurosci</source>. (<year>2009</year>) <volume>259</volume>:<page-range>293&#x02013;7</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s00406-009-0869-4</pub-id>
</mixed-citation></ref><ref id="B215"><label>215</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Song</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Yoon</surname><given-names>HK</given-names></name><name><surname>Choi</surname><given-names>YK</given-names></name><name><surname>Jung</surname><given-names>HY</given-names></name><etal/></person-group>. <article-title>Association between CLOCK 3111T/C and preferred circadian phase in Korean patients with bipolar disorder</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source>. (<year>2010</year>) <volume>34</volume>:<page-range>1196&#x02013;201</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.pnpbp.2010.06.010</pub-id>
</mixed-citation></ref><ref id="B216"><label>216</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mansour</surname><given-names>HA</given-names></name><name><surname>Wood</surname><given-names>J</given-names></name><name><surname>Logue</surname><given-names>T</given-names></name><name><surname>Chowdari</surname><given-names>KV</given-names></name><name><surname>Dayal</surname><given-names>M</given-names></name><name><surname>Kupfer</surname><given-names>DJ</given-names></name><etal/></person-group>. <article-title>Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia</article-title>. <source>Genes Brain Behav</source>. (<year>2006</year>) <volume>5</volume>:<page-range>150&#x02013;7</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.1601-183X.2005.00147.x</pub-id>
</mixed-citation></ref><ref id="B217"><label>217</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nievergelt</surname><given-names>CM</given-names></name><name><surname>Kripke</surname><given-names>DF</given-names></name><name><surname>Barrett</surname><given-names>TB</given-names></name><name><surname>Burg</surname><given-names>E</given-names></name><name><surname>Remick</surname><given-names>RA</given-names></name><name><surname>Sadovnick</surname><given-names>AD</given-names></name><etal/></person-group>. <article-title>Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder</article-title>. <source>Am J Med Genet B Neuropsychiatr Genet</source>. (<year>2006</year>) <volume>141B</volume>:<page-range>234&#x02013;41</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/ajmg.b.30252</pub-id>
</mixed-citation></ref><ref id="B218"><label>218</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Wittke-Thompson</surname><given-names>JK</given-names></name><name><surname>Badner</surname><given-names>JA</given-names></name><name><surname>Hattori</surname><given-names>E</given-names></name><name><surname>Potash</surname><given-names>JB</given-names></name><name><surname>Willour</surname><given-names>VL</given-names></name><etal/></person-group>. <article-title>Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm</article-title>. <source>Am J Med Genet B Neuropsychiatr Genet</source>. (<year>2008</year>) <volume>147B</volume>:<page-range>1047&#x02013;55</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1002/ajmg.b.30714</pub-id>
</mixed-citation></ref><ref id="B219"><label>219</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Drago</surname><given-names>A</given-names></name><name><surname>Monti</surname><given-names>B</given-names></name><name><surname>De Ronchi</surname><given-names>D</given-names></name><name><surname>Serretti</surname><given-names>A</given-names></name></person-group>. <article-title>CRY1 variations impacts on the depressive relapse rate in a sample of bipolar patients</article-title>. <source>Psychiatry Invest</source>. (<year>2015</year>) <volume>12</volume>:<fpage>118</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.4306/pi.2015.12.1.118</pub-id>
</mixed-citation></ref><ref id="B220"><label>220</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Titone</surname><given-names>MK</given-names></name><name><surname>Goel</surname><given-names>N</given-names></name><name><surname>Ng</surname><given-names>TH</given-names></name><name><surname>MacMullen</surname><given-names>LE</given-names></name><name><surname>Alloy</surname><given-names>LB</given-names></name></person-group>. <article-title>Impulsivity and sleep and circadian rhythm disturbance predict next-day mood symptoms in a sample at high risk for or with recent-onset bipolar spectrum disorder: An ecological momentary assessment study</article-title>. <source>J Affect Disord</source>. (<year>2022</year>) <volume>298</volume>:<fpage>17</fpage>&#x02013;<lpage>25</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2021.08.155</pub-id>
<pub-id pub-id-type="pmid">34728283</pub-id>
</mixed-citation></ref><ref id="B221"><label>221</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alloy</surname><given-names>LB</given-names></name><name><surname>Walsh</surname><given-names>RF</given-names></name><name><surname>Smith</surname><given-names>LT</given-names></name><name><surname>Maddox</surname><given-names>MA</given-names></name><name><surname>Olino</surname><given-names>TM</given-names></name><name><surname>Zee</surname><given-names>PC</given-names></name><etal/></person-group>. <article-title>Circadian, Reward, and Emotion Systems in Teens prospective longitudinal study: protocol overview of an integrative reward-circadian rhythm model of first onset of bipolar spectrum disorder in adolescence</article-title>. <source>BMC Psychiatry</source>. (<year>2023</year>) <volume>23</volume>:<fpage>602</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/s12888-023-05094-z</pub-id>
<pub-id pub-id-type="pmid">37592214</pub-id>
</mixed-citation></ref><ref id="B222"><label>222</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reppert</surname><given-names>SM</given-names></name><name><surname>Wever</surname><given-names>DR</given-names></name></person-group>. <article-title>Molecular analysis of mammalian circadian rhythms</article-title>. <source>Ann Rev Physiol</source>. (<year>2001</year>) <volume>63</volume>:<page-range>647&#x02013;76</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1146/annurev.physiol.63.1.647</pub-id>
</mixed-citation></ref><ref id="B223"><label>223</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roenneberg</surname><given-names>T</given-names></name><name><surname>Merrow</surname><given-names>M</given-names></name></person-group>. <article-title>Entrainment of the human circadian clock</article-title>. <source>Cold Spring Harb Symp Quant Biol</source>. (<year>2007</year>) <volume>72</volume>:<page-range>293&#x02013;9</page-range>.</mixed-citation></ref><ref id="B224"><label>224</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jagannath</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>L</given-names></name><name><surname>Wakaf</surname><given-names>Z</given-names></name><name><surname>Vasudevan</surname><given-names>SR</given-names></name><name><surname>Foster</surname><given-names>RG</given-names></name></person-group>. <article-title>The genetics of circadian rhythms, sleep and health</article-title>. <source>Hum Mol Genet</source>. (<year>2017</year>) <volume>26</volume>:<page-range>R128&#x02013;38</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1093/hmg/ddx240</pub-id>
</mixed-citation></ref><ref id="B225"><label>225</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Melo</surname><given-names>MC</given-names></name><name><surname>Garcia</surname><given-names>RF</given-names></name><name><surname>Linhares Neto</surname><given-names>VB</given-names></name><name><surname>Sa</surname><given-names>MB</given-names></name><name><surname>de Mesquita</surname><given-names>LM</given-names></name><name><surname>de Araujo</surname><given-names>CF</given-names></name><etal/></person-group>. <article-title>Sleep and circadian alterations in people at risk for bipolar disorder: a systematic review</article-title>. <source>J Psychiatr Res</source>. (<year>2016</year>) <volume>83</volume>:<page-range>211&#x02013;9</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jpsychires.2016.09.005</pub-id>
</mixed-citation></ref><ref id="B226"><label>226</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Robillard</surname><given-names>R</given-names></name><name><surname>Naismith</surname><given-names>SL</given-names></name><name><surname>Rogers</surname><given-names>NL</given-names></name><name><surname>Scott</surname><given-names>EM</given-names></name><name><surname>Ip</surname><given-names>TKC</given-names></name><name><surname>Hermens</surname><given-names>DF</given-names></name><etal/></person-group>. <article-title>Sleep-wake cycle and melatonin rhythms in adolescents and young adults with mood disorders: comparison of unipolar and bipolar phenotypes</article-title>. <source>Eur Psychiat</source>. (<year>2013</year>) <volume>28</volume>:<page-range>412&#x02013;6</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.eurpsy.2013.04.001</pub-id>
</mixed-citation></ref><ref id="B227"><label>227</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Robillard</surname><given-names>R</given-names></name><name><surname>Hermens</surname><given-names>DF</given-names></name><name><surname>Naismith</surname><given-names>SL</given-names></name><name><surname>White</surname><given-names>D</given-names></name><name><surname>Rogers</surname><given-names>NL</given-names></name><name><surname>Ip</surname><given-names>TK</given-names></name><etal/></person-group>. <article-title>Ambulatory sleep-wake patterns and variability in young people with emerging mental disorders</article-title>. <source>J Psychiatry Neurosci</source>. (<year>2015</year>) <volume>40</volume>:<fpage>28</fpage>&#x02013;<lpage>37</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1503/jpn.130247</pub-id>
<pub-id pub-id-type="pmid">25203899</pub-id>
</mixed-citation></ref><ref id="B228"><label>228</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smagula</surname><given-names>SF</given-names></name><name><surname>Krafty</surname><given-names>RT</given-names></name><name><surname>Thayer</surname><given-names>JF</given-names></name><name><surname>Buysse</surname><given-names>DJ</given-names></name><name><surname>Hall</surname><given-names>MH</given-names></name></person-group>. <article-title>Rest-activity rhythm profiles associated with manic-hypomanic and depressive symptoms</article-title>. <source>J Psychiatr Res</source>. (<year>2018</year>) <volume>102</volume>:<page-range>238&#x02013;44</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jpsychires.2018.04.015</pub-id>
</mixed-citation></ref><ref id="B229"><label>229</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Steinan</surname><given-names>MK</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>Lagerberg</surname><given-names>TV</given-names></name><name><surname>Melle</surname><given-names>I</given-names></name><name><surname>Andreassen</surname><given-names>OA</given-names></name><name><surname>Vaaler</surname><given-names>AE</given-names></name><etal/></person-group>. <article-title>Sleep problems in bipolar disorders: more than just insomnia</article-title>. <source>Acta Psychiatrica Scandinavica</source>. (<year>2016</year>) <volume>133</volume>:<page-range>368&#x02013;77</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/acps.12523</pub-id>
</mixed-citation></ref><ref id="B230"><label>230</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Glozier</surname><given-names>N</given-names></name><name><surname>O&#x02019;Dea</surname><given-names>B</given-names></name><name><surname>McGorry</surname><given-names>PD</given-names></name><name><surname>Pantelis</surname><given-names>C</given-names></name><name><surname>Amminger</surname><given-names>GP</given-names></name><name><surname>Hermens</surname><given-names>DF</given-names></name><etal/></person-group>. <article-title>Delayed sleep onset in depressed young people</article-title>. <source>BMC Psychiatry</source>. (<year>2014</year>) <volume>14</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1186/1471-244X-14-33</pub-id>
</mixed-citation></ref><ref id="B231"><label>231</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Paksarian</surname><given-names>D</given-names></name><name><surname>Lamers</surname><given-names>F</given-names></name><name><surname>Hickie</surname><given-names>IB</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Merikangas</surname><given-names>KR</given-names></name></person-group>. <article-title>Sleep patterns and mental health correlates in US adolescents</article-title>. <source>J Pediatr</source>. (<year>2017</year>) <volume>182</volume>:<page-range>137&#x02013;43</page-range>.</mixed-citation></ref><ref id="B232"><label>232</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Logan</surname><given-names>RW</given-names></name><name><surname>McClung</surname><given-names>CA</given-names></name></person-group>. <article-title>Rhythms of life: Circadian disruption and brain disorders across the lifespan</article-title>. <source>Nat Rev Neurosci</source>. (<year>2019</year>) <volume>20</volume>:<fpage>49</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">30459365</pub-id>
</mixed-citation></ref><ref id="B233"><label>233</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Faria</surname><given-names>AD</given-names></name><name><surname>de Azevedo Cardoso</surname><given-names>T</given-names></name><name><surname>Mondin</surname><given-names>TC</given-names></name><name><surname>de Mattos Souza</surname><given-names>LD</given-names></name><name><surname>da Silva Magalhaes</surname><given-names>PV</given-names></name><name><surname>Zeni</surname><given-names>CP</given-names></name><etal/></person-group>. <article-title>Biological rhythms in bipolar and depressive disorders: a community study with drug-na&#x000ef;ve young adults</article-title>. <source>J Affect Disord</source>. (<year>2015</year>) <volume>186</volume>:<page-range>145&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2015.07.004</pub-id>
</mixed-citation></ref><ref id="B234"><label>234</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mondin</surname><given-names>TC</given-names></name><name><surname>de Azevedo Cardoso</surname><given-names>T</given-names></name><name><surname>de Mattos Souza</surname><given-names>LD</given-names></name><name><surname>Jansen</surname><given-names>K</given-names></name><name><surname>da Silva Magalh&#x000e3;es</surname><given-names>PV</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Mood disorders and biological rhythms in young adults: a large population-based study</article-title>. <source>J Psychiatr Res</source>. (<year>2017</year>) <volume>84</volume>:<fpage>98</fpage>&#x02013;<lpage>104</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jpsychires.2016.09.030</pub-id>
<pub-id pub-id-type="pmid">27716514</pub-id>
</mixed-citation></ref><ref id="B235"><label>235</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Altena</surname><given-names>E</given-names></name><name><surname>Micoulaud-Franchi</surname><given-names>J-A</given-names></name><name><surname>Geoffroy</surname><given-names>P-A</given-names></name><name><surname>Sanz-Arigita</surname><given-names>E</given-names></name><name><surname>Bioulac</surname><given-names>S</given-names></name><name><surname>Philip</surname><given-names>P</given-names></name></person-group>. <article-title>The bidirectional relation between emotional reactivity and sleep: From disruption to recovery</article-title>. <source>Behav Neurosci</source>. (<year>2016</year>) <volume>130</volume>:<page-range>336&#x02013;50</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1037/bne0000128</pub-id>
</mixed-citation></ref><ref id="B236"><label>236</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baglioni</surname><given-names>C</given-names></name><name><surname>Spiegelhalder</surname><given-names>K</given-names></name><name><surname>Lombardo</surname><given-names>C</given-names></name><name><surname>Riemann</surname><given-names>D</given-names></name></person-group>. <article-title>Sleep and emotions: a focus on insomnia</article-title>. <source>Sleep Med Rev</source>. (<year>2010</year>) <volume>14</volume>:<page-range>227&#x02013;38</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.smrv.2009.10.007</pub-id>
</mixed-citation></ref><ref id="B237"><label>237</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kanady</surname><given-names>JC</given-names></name><name><surname>Soehnera</surname><given-names>AM</given-names></name><name><surname>Harvey</surname><given-names>AGA</given-names></name></person-group>. <article-title>Retrospective examination of sleep disturbance across the course of bipolar disorder</article-title>. <source>J Sleep Disord Ther</source>. (<year>2015</year>) <volume>30</volume>:<fpage>4</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.4172/2167-0277.1000193</pub-id>
</mixed-citation></ref><ref id="B238"><label>238</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krause</surname><given-names>AJ</given-names></name><name><surname>Simon</surname><given-names>EB</given-names></name><name><surname>Mander</surname><given-names>BA</given-names></name><name><surname>Greer</surname><given-names>SM</given-names></name><name><surname>Saletin</surname><given-names>JM</given-names></name><name><surname>Goldstein-Piekarski An</surname></name><etal/></person-group>. <article-title>The sleep-deprived human brain</article-title>. <source>Nat Rev Neurosci</source>. (<year>2017</year>) <volume>18</volume>:<page-range>404&#x02013;18</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/nrn.2017.55</pub-id>
</mixed-citation></ref><ref id="B239"><label>239</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Riemann</surname><given-names>D</given-names></name><name><surname>Nissen</surname><given-names>C</given-names></name><name><surname>Palagini</surname><given-names>L</given-names></name><name><surname>Otte</surname><given-names>A</given-names></name><name><surname>Perlis</surname><given-names>ML</given-names></name><name><surname>Spiegelhalder</surname><given-names>K</given-names></name></person-group>. <article-title>The neurobiology, investigation, and treatment of chronic insomnia</article-title>. <source>Lancet Neurol</source>. (<year>2015</year>) <volume>14</volume>:<page-range>547&#x02013;58</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/S1474-4422(15)00021-6</pub-id>
</mixed-citation></ref><ref id="B240"><label>240</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yoo</surname><given-names>SS</given-names></name><name><surname>Gujar</surname><given-names>N</given-names></name><name><surname>Hu</surname><given-names>P</given-names></name><name><surname>Jolesz</surname><given-names>FA</given-names></name><name><surname>Walker</surname><given-names>MP</given-names></name></person-group>. <article-title>The human emotional brain without sleep&#x02014;a prefrontal amygdala disconnect</article-title>. <source>Curr Biol</source>. (<year>2007</year>) <volume>17</volume>:<page-range>877&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.cub.2007.08.007</pub-id>
</mixed-citation></ref><ref id="B241"><label>241</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rossa</surname><given-names>KR</given-names></name><name><surname>Smith</surname><given-names>SS</given-names></name><name><surname>Allan</surname><given-names>AC</given-names></name><name><surname>Sullivan</surname><given-names>KA</given-names></name></person-group>. <article-title>The effects of sleep restriction on executive inhibitory control and affect in young adults</article-title>. <source>J Adolesc Health</source>. (<year>2014</year>) <volume>55</volume>:<page-range>287&#x02013;92</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jadohealth.2013.12.034</pub-id>
</mixed-citation></ref><ref id="B242"><label>242</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Someren</surname><given-names>EJ</given-names></name><name><surname>Cirelli</surname><given-names>C</given-names></name><name><surname>Dijk</surname><given-names>DJ</given-names></name><name><surname>Van Cauter</surname><given-names>E</given-names></name><name><surname>Schwartz</surname><given-names>S</given-names></name><name><surname>Chee</surname><given-names>MW</given-names></name></person-group>. <article-title>Disrupted sleep: from molecules to cognition</article-title>. <source>J Neurosci</source>. (<year>2015</year>) <volume>35</volume>:<page-range>13889&#x02013;95</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2592-15.2015</pub-id>
</mixed-citation></ref><ref id="B243"><label>243</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Geoffroy</surname><given-names>PA</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>Boudebesse</surname><given-names>C</given-names></name><name><surname>Lajnef</surname><given-names>M</given-names></name><name><surname>Henry</surname><given-names>C</given-names></name><name><surname>Leboyer</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Sleep in patients with remitted bipolar dis- orders: a meta-analysis of actigraphy studies</article-title>. <source>Acta Psychiatr Scand</source>. (<year>2015</year>) <volume>131</volume>:<fpage>89</fpage>&#x02013;<lpage>99</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/acps.2014.131.issue-2</pub-id>
<pub-id pub-id-type="pmid">25430914</pub-id>
</mixed-citation></ref><ref id="B244"><label>244</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ritter</surname><given-names>PS</given-names></name><name><surname>Marx</surname><given-names>C</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Leopold</surname><given-names>K</given-names></name><name><surname>Pfennig</surname><given-names>A</given-names></name></person-group>. <article-title>The role of disturbed sleep in the early recognition of bipolar disorder: a systematic review</article-title>. <source>Bipolar Disord</source>. (<year>2011</year>) <volume>13</volume>:<page-range>227&#x02013;37</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.1399-5618.2011.00917.x</pub-id>
</mixed-citation></ref><ref id="B245"><label>245</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ritter</surname><given-names>PS</given-names></name><name><surname>Marx</surname><given-names>C</given-names></name><name><surname>Lewtschenko</surname><given-names>N</given-names></name><name><surname>Pfeiffer</surname><given-names>S</given-names></name><name><surname>Leopold</surname><given-names>K</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The characteristics of sleep in patients with manifest bipolar disorder, subjects at high risk of developing the disease and healthy controls</article-title>. <source>J Neural Transm</source>. (<year>2012</year>) <volume>119</volume>:<page-range>1173&#x02013;84</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1007/s00702-012-0883-y</pub-id>
</mixed-citation></ref><ref id="B246"><label>246</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ritter</surname><given-names>PS</given-names></name><name><surname>H&#x000f6;fler</surname><given-names>M</given-names></name><name><surname>Wittchen</surname><given-names>HU</given-names></name><name><surname>Lieb</surname><given-names>R</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Pfenning</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Disturbed sleep as risk factor for the subsequent onset of bipolar disorder&#x02014;data from a 10-year prospective-longitudinal study among adolescents and young adults</article-title>. <source>J Psychiatr Res</source>. (<year>2015</year>) <volume>68</volume>:<fpage>76</fpage>&#x02013;<lpage>82</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jpsychires.2015.06.005</pub-id>
<pub-id pub-id-type="pmid">26228404</pub-id>
</mixed-citation></ref><ref id="B247"><label>247</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boudebesse</surname><given-names>C</given-names></name><name><surname>Henry</surname><given-names>C</given-names></name></person-group>. <article-title>Emotional hyper-reactivity and sleep disturbances in remitted patients with bipolar disorders</article-title>. <source>Enc&#x000e9;phale</source>. (<year>2012</year>) <volume>38</volume>:<page-range>173&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/S0013-7006(12)70096-9</pub-id>
</mixed-citation></ref><ref id="B248"><label>248</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Godin</surname><given-names>O</given-names></name><name><surname>Boudebesse</surname><given-names>C</given-names></name><name><surname>Aubin</surname><given-names>V</given-names></name><name><surname>Azorin</surname><given-names>JM</given-names></name><name><surname>Bellivier</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Sleep quality and emotional reactivity cluster in bipolar disorders and impact on functioning</article-title>. <source>European Psychiatry</source>. (<year>2017</year>) <volume>45</volume>:<page-range>190&#x02013;7</page-range>.</mixed-citation></ref><ref id="B249"><label>249</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Horne</surname><given-names>CM</given-names></name><name><surname>Norbury</surname><given-names>R</given-names></name></person-group>. <article-title>Altered resting-state connectivity within default mode network associated with late chronotype</article-title>. <source>J Psychiatr Res</source>. (<year>2018</year>) <volume>102</volume>:<page-range>223&#x02013;9</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jpsychires.2018.04.013</pub-id>
</mixed-citation></ref><ref id="B250"><label>250</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kitamura</surname><given-names>S</given-names></name><name><surname>Hida</surname><given-names>A</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Enomoto</surname><given-names>M</given-names></name><name><surname>Aritake-Okada</surname><given-names>S</given-names></name><name><surname>Moriguchi</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Evening prefer- ence is related to the incidence of depressive states inde- pendent of sleep-wake conditions</article-title>. <source>Chronobiol. Int</source>. (<year>2010</year>) <volume>27</volume>:<page-range>1797&#x02013;812</page-range>.</mixed-citation></ref><ref id="B251"><label>251</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>H</given-names></name><name><surname>Taki</surname><given-names>Y</given-names></name><name><surname>Sekiguchi</surname><given-names>A</given-names></name><name><surname>Nouchi</surname><given-names>R</given-names></name><name><surname>Kotozaki</surname><given-names>Y</given-names></name><name><surname>Nakagawa</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Regional gray matter density is associated with morningness&#x02013; eveningness: evidence from voxel-based morphometry</article-title>. <source>Neuroimage</source>. (<year>2015</year>) <volume>117</volume>:<fpage>294</fpage>&#x02013;<lpage>304</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.05.037</pub-id>
<pub-id pub-id-type="pmid">26003859</pub-id>
</mixed-citation></ref><ref id="B252"><label>252</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Santos</surname><given-names>IM</given-names></name><name><surname>Bem-Haja</surname><given-names>P</given-names></name><name><surname>Silva</surname><given-names>A</given-names></name><name><surname>Rosa</surname><given-names>C</given-names></name><name><surname>Queiroz</surname><given-names>DF</given-names></name><name><surname>Alves</surname><given-names>MF</given-names></name><etal/></person-group>. <article-title>The interplay between chronotype and emotion regulation in the recognition of facial expressions of emotion</article-title>. <source>Behav Sci</source>. (<year>2022</year>) <volume>13</volume>:<fpage>38</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3390/bs13010038</pub-id>
<pub-id pub-id-type="pmid">36661610</pub-id>
</mixed-citation></ref><ref id="B253"><label>253</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gershon</surname><given-names>A</given-names></name><name><surname>Kaufmann</surname><given-names>CN</given-names></name><name><surname>Depp</surname><given-names>CA</given-names></name><name><surname>Miller</surname><given-names>S</given-names></name><name><surname>Do</surname><given-names>D</given-names></name><name><surname>Zeitzer</surname><given-names>JM</given-names></name><etal/></person-group>. <article-title>Subjective versus objective evening chronotypes in bipolar disorder</article-title>. <source>J Affect. Disord</source>. (<year>2018</year>) <volume>225</volume>:<page-range>342&#x02013;9</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2017.08.055</pub-id>
</mixed-citation></ref><ref id="B254"><label>254</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>CN</given-names></name><name><surname>Gershon</surname><given-names>A</given-names></name><name><surname>Depp</surname><given-names>CA</given-names></name><name><surname>Miller</surname><given-names>S</given-names></name><name><surname>Zeitzer</surname><given-names>JM</given-names></name><name><surname>Ketter</surname><given-names>TA</given-names></name></person-group>. <article-title>Daytime midpoint as a digital biomarker for chronotype in bipolar disorder</article-title>. <source>J Affect Disord</source>. (<year>2018</year>) <volume>241</volume>:<page-range>586&#x02013;91</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2018.08.032</pub-id>
</mixed-citation></ref><ref id="B255"><label>255</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koskenvuo</surname><given-names>M</given-names></name><name><surname>Hublin</surname><given-names>C</given-names></name><name><surname>Partinen</surname><given-names>M</given-names></name><name><surname>Heikkil&#x000e4;</surname><given-names>K</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name></person-group>. <article-title>Heritability of diurnal type: a nationwide study of 8753 adult twin pairs</article-title>. <source>J sleep Res</source>. (<year>2007</year>) <volume>16</volume>:<page-range>156&#x02013;62</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/j.1365-2869.2007.00580.x</pub-id>
</mixed-citation></ref><ref id="B256"><label>256</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vink</surname><given-names>JM</given-names></name><name><surname>Vink</surname><given-names>JM</given-names></name><name><surname>Groot</surname><given-names>AS</given-names></name><name><surname>Kerkhof</surname><given-names>GA</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name></person-group>. <article-title>Genetic analysis of morningness and eveningness</article-title>. <source>Chronobiology Int</source>. (<year>2001</year>) <volume>18</volume>:<page-range>809&#x02013;22</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1081/CBI-100107516</pub-id>
</mixed-citation></ref><ref id="B257"><label>257</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>N</given-names></name><name><surname>Shinohara</surname><given-names>K</given-names></name><name><surname>Saunders</surname><given-names>KE</given-names></name><name><surname>Geddes</surname><given-names>JR</given-names></name><name><surname>Cipriani</surname><given-names>A</given-names></name></person-group>. <article-title>Effect of lithium on circadian rhythm in bipolar disorder: A systematic review and meta-analysis</article-title>. <source>Bipolar Disord</source>. (<year>2021</year>) <volume>23</volume>:<page-range>445&#x02013;53</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1111/bdi.13070</pub-id>
</mixed-citation></ref><ref id="B258"><label>258</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zou</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>R</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name></person-group>. <article-title>Chronotype, circadian rhythm, and psychiatric disorders: Recent evidence and potential mechanisms</article-title>. <source>Front Neurosci</source>. (<year>2022</year>) <volume>16</volume>:<elocation-id>811771</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fnins.2022.811771</pub-id>
<pub-id pub-id-type="pmid">36033630</pub-id>
</mixed-citation></ref><ref id="B259"><label>259</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>MJ</given-names></name><name><surname>Nievergelt</surname><given-names>CM</given-names></name><name><surname>Kelsoe</surname><given-names>JR</given-names></name><name><surname>Welsh</surname><given-names>DK</given-names></name></person-group>. <article-title>A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response</article-title>. <source>PloS One</source>. (<year>2012</year>) <volume>7</volume>:<elocation-id>e32091</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1371/journal.pone.0032091</pub-id>
<pub-id pub-id-type="pmid">22384149</pub-id>
</mixed-citation></ref><ref id="B260"><label>260</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pisanu</surname><given-names>C</given-names></name><name><surname>Congiu</surname><given-names>D</given-names></name><name><surname>Melis</surname><given-names>C</given-names></name><name><surname>Severino</surname><given-names>G</given-names></name><name><surname>Angius</surname><given-names>A</given-names></name><name><surname>Ardau</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Involvement of core clock genes in lithium response</article-title>. <source>World J Biol Psychiatry</source>. (<year>2017</year>), <fpage>1</fpage>&#x02013;<lpage>2</lpage>.<pub-id pub-id-type="pmid">28079489</pub-id>
</mixed-citation></ref><ref id="B261"><label>261</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Honma</surname><given-names>S</given-names></name></person-group>. <article-title>Lithium lengthens circadian period of cultured brain slices in area specific manner</article-title>. <source>Behav Brain Res</source>. (<year>2016</year>) <volume>314</volume>:<page-range>30&#x02013;7</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.bbr.2016.07.045</pub-id>
</mixed-citation></ref><ref id="B262"><label>262</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Klein</surname><given-names>PS</given-names></name><name><surname>Lazar</surname><given-names>MA</given-names></name></person-group>. <article-title>Nuclear receptor Rev-erb&#x003b1; is a critical lithium-sensitive component of the circadian clock</article-title>. <source>Science</source>. (<year>2006</year>) <volume>311</volume>:<page-range>1002&#x02013;5</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1126/science.1121613</pub-id>
</mixed-citation></ref><ref id="B263"><label>263</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chung</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>EJ</given-names></name><name><surname>Yun</surname><given-names>S</given-names></name><name><surname>Choe</surname><given-names>HK</given-names></name><name><surname>Park</surname><given-names>SB</given-names></name><name><surname>Son</surname><given-names>HJ</given-names></name><etal/></person-group>. <article-title>Impact of circadian nuclear receptor REV-ERB&#x003b1; on midbrain dopamine production and mood regulation</article-title>. <source>Cell</source>. (<year>2014</year>) <volume>157</volume>:<page-range>858&#x02013;68</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.cell.2014.03.039</pub-id>
</mixed-citation></ref><ref id="B264"><label>264</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Jang</surname><given-names>S</given-names></name><name><surname>Choe</surname><given-names>HK</given-names></name><name><surname>Chung</surname><given-names>S</given-names></name><name><surname>Son</surname><given-names>GH</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name></person-group>. <article-title>Implications of circadian rhythm in dopamine and mood regulation</article-title>. <source>Molecules Cells</source>. (<year>2017</year>) <volume>40</volume>:<page-range>450&#x02013;6</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.14348/molcells.2017.0065</pub-id>
</mixed-citation></ref><ref id="B265"><label>265</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berking</surname><given-names>M</given-names></name><name><surname>Wupperman</surname><given-names>P</given-names></name></person-group>. <article-title>Emotion regulation and mental health: Recent findings, current challenges, and future directions</article-title>. <source>Curr Opin Psychiatry</source>. (<year>2012</year>) <volume>25</volume>:<page-range>128&#x02013;34</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1097/YCO.0b013e3283503669</pub-id>
</mixed-citation></ref><ref id="B266"><label>266</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gruber</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>SL</given-names></name><name><surname>Oveis</surname><given-names>C</given-names></name><name><surname>Keltner</surname><given-names>D</given-names></name></person-group>. <article-title>Risk for mania and positive emotional responding: Too much of a good thing</article-title>? <source>Emotion</source>. (<year>2014</year>) <volume>8</volume>:<fpage>23</fpage>&#x02013;<lpage>33</lpage>.</mixed-citation></ref><ref id="B267"><label>267</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thompson</surname><given-names>ER</given-names></name><name><surname>Wright</surname><given-names>AG</given-names></name><name><surname>Gotlib</surname><given-names>IH</given-names></name></person-group>. <article-title>Assessment of emotion regulation: Theories, measures, and translational challenges</article-title>. <source>psychol Bull</source>. (<year>2020</year>) <volume>146</volume>:<page-range>321&#x02013;49</page-range>.</mixed-citation></ref><ref id="B268"><label>268</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Rheenen</surname><given-names>TE</given-names></name><name><surname>Murray</surname><given-names>G</given-names></name><name><surname>Rossell</surname><given-names>SL</given-names></name></person-group>. <article-title>Emotion regulation in bipolar disorder: Profiling strengths and weaknesses</article-title>. <source>J Affect Disord</source>. (<year>2020</year>) <volume>273</volume>:<page-range>124&#x02013;34</page-range>.</mixed-citation></ref><ref id="B269"><label>269</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yatham</surname><given-names>LN</given-names></name><name><surname>Kennedy</surname><given-names>SH</given-names></name><name><surname>Parikh</surname><given-names>SV</given-names></name><name><surname>Schaffer</surname><given-names>A</given-names></name><name><surname>Bond</surname><given-names>DJ</given-names></name><name><surname>Frey</surname><given-names>BN</given-names></name><etal/></person-group>. <article-title>Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder</article-title>. <source>Bipolar Disord</source>. (<year>2018</year>) <volume>20</volume>:<fpage>97</fpage>&#x02013;<lpage>170</lpage>.<pub-id pub-id-type="pmid">29536616</pub-id>
</mixed-citation></ref><ref id="B270"><label>270</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brietzke</surname><given-names>E</given-names></name><name><surname>Mansur</surname><given-names>RB</given-names></name><name><surname>Subramaniapillai</surname><given-names>M</given-names></name><name><surname>Balanz&#x000e1;-Mart&#x000ed;nez</surname><given-names>V</given-names></name><name><surname>Vinberg</surname><given-names>M</given-names></name><name><surname>Gonz&#x000e1;lez-Pinto</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Ketogenic diet as a metabolic therapy for mood disorders: evidence and developments</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2018</year>) <volume>94</volume>:<page-range>11&#x02013;6</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neubiorev.2018.07.020</pub-id>
</mixed-citation></ref><ref id="B271"><label>271</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Needham</surname><given-names>N</given-names></name><name><surname>Campbell</surname><given-names>IH</given-names></name><name><surname>Grossi</surname><given-names>H</given-names></name><name><surname>Kamenska</surname><given-names>I</given-names></name><name><surname>Rigby</surname><given-names>BP</given-names></name><name><surname>Simpson</surname><given-names>SA</given-names></name><etal/></person-group>. <article-title>Pilot study of a ketogenic diet in bipolar disorder</article-title>. <source>BJPsych Open</source>. (<year>2023</year>) <volume>9</volume>:<elocation-id>e176</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1192/bjo.2023.568</pub-id>
<pub-id pub-id-type="pmid">37814952</pub-id>
</mixed-citation></ref><ref id="B272"><label>272</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gim&#x000e9;nez-Palomo</surname><given-names>A</given-names></name><name><surname>Dodd</surname><given-names>S</given-names></name><name><surname>Anmella</surname><given-names>G</given-names></name><name><surname>Carvalho</surname><given-names>AF</given-names></name><name><surname>Scaini</surname><given-names>G</given-names></name><name><surname>Quevedo</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment</article-title>. <source>Front Psychiatry</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>546801</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3389/fpsyt.2021.546801</pub-id>
<pub-id pub-id-type="pmid">34295268</pub-id>
</mixed-citation></ref><ref id="B273"><label>273</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sethi</surname><given-names>S</given-names></name><name><surname>Ford</surname><given-names>JM</given-names></name></person-group>. <article-title>The role of ketogenic metabolic therapy on the brain in serious. mental illness: a review</article-title>. <source>J Psychiatr Brain Sci</source>. (<year>2022</year>) <volume>7</volume>:<elocation-id>e220009</elocation-id>.<pub-id pub-id-type="pmid">36483840</pub-id>
</mixed-citation></ref><ref id="B274"><label>274</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koppel</surname><given-names>SJ</given-names></name><name><surname>Swerdlow</surname><given-names>RH</given-names></name></person-group>. <article-title>Neuroketotherapeutics: a modern review of a century-old therapy</article-title>. <source>Neurochemistry Int</source>. (<year>2018</year>) <volume>117</volume>:<page-range>114&#x02013;25</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.neuint.2017.05.019</pub-id>
</mixed-citation></ref><ref id="B275"><label>275</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sethi</surname><given-names>S</given-names></name><name><surname>Wakeham</surname><given-names>D</given-names></name><name><surname>Ketter</surname><given-names>T</given-names></name><name><surname>Hooshmand</surname><given-names>F</given-names></name><name><surname>Bjornstad</surname><given-names>J</given-names></name><name><surname>Richards</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Ketogenic diet intervention on metabolic and psychiatric health in bipolar and schizophrenia: A pilot trial</article-title>. <source>Psychiatry Res</source>. (<year>2024</year>) <volume>335</volume>:<fpage>115866</fpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.psychres.2024.115866</pub-id>
<pub-id pub-id-type="pmid">38547601</pub-id>
</mixed-citation></ref><ref id="B276"><label>276</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brenda</surname><given-names>JY</given-names></name><name><surname>Oz</surname><given-names>RS</given-names></name><name><surname>Sethi</surname><given-names>S</given-names></name></person-group>. <article-title>Ketogenic diet as a metabolic therapy for bipolar disorder: Clinical developments</article-title>. <source>J Affect Disord Rep</source>. (<year>2023</year>) <volume>11</volume>:<fpage>100457</fpage>.</mixed-citation></ref><ref id="B277"><label>277</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ancoli-Israel</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>JL</given-names></name><name><surname>Blackwell</surname><given-names>T</given-names></name><name><surname>Buenaver</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Meltzer</surname><given-names>LJ</given-names></name><etal/></person-group>. <article-title>The SBSM guide to actigraphy monitoring: clinical and research applications</article-title>. <source>Behav Sleep Med</source>. (<year>2015</year>) <volume>13</volume>:<fpage>S4</fpage>&#x02013;<lpage>S38</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1080/15402002.2015.1046356</pub-id>
<pub-id pub-id-type="pmid">26273913</pub-id>
</mixed-citation></ref><ref id="B278"><label>278</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zinkhan</surname><given-names>M</given-names></name><name><surname>Kantelhardt</surname><given-names>JW</given-names></name></person-group>. <article-title>Sleep assessment in large cohort studies with high-resolution accelerometers</article-title>. <source>Sleep Med Clin</source>. (<year>2016</year>) <volume>11</volume>:<page-range>469&#x02013;88</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jsmc.2016.08.006</pub-id>
</mixed-citation></ref><ref id="B279"><label>279</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krane-Gartiser</surname><given-names>K</given-names></name><name><surname>Steinan</surname><given-names>MK</given-names></name><name><surname>Langsrud</surname><given-names>K</given-names></name><name><surname>Vestvik</surname><given-names>V</given-names></name><name><surname>Sand</surname><given-names>T</given-names></name><name><surname>Fasmer</surname><given-names>OB</given-names></name><etal/></person-group>. <article-title>Mood and motor activity in euthymic bipolar disorder with sleep disturbance</article-title>. <source>J Affect. Disord</source>. (<year>2016</year>) <volume>202</volume>:<fpage>23</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">27253213</pub-id>
</mixed-citation></ref><ref id="B280"><label>280</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Urbanek</surname><given-names>JK</given-names></name><name><surname>Spira</surname><given-names>AP</given-names></name><name><surname>Di</surname><given-names>J</given-names></name><name><surname>Leroux</surname><given-names>A</given-names></name><name><surname>Crainiceanu</surname><given-names>C</given-names></name><name><surname>Zipunnikov</surname><given-names>V</given-names></name></person-group>. <article-title>Epidemiology of objectively measured bedtime and chronotype in US adolescents and adults: NHANES 2003-2006</article-title>. <source>Chronobiol Int</source>. (<year>2018</year>) <volume>35</volume>:<page-range>416&#x02013;34</page-range>.</mixed-citation></ref><ref id="B281"><label>281</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matthews</surname><given-names>CE</given-names></name><name><surname>George</surname><given-names>SM</given-names></name><name><surname>Moore</surname><given-names>SC</given-names></name><name><surname>Bowles</surname><given-names>HR</given-names></name><name><surname>Blar</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Amount of time spent in sedentary behaviors and cause-specific mortality in US adults</article-title>. <source>Am J Clin Nutr</source>. (<year>2012</year>) <volume>95</volume>:<page-range>437&#x02013;45</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.3945/ajcn.111.019620</pub-id>
</mixed-citation></ref><ref id="B282"><label>282</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Doherty</surname><given-names>A</given-names></name><name><surname>Jackson</surname><given-names>D</given-names></name><name><surname>Hammerla</surname><given-names>N</given-names></name><name><surname>Plotz</surname><given-names>T</given-names></name><name><surname>Olivier</surname><given-names>P</given-names></name><name><surname>Granat</surname><given-names>MH</given-names></name><etal/></person-group>. <article-title>Large scale population assessment of physical activity using wrist worn accelerometers: The UK Biobank Study</article-title>. <source>PloS One</source>. (<year>2017</year>) <volume>12</volume>:<elocation-id>e0169649</elocation-id>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1371/journal.pone.0169649</pub-id>
<pub-id pub-id-type="pmid">28146576</pub-id>
</mixed-citation></ref><ref id="B283"><label>283</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Merikangas</surname><given-names>KR</given-names></name><name><surname>Swendsen</surname><given-names>J</given-names></name><name><surname>Hickie</surname><given-names>IB</given-names></name><name><surname>Cui</surname><given-names>L</given-names></name><name><surname>Shou</surname><given-names>H</given-names></name><name><surname>Merikangas</surname><given-names>AK</given-names></name><etal/></person-group>. <article-title>Real-time mobile monitoring of the dynamic associations among motor activity, energy, mood, and sleep in adults with bipolar disorder</article-title>. <source>JAMA Psychiatry</source>. (<year>2019</year>) <volume>76</volume>:<page-range>190&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1001/jamapsychiatry.2018.3546</pub-id>
</mixed-citation></ref><ref id="B284"><label>284</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burton</surname><given-names>C</given-names></name><name><surname>McKinstry</surname><given-names>B</given-names></name><name><surname>T&#x00103;tar</surname><given-names>AS</given-names></name><name><surname>Serrano-Blanco</surname><given-names>A</given-names></name><name><surname>Pagliari</surname><given-names>C</given-names></name><name><surname>Wolters</surname><given-names>M</given-names></name></person-group>. <article-title>Activity monitoring in patients with depression: a systematic review</article-title>. <source>J Affect Disord</source>. (<year>2013</year>) <volume>145</volume>:<page-range>21&#x02013;8</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.jad.2012.07.001</pub-id>
</mixed-citation></ref><ref id="B285"><label>285</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Crescenzo</surname><given-names>F</given-names></name><name><surname>Economou</surname><given-names>A</given-names></name><name><surname>Sharpley</surname><given-names>AL</given-names></name><name><surname>Gormez</surname><given-names>A</given-names></name><name><surname>Quested</surname><given-names>DJ</given-names></name></person-group>. <article-title>Actigraphic features of bipolar disorder: a systematic review and meta-analysis</article-title>. <source>Sleep Med Rev</source>. (<year>2017</year>) <volume>33</volume>:<fpage>58</fpage>&#x02013;<lpage>69</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.smrv.2016.05.003</pub-id>
<pub-id pub-id-type="pmid">28185811</pub-id>
</mixed-citation></ref><ref id="B286"><label>286</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lyall</surname><given-names>LM</given-names></name><name><surname>Wyse</surname><given-names>CA</given-names></name><name><surname>Graham</surname><given-names>N</given-names></name><name><surname>Ferguson</surname><given-names>A</given-names></name><name><surname>Lyall</surname><given-names>DM</given-names></name><name><surname>Cullen</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Association of disrupted circadian rhythmicity with mood disorders, subjective wellbeing, and cognitive function: a cross-sectional study of 91 105 participants from the UK Biobank</article-title>. <source>Lancet Psychiatry</source>. (<year>2018</year>) <volume>5</volume>:<page-range>507&#x02013;14</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/s2215-0366(18)30139-1</pub-id>
</mixed-citation></ref><ref id="B287"><label>287</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Andreassen</surname><given-names>OA</given-names></name><name><surname>Geddes</surname><given-names>JR</given-names></name><name><surname>Kessing</surname><given-names>LV</given-names></name><name><surname>Lewitzka</surname><given-names>U</given-names></name><name><surname>Schulze</surname><given-names>TG</given-names></name><etal/></person-group>. <article-title>Areas of uncertainties and unmet needs in bipolar disorders: clinical and research perspectives</article-title>. <source>Lancet Psychiatry</source>. (<year>2018</year>) <volume>5</volume>:<page-range>930&#x02013;9</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/S2215-0366(18)30253-0</pub-id>
</mixed-citation></ref><ref id="B288"><label>288</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vieta</surname><given-names>E</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name><name><surname>Schulze</surname><given-names>TG</given-names></name><name><surname>Carvalho</surname><given-names>AF</given-names></name><name><surname>Suppes</surname><given-names>T</given-names></name><name><surname>Calabrese</surname><given-names>JR</given-names></name><etal/></person-group>. <article-title>Bipolar disorders</article-title>. <source>Nat Rev Dis Primers</source>. (<year>2018</year>) <volume>4</volume>:<fpage>1</fpage>&#x02013;<lpage>16</lpage>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1038/nrdp.2018.8</pub-id>
<pub-id pub-id-type="pmid">29930242</pub-id>
</mixed-citation></ref><ref id="B289"><label>289</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>O&#x02019;Leary</surname><given-names>E</given-names></name><name><surname>Dodd</surname><given-names>S</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name></person-group>. <article-title>Biomarkers for bipolar disorder</article-title>. In: <source>Biomarkers in neuropsychiatry: A primer</source>. <publisher-name>Springer International Publishing</publisher-name>, <publisher-loc>Cham</publisher-loc> (<year>2023</year>). p. <page-range>219&#x02013;31</page-range>.</mixed-citation></ref><ref id="B290"><label>290</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hay</surname><given-names>AC</given-names></name><name><surname>Sheppes</surname><given-names>G</given-names></name><name><surname>Gross</surname><given-names>JJ</given-names></name><name><surname>Gruber</surname><given-names>J</given-names></name></person-group>. <article-title>Choosing how to feel: Emotion regulation choice in bipolar disorder</article-title>. <source>Emotion</source>. (<year>2015</year>) <volume>15</volume>:<page-range>139&#x02013;45</page-range>.</mixed-citation></ref><ref id="B291"><label>291</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morris</surname><given-names>RW</given-names></name><name><surname>Sparks</surname><given-names>A</given-names></name><name><surname>Mitchell</surname><given-names>PB</given-names></name><name><surname>Weickert</surname><given-names>CS</given-names></name><name><surname>Green</surname><given-names>MJ</given-names></name></person-group>. <article-title>Lack of cortico-limbic coupling in bipolar disorder and schizophrenia during emotion regulation</article-title>. <source>Trans Psychiatry</source>. (<year>2012</year>) <volume>2</volume>:<page-range>e90&#x02013;0</page-range>.</mixed-citation></ref><ref id="B292"><label>292</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Broch-Due</surname><given-names>I</given-names></name><name><surname>Kj&#x000e6;rstad</surname><given-names>HL</given-names></name><name><surname>Kessing</surname><given-names>LV</given-names></name><name><surname>Miskowiak</surname><given-names>K</given-names></name></person-group>. <article-title>Subtle behavioural responses during negative emotion reactivity and down-regulation in bipolar disorder: A facial expression and eye-tracking study</article-title>. <source>Psychiatry Res</source>. (<year>2018</year>) <volume>266</volume>:<page-range>152&#x02013;9</page-range>.</mixed-citation></ref><ref id="B293"><label>293</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garcia-Blanco</surname><given-names>AC</given-names></name><name><surname>Perea</surname><given-names>M</given-names></name><name><surname>Salmeron</surname><given-names>L</given-names></name></person-group>. <article-title>Attention orienting and inhibitory control across the different mood states in bi- polar disorder: an emotional antisaccade task</article-title>. <source>Biol Psychol</source>. (<year>2013</year>) <volume>94</volume>:<page-range>556&#x02013;61</page-range>.</mixed-citation></ref><ref id="B294"><label>294</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Soncin</surname><given-names>S</given-names></name><name><surname>Brien</surname><given-names>DC</given-names></name><name><surname>Coe</surname><given-names>BC</given-names></name><name><surname>Marin</surname><given-names>A</given-names></name><name><surname>Munoz</surname><given-names>DP</given-names></name></person-group>. <article-title>Contrasting emotion processing and executive functioning in attention-defi- cit/hyperactivity disorder and bipolar disorder</article-title>. <source>Behav Neurosci</source>. (<year>2016</year>) <volume>130</volume>:<page-range>531&#x02013;43</page-range>.</mixed-citation></ref><ref id="B295"><label>295</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yep</surname><given-names>R</given-names></name><name><surname>Soncin</surname><given-names>S</given-names></name><name><surname>Brien</surname><given-names>DC</given-names></name><name><surname>Coe</surname><given-names>BC</given-names></name><name><surname>Marin</surname><given-names>A</given-names></name><name><surname>Munoz</surname><given-names>DP</given-names></name></person-group>. <article-title>Using an emotional saccade task to characterize executive functioning and emotion processing in attention-deficit hyperactivity disorder and bipolar disorder</article-title>. <source>Brain Cogn</source>. (<year>2018</year>) <volume>124</volume>:<fpage>1</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">29698907</pub-id>
</mixed-citation></ref><ref id="B296"><label>296</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berk</surname><given-names>M</given-names></name></person-group>. <article-title>Biomarkers in psychiatric disorders: status quo, impediments and facilitators</article-title>. <source>World Psychiatry</source>. (<year>2023</year>) <volume>22</volume>:<fpage>174</fpage>.<pub-id pub-id-type="pmid">37159364</pub-id>
</mixed-citation></ref><ref id="B297"><label>297</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>AF</given-names></name><name><surname>K&#x000f6;hler</surname><given-names>CA</given-names></name><name><surname>Fernandes</surname><given-names>BS</given-names></name><name><surname>Quevedo</surname><given-names>J</given-names></name><name><surname>Miskowiak</surname><given-names>KW</given-names></name><name><surname>Brunoni</surname><given-names>AR</given-names></name><etal/></person-group>. <article-title>Bias in emerging biomarkers for bipolar disorder</article-title>. <source>psychol Med</source>. (<year>2016</year>) <volume>46</volume>:<page-range>2287&#x02013;97</page-range>.</mixed-citation></ref><ref id="B298"><label>298</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Manchia</surname><given-names>M</given-names></name><name><surname>Vieta</surname><given-names>E</given-names></name><name><surname>Smeland</surname><given-names>OB</given-names></name><name><surname>Altimus</surname><given-names>C</given-names></name><name><surname>Bechdolf</surname><given-names>A</given-names></name><name><surname>Bellivier</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Translating big data to better treatment in bipolar disorder-a manifesto for coordinated action</article-title>. <source>Eur Neuropsychopharmacol</source>. (<year>2020</year>) <volume>36</volume>:<page-range>121&#x02013;36</page-range>.</mixed-citation></ref><ref id="B299"><label>299</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vallarino</surname><given-names>M</given-names></name><name><surname>Henry</surname><given-names>C</given-names></name><name><surname>Etain</surname><given-names>B</given-names></name><name><surname>Gehue</surname><given-names>LJ</given-names></name><name><surname>Macneil</surname><given-names>C</given-names></name><name><surname>Scott</surname><given-names>EM</given-names></name><etal/></person-group>. <article-title>An evidence map of psychosocial interventions for the earliest stages of bipolar disorder</article-title>. <source>Lancet Psychiatry</source>. (<year>2015</year>) <volume>2</volume>:<page-range>548&#x02013;63</page-range>.</mixed-citation></ref><ref id="B300"><label>300</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vieta</surname><given-names>E</given-names></name><name><surname>Angst</surname><given-names>J</given-names></name></person-group>. <article-title>Bipolar disorder cohort studies: Crucial, but underfunded</article-title>. <source>Eur Neuropsychopharmacol</source>. (<year>2021</year>) <volume>47</volume>:<page-range>3&#x02013;5</page-range>. doi:&#x000a0;<pub-id pub-id-type="doi">10.1016/j.euroneuro.2021.03.008</pub-id>
</mixed-citation></ref><ref id="B301"><label>301</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mansur</surname><given-names>RB</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>McIntyre</surname><given-names>RS</given-names></name><name><surname>Brietzke</surname><given-names>E</given-names></name></person-group>. <article-title>What is bipolar disorder? A disease model of dysregulated energy expenditure</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2020</year>) <volume>113</volume>:<page-range>529&#x02013;45</page-range>.</mixed-citation></ref><ref id="B302"><label>302</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harrison</surname><given-names>PJ</given-names></name><name><surname>Colbourne</surname><given-names>L</given-names></name><name><surname>Harrison</surname><given-names>CH</given-names></name></person-group>. <article-title>The neuropathology of bipolar disorder: systematic review and meta-analysis</article-title>. <source>Mol Psychiatry</source>. (<year>2020</year>) <volume>25</volume>:<page-range>1787&#x02013;808</page-range>.</mixed-citation></ref><ref id="B303"><label>303</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scangos</surname><given-names>KW</given-names></name><name><surname>State</surname><given-names>MW</given-names></name><name><surname>Miller</surname><given-names>AH</given-names></name><name><surname>Baker</surname><given-names>JT</given-names></name><name><surname>Williams</surname><given-names>LM</given-names></name></person-group>. <article-title>New and emerging approaches to treat psychiatric disorders</article-title>. <source>Nat Med</source>. (<year>2023</year>) <volume>29</volume>:<page-range>317&#x02013;33</page-range>.</mixed-citation></ref></ref-list></back></article>